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Bacteria of the genus Helicobacter are related to gastrointestinal and hepatic 
disease in humans. Helicobacter pylori infects the gastric mucosa of a large 
percentage of the human population and has been reported to cause gastric ulcer and 
stomach cancer. Other Helicobacter related species, such as the enterohepatic 
Helicobacter pullorum, although firstly discovered in chickens are now known to be 
associated with human digestive disorders such as gastroenteritis, inflammatory 
bowel disease, hepatobiliary disease and hepatic cancer.  
During host invasion, all pathogens are exposed to the antimicrobials 
produced by the innate immunity’s phagocytes such as nitric oxide (NO) and derivate 
reactive nitrogen species (RNS), which constitute one of the main strategies 
employed by the host to eliminate pathogens. Due to the high importance of H. pylori 
as a human pathogen and the more recent recognition of H. pullorum as an emergent 
human pathogen, the so far unknown mechanisms used by these bacteria to 
circumvent the innate immune system need to be addressed. Therefore, the objectives 
of this work were: i) investigation of the role of H. pylori nitroreductases in the 
defence against the host induced nitrosative stress, ii) evaluation of the sensitivity of 
H. pullorum to antimicrobials, iii) assessment of the ability of H. pullorum to activate, 
infect and survive within macrophages, and iv) identification and characterization of 
the enzymes putatively involved in H. pullorum defence against host antimicrobials.  
H. pylori nitroreductases activate metronidazole, which is the antibiotic 
commonly used for H. pylori treatment. In this work, a new function of these enzymes 
was explored. For this purpose, an H. pylori strain deleted in the nitroreductase frxA 
gene was constructed, its phenotype and the expression of the frxA gene was analysed 
under NO stress conditions. Inactivation of the frxA gene resulted in a strain that is 
more sensitive to nitrosative stress. Furthermore, H. pylori frxA is induced in 
response to nitrosative stress generators. Studies on the capacity of the wild type and 
frxA deficient cell extracts to degrade the toxic compound nitrosoglutathione (GSNO) 
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showed that in the absence of frxA H. pylori cells have significantly lower GSNO 
reductase activity. Accordingly, experiments on theactivity of the purified FrxA 
protein towards nitrocompounds and S-nitrosothiols revealed that not only FrxA 
reduces metronidazole, but exhibits a GSNO reductase activity. The interaction of H. 
pylori frxA mutant with macrophages and mice was also analysed. FrxA was shown 
to contribute to the survival of H. pylori within macrophages and to the bacterium´s 
virulence during mice colonization.  
The resistance of the enterohepatic H. pullorum to nitrosative stress was also 
analysed. H. pullorum was exposed at different growth phases to nitrosative stress 
generated by several NO donors. Treatment with NO lowered the H. pullorum 
viability, in a growth-phase-dependent manner and, H. pullorum cells suffered a 
decrease in the mean bacterial cell size. In the second part of this study, the interaction 
between H. pullorum and host cells was analysed. Confocal microscopy revealed that 
H. pullorum is internalized by murine macrophages, triggering the production of NO 
that promoted phagocytosis and bacterial clearance. I teraction between H. pullorum 
and macrophages was shown to stimulate secretion of pro-inflammatory cytokines, 
such as TNF-α, IL-1β, IL-6 and MIP-2, indicating that H. pullorum triggers a host 
inflammatory response.  
To identify the nitrosative protective genes of H. pullorum a sequence 
comparison analysis of its genome was performed. Five gene products were selected 
and studied. To this end, their expression pattern was analysed, mutant strains were 
constructed and characterized under stressed conditions. Furthermore, the survival of 
the mutants was studied in phagocytic cells such as m crophages. Finally, all the 
respective proteins were recombinantly produced, purified and biochemically 
characterized. We show that H. pullorum contains two haemoglobins, namely, a 
single domain and a truncated haemoglobin, which genes are induced by GSNO. 
Complementation studies showed that the H. pullorum haemoglobins abolished the 
nitrosative stress sensitive phenotype of an E. coli flavohaemoglobin mutant. 
Furthermore, H. pullorum single domain globin increased the resistance to NO stress 
and improved the ability of H. pullorum to survive within macrophages. On the 
contrary, the deletion of the truncated globin did not alter the sensitivity of H. 
pullorum to nitrosative stress and macrophage killing.  
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The analysis of H. pullorum genome also revealed the presence of homologs 
of peroxiredoxins, named Prx1, Prx2 and Prx3. Expression of prx1 was not modified 
by oxidative and nitrosative stresses. Prx2 and prx3 were induced in response to 
peroxynitrite and hydrogen peroxide, respectively. Whereas the prx1 mutant did not 
show susceptibility to oxidative and nitrosative stre ses the prx2 mutant showed a 
significant growth defect even under normal growth conditions. H. pullorum prx1 
mutant showed a survival to macrophage killing similar to the wild type strain. 
Furthermore, purified H. pullorum peroxiredoxins were shown to detoxify 
peroxynitrite, having Prx3 the highest activity. Therefore it was concluded that 
peroxiredoxins contribute to nitrosative stress protection of H. pullorum. Data also 
suggest that prx3 may be an essential gene of H. pullorum. 
In summary, H. pylori nitroreductase FrxA was shown to protect from 
nitrosative stress injury due to its ability to reduce S-nitrosothiols, and to contribute 
for the pathogen´s virulence. H pullorum was shown for the first time to activate and 
to be internalised by macrophages, and to have a decreased viability when exposed 
to NO producing macrophages. Furthermore, proteins that confer resistance to H. 
pullorum when facing RNS, such as a single domain haemoglobin, were unveiled.  
Altogether this study contributed to further understand the defence mechanisms used 
by Helicobacter species against the antimicrobials produced by the host immunity. 
This study also provided new insights about the ability of H. pullorum to trigger host 












As bactérias do género Helicobacter estão relacionadas com doenças 
gastrintestinais e hepáticas em seres humanos. Helicobacter pylori infecta a mucosa 
gástrica de uma grande percentagem da população humana, e é o agente responsável 
pelo desenvolvimento de úlcera gástrica e cancro do estômago. Outras bactérias do 
género Helicobacter, tal como a espécie enterohepática Helicobacter pullorum, 
embora de origem aviária, tem sido associada a doenças digestivas humanas como 
gastroenterite, doença inflamatória do intestino, dença hepatobiliar e cancro 
hepático. 
Durante a invasão do hospedeiro, os organismos patogénicos são expostos a 
agentes antimicrobianos produzidos pelos fagócitos d  sistema imune inato, 
nomeadamente o óxido nítrico (NO) e as espécies reativas de nitrogénio (ERN) 
derivadas, que constituem uma das principais estratégias do hospedeiro para eliminar 
os organismos patogénicos. Devido à elevada importância de H. pylori como um 
patogénico humano e ao recente reconhecimento de H. pullorum como um agente 
patogénico humano emergente, os mecanismos utilizados por estas bactérias para 
contornar o sistema imune inato, que embora até agora desconhecidos, necessitam de 
ser compreendidas. Assim, os objetivos deste trabalho incluíram: i) investigação do 
papel das nitroredutases de H. pylori na defesa contra o stress nitrosativo gerado pelo 
hospedeiro, ii) avaliação da sensibilidade de H. pullorum aos agentes 
antimicrobianos, iii) apreciação da capacidade de H. pullorum para ativar, infetar e 
sobreviver dentro dos macrófagos, e iv) identificação e caracterização de enzimas 
com potencial para estar envolvidas na defesa de H. pullorum contra os agentes 
antimicrobianos produzidos pelo hospedeiro. 
As nitroredutases de H. pylori ativam o metronidazol, que é o antibiótico 
normalmente usado para o tratamento de H. pylori. Neste estudo, uma nova função 
para estas enzimas foi explorada. Para este efeito, foi construída uma estirpe de H.
pylori deletada no gene da nitroredutase frxA, o seu fenótipo e a expressão do gene 
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frxA foi analisada sob condições de stress. A inativação do gene frxA resultou numa 
estirpe que é mais sensível ao stress nitrosativo. Verifica-se também que o gene frxA 
de H. pylori é induzido em resposta aos agentes geradores de stress nitrosativo. 
Estudos sobre a capacidade de degradação do compost tóxico nitrosoglutationa 
(GSNO) na estirpe selvagem e na estirpe deficiente m frxA mostraram que na 
ausência de frxA as células têm significativamente menor capacidade para reduzir 
GSNO. Assim, as atividades enzimáticas da proteína FrxA para nitrocompostos e 
para S-nitrosotióis foram realizadas, e revelaram que FrxA não só reduz metronidazol 
mas exibe também uma atividade de GSNO redutase. A interação da estirpe de H. 
pylori mutada no gene frxA com macrófagos e ratinhos foi também analisada. FrxA
mostrou contribuir para a sobrevivência de H. pylori no interior de macrófagos e para 
a virulência da bactéria durante a colonização de ratinhos. 
A resistência da bactéria enterohepática H. pullorum ao stress nitrosativo foi 
também analisada. Em diferentes fases do seu crescimento, H. pullorum foi exposta 
ao stress nitrosativo gerado por vários dadores de NO. O tratamento com NO reduziu 
a viabilidade de H. pullorum, de um modo dependente da fase de crescimento 
bacteriana, e promoveu uma diminuição no tamanho médio das células de H. 
pullorum. Na segunda parte deste estudo, foi analisada a inter ção entre as células de 
H. pullorum e do hospedeiro. Experiências de microscopia confoal mostraram que 
H. pullorum é internalizada por macrófagos de ratinho e que induz a produção de 
NO, que por sua vez promove a fagocitose e a eliminação da bactéria. A interação 
entre H. pullorum e os macrófagos resultou na indução da secreção de citoquinas pró-
inflamatórias, tais como TNF-α, IL-1β, IL-6 e de MIP-2, indicando que a H. pullorum 
desencadeia uma resposta inflamatória no hospedeiro. 
A análise da comparação de sequências do genoma de H. pullorum permitiu 
identificar cinco genes envolvidos na proteção de H. pullorum contra o stress 
nitrosativo. O padrão de expressão destes genes foi analisado e as estirpes mutantes 
nestes genes foram construídas e caracterizadas em condições de stress. Além disso, 
a sobrevivência dos mutantes foi estudada em células fagocíticas, tais como 
macrófagos. Por último, as respetivas proteínas recombinantes foram purificadas e 
caracterizadas bioquimicamente. Mostrou-se que H. pullorum contém duas 
hemoglobinas, nomeadamente uma hemoglobina “single-domain” e uma 
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hemoglobina truncada, cujos genes são induzidos por GSNO. Estudos de 
complementação mostraram que a expressão das hemoglobinas de H. pullorum 
suprime o fenótipo de sensibilidaade ao stress nitrosa ivo de uma estirpe de E. coli 
deletada no gene flavohemoglobina. Além disso, a hemoglobina “single-domain” de 
H. pullorum aumenta a resistência ao stress nitrosativo e melhora a capacidade de H.
pullorum para sobreviver em macrófagos. Pelo contrário, a ausência da hemoglobina 
truncada não alterou a sensibilidade de H. pullorum ao stress nitrosativo e aos 
macrófagos. 
A análise do genoma de H. pullorum revelou também a presença de 
potenciais homólogos de peroxiredoxinas, que foram denominados Prx1, Prx2 e 
Prx3. O estudo da expressão do gene prx1 mostrou que este não é alterada pelos 
stresses oxidativo e nitrosativo. Os genes prx2 e prx3 são induzidos em resposta ao 
peroxinitrito e ao peróxido de hidrogénio, respetivamente. Enquanto que o mutante 
prx1 não apresentou suscetibilidade aos stresses oxidativo e nitrosativo, o mutante 
prx2 apresenta um crescimento deficiente mesmo sob condições de não stress. A 
estirpe de H. pullorum mutada no gene prx1 tem níveis de sobrevivência no interior 
de macrófagos semelhantes aos da estirpe selvagem. As peroxiredoxinas de H. 
pullorum purificadas mostraram ser destoxificantes de peroxinitrito, tendo Prx3 a 
maior atividade enzimática. Por conseguinte, conclui-se que as peroxiredoxinas 
contribuem para a proteção de H. pullorum contra o stress nitrosativo. Os dados 
também sugerem que prx3 deverá ser um gene essencial para H. pullorum. 
Em resumo, foi mostrado que a nitroredutase FrxA de H. pylori protege a 
bactéria de lesões geradas pelo stress nitrosativo, de ido à sua capacidade de reduzir 
a S-nitrosotióis, e contribuiu também para a virulência do organismo patogénico. 
Também pela primeira vez, foi mostrado que H. pullorum é internalizada por 
macrófagos e promove a sua ativação. H. pullorum mostrou ter uma viabilidade 
diminuída quando exposta ao NO produzido pelos macróf gos. As proteínas que 
conferem resistência a H. pullorum contra o stress nitrosativo, tal como a 
hemoglobina “single-domain”, foram estudadas. 
Este estudo contribuiu para um melhor conhecimento dos mecanismos de defesa 
utilizados pelas espécies Helicobacter contra os agentes antimicrobianos produzidos 
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pelo sistema imunitário do hospedeiro. Este trabalho forneceu também novos dados 
acerca da capacidade de H. pullorum para promover uma inflamação no hospedeiro 
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1.1 Innate and Adaptive Immunity  
The mammalian immune system is divided into two distinct yet interrelated 
subsystems: the innate and the adaptive immunity. The innate immunity operates at 
the early stages of infection through nonspecific re ognition of a pathogen and 
subsequent activation of the adaptive immune response. The cells involved in innate 
immunity are: macrophages, dendritic cells, mast cells, neutrophils, eosinophils, 
natural killer, and epithelial cells. Contrary to the innate immunity, the adaptive 
immunity involves specific recognition of a pathogen, due to a vast repertoire of 
antigen-specific recognition receptors of its effector cells, the T and B lymphocytes. 
A specific property of the adaptive immunity is its memory, which is generated after 
a first contact of B and T cells with the pathogen that leads to their differentiation in 
memory B cells and T cells. These memory cells are long lived and in subsequent 
encounters with the same pathogen originate a faster nd enhanced immune response. 
Depending on the type of cells employed, the adaptive immunity can also be divided 
in type 1 immunity, which is usually involved in the elimination of bacteria, viruses 
and other microbes and type 2 immunity, mainly involved in multicellular parasites 
and allergens responses (1, 2). 
The innate immune system uses several pattern recognition receptors, like 
Toll-like receptors (TLRs), C-type lectin receptors and NOD-like receptors to detect 
common structural and functional features associated with different classes of 
microorganisms, the so-called pathogen associated molecular patterns (PAMPs). In 
a general view, the immune system presents the following common principle to 
respond to an invader organism: PAMPs recognition by the innate immunity results 
in a primary innate response which includes the production of a first set of cytokines 
(level 1 cytokines). The profiles of level 1 cytokines produced depend on several 
factors, such as the compartment in which the bacteri l PAMP is recognized, 
microorganism viability and virulence, which leads to different types and intensities 
of the adaptive and effector responses. For example, bacteria detected in the lumen 
of the intestine usually do not trigger inflammation, whereas those that have crossed 
the epithelium induce a local inflammation, and bacteria in the bloodstream, which 
represents a higher level of danger for the host, originate a strong systemic response. 










Then, level 1 cytokines trigger specific B lymphocytes recruitment and development 
of specific T helper (Th) phenotypes. Once activated, adaptive cells, produce a 
second set of cytokines (level 2 cytokines) that poentiate the innate effector 
responses (1). In the case of type 1 immune responses, which are related to bacterial 
elimination, level 1 cytokines produced include interleukin (IL)-12, IL-23, IL-6 and 
IL-1β and level 2 cytokines include interferon (INF)-γ, IL-17 and IL-22 (1). 
Phagocytosis is one of the most important effector mechanisms of the innate 
immunity to eliminate pathogens. Phagocytosis consists in the recognition, ingestion, 
digestion, and elimination of microorganisms, “non-self” particles and damaged or 
apoptotic cells from the host. Receptor-mediated internalization occurs through an 
actin-dependent zippering of the phagocyte membrane around the antigen, forming a 
cup that leads to progressive microorganism engulfment in a phagocytic vacuole or 
phagosome. This compartment then interacts and fuses sequentially with early 
endosomes, late endosomes and finally with lysosome, culminating in the formation 
of the phagolysosome. These vesicles provide a closed hostile environment to 
microorganisms, as they are exposed to low pH, low ir n and nutrient availability, 
and to an array of bactericidal molecules such as antimicrobial peptides, reactive 
oxygen species (ROS), produced by the phagocyte nicoti amide adenine dinucleotide 
phosphate (NADPH) oxidase (NOX), and reactive nitrogen species (RNS) generated 
by the inducible nitic oxide synthase (iNOS). When bacterial enzymatic defences are 
not enough to completely scavenge the ROS and RNS, the so-called oxidative and 
nitrosative stresses, these chemical species react with bacterial biomolecules causing 
their damage (see below). In addition to their role in microorganisms’ engulfment 
and killing, phagocytes are also responsible to present the digested microorganisms 
to lymphocytes to activate the adaptive response (3-6). In particular, dendritic cells 
play an important role in directing the nature of the adaptive immune response, since 
these cells are the main responsible for the priming of naive T cells in effector T cells, 
such as Th1, Th17, and Th2 through antigen presentatio  nd also by co-stimulatory 
signals and T cell inducing cytokines production. On the contrary, when dendritic 
cells receive tolerance-promoting signals these cells play important roles in establish 
and maintain the immunological tolerance by inducing the priming of regulatory T 





The ROS and RNS production has been shown to be essential for efficient 
bacterial killing. For example, the deletion in mice of either iNOS or NOX resulted 
in animals more susceptible to infection by different pathogens (8-12), and, the 
deletion of the two enzymes leads to a substantial mice death caused by spontaneous 
infections arising from endogenous flora (13). Furthe more, defects in human genes 
that encode different subunits of NOX result in chronic granulomatous disease, which 
is characterized by the occurrence of recurrent infections and a reduced life 
expectancy (14).  
 
1.2 Oxidative and nitrosative stresses generated in phagocytes 
The generation of ROS in phagocytes is initiated by NOX, through the one 
electron reduction of oxygen to the high reactive radical superoxide in the presence 
of NADPH. Activation of NOX occurs in response to binding of microorganisms or 
soluble inflammatory mediators to specific receptors n the phagocyte and involves 
translocation and assembly of several NOX cytosolic components (p40phox, 
p47phox, p67phox, and the Rho GTPase, Rac) to the NOX membrane-bound 
flavocytochrome b558 complex (p91phox-p22phox) present in the granules fused to 
phagosomes (15, 16). The generation of superoxide leads to the production of others 
ROS. Namely, a further one electron reduction of superoxide catalysed by the 
scavenger enzyme superoxide dismutase (Sod) (17, 18) or the spontaneous 
dismutation of superoxide with another superoxide molecule, originates hydrogen 
peroxide (Reaction 1.1).  
Hydrogen peroxide is next converted into the highly reactive hydroxyl 
radical and hydroxide ion by the iron-catalysed Fenton reaction (Reaction 1.2) or 
used by myeloperoxidase (MPO) together with chloride in neutrophils to synthesize 
the highly toxic hypochlorous acid (Reaction 1.3) (Figure 1.1) (19). In addition, the 
hydroxyl radical is generated by the reaction of superoxide with hypochlorous acid 
(Reaction 1.4).  
 










 Reaction 1.1  2O2- + 2H+→H2O2 + O2 
 Reaction 1.2  H2O2 + Fe2+ → OH• + OH- + Fe3+ 
 Reaction 1.3  Cl- + H2O2 → OCl- + H2O 





Figure 1.1 Generation of ROS and hypochlorous acid in biological systems. Adapted 
from (20). 
 
Nitrosative stress is generated by nitric oxide (NO) and derived species. NO 
is a diatomic gas that is soluble in aqueous systems and freely diffusible across 
biological membranes. Furthermore, NO is a radical th t stabilizes its unpaired 
electron by reacting with species containing other unpaired electrons or by interacting 
with the d-orbitals of transition metals (21, 22). In animal tissues, NO is generated 
enzymatically by nitric oxide synthases (NOS), which n the presence of NADPH, 
convert L-arginine and oxygen into L-citrulline and NO (23). There are three types 
of NOS: two constitutively expressed, the endothelial and neuronal NOS, and an 
inducible enzyme, iNOS. The latter, is expressed in phagocytes and is mainly 
regulated at the transcriptional level, particularly, in response to microorganisms and 
pro-inflammatory molecules (24).  
NO is not particularly susceptible to oxidation or reduction. Instead, NO 
reacts: i) with oxygen species such as superoxide and molecular oxygen to form 
several types of RNS; ii) directly with the formed RNS; and iii) directly with metal 
centres. In particular, the reaction of NO with oxygen results in the generation of the 
strong oxidant radical nitrogen dioxide, which by reacting with another NO molecule 
gives dinitrogen trioxide that in aqueous systems reacts with water to give two 





the potent oxidant peroxynitrite (Reaction 1.8), which may decompose to nitrogen 
dioxide and hydroxyl radical, and that in the presence of carbon dioxide is converted 
to nitrate and carbonate (25). 
 Reaction 1.5  2NO + O2 → 2NO2 
 Reaction 1.6  NO + NO2 → N2O3 
 Reaction 1.7  N2O3 + H2O → 2NO2-+ 2H+ 
 Reaction 1.8  NO + O2- → ONOO- 
 
 
1.3 Biological targets of oxidative and nitrosative stress 
The effect of ROS and NO in biological systems is related to its 
concentrations. Moderate quantities of ROS have important regulatory functions in 
several cellular processes, such as cardiovascular function (26), cell cycle (27) and 
cell survival (28). In similarity, at concentrations as low as the ones produced by the 
constitutive neuronal and endothelial NOS, NO has been shown to be involved in 
biological processes such as signalling, vasodilatation, inhibition of platelet 
aggregation, blood pressure regulation and neurotransmission. On the contrary, when 
produced at high concentrations, NO, derived RNS and ROS, have bacteriostatic and 
bactericidal properties, promoting DNA damage, lipid eroxidation and inactivation 
of key metabolic enzyme (21-23).  
The most common forms of damages in DNA by oxidative stress are strand 
breaks caused by the attack of hydroxyl radicals to nucleotide sugar moieties and 
formation of 8-oxoguanine generated by guanine oxidation (29). It has been shown 
that some RNS, such as nitrogen dioxide, nitrogen trioxide and peroxynitrite, can also 
directly damage DNA through one-electron oxidation, causing several DNA lesions 
such as DNA bases deamination and strand breaks (30, 31). 
Relatively to lipids, among the ROS, superoxide andhy roxyl radical are 
able to initiate the process of lipid peroxidation i  membranes, damaging 
polyunsaturated fatty acids, which increases the membrane fluidity and causes loss 
of function (29). Similarity, peroxynitrite and nitrogen dioxide are strong oxidants 
capable of initiating lipid peroxidation (32, 33). Amino acid residues such as 










cysteine, methionine, tyrosine, phenylalanine and tryptophan react with ROS, NO 
and RNS leading to functional modifications of proteins (20, 25, 34). Due to the high 
reactivity of their thiol groups, cysteines are the protein residues most affected. 
Cysteine thiols are firstly reversibly oxidized to protein disulfides and then 
irreversibly overoxidized to sulfinic (R-SO2H) or sulfonic (R-SO3H) acids by ROS 
(20). The reaction between cysteine and RNS or NO leads to the formation of 
reversible S-nitrosothiols by two mechanisms. In the first mechanism, thiolates in 
redox active cysteines are strong nucleophiles that react with the nitrosonium cation 
to form S-nitrosothiols. Transnitrosation reactions from low-molecular weight S-
nitrosothiols, dinitrosyl iron complexes (DNICs) (see below), and dinitrogen trioxide 
are the donors of nitrosonium. In the second, S-nitrosothiols are generated through 
the reaction of thiyl and NO radicals. Nitrogen dioxide is proposed to mediate the 
abstraction of an electron from the thiol to form the thiyl radical (Figure 1.2) (35). 
Some bacterial cells use low molecular peptides, as thiol-redox buffer, to maintain 
the reduced state and alleviate the nitrosative stres  within a cell. Glutathione, for 
example, is a low molecular weight tripeptide composed by glutamate, cysteine and 
glycine that can be converted to S-nitrosoglutathione (GSNO), and then back 
converted to glutathione by endogenous GSNO reductases (also known as alcohol 
dehydrogenase 3, class III alcohol dehydrogenase and glutathione-dependent 
formaldehyde dehydrogenase) or by the thioredoxin system (36), with the release of 
less toxic products. However, the generation of large amounts of NO in mammalian 
cells leads to the formation of large quantities of GSNO molecules, which are 
nitrosative stress generators by performing nitrosonium groups transfer to bacterial 
protein thiols (20, 35). Another posttranslational protein modification formed in the 
presence of NO is nitrotyrosine (Tyr-NO2). Peroxynitrite, for example, have shown 
to react with tyrosine residues of some enzymes such as glutamine synthase (37, 38) 
and ribonucleotide reductase (39), leading to the formation of nitrotyrosine and to 







Figure 1.2 Biochemistry of S-nitrosothiols formation in biological systems (35). 
 
Iron-sulphur (Fe-S) clusters are targets of ROS andRNS. Hydrogen 
peroxide oxidizes solvent exposed 4Fe-4S clusters of red x enzymes resulting in the 
loss of one or more iron ions, and consequent inactivation of the enzymes. Moreover, 
the release of free iron contributes to increase the oxidative stress via the Fenton 
reaction (19). NO reaction with protein Fe-S clusters generates DNICs, which are 
shown to inhibit the activity of Fe-S cluster contai ing enzymes such as aconitase, 
nicotinamide adenine dinucleotide (NADH) and succinate dehydrogenases (40, 41). 
Moreover, as stated above, DNICs and haem-bond NO groups also mediate the 
formation of S-nitrosothiols through transnitrosation of nitrosonium equivalents from 
nitrosylated metals to protein thiols (42). Additionally, NO reacts readily with haem 
iron centers of proteins like cytochrome bd or bo’ complexes, the two terminal 
oxidases in Escherichia coli, inhibiting oxygen respiration (43). In the same way, NO 
binds to the haem center of catalase inhibiting its function (41, 44).  
In response to the nitrosative and oxidative stresses, bacterial pathogens 
have evolved mechanisms to sense oxygen and NO and respond through defensive 
mechanisms that detoxify ROS and RNS and repair damaged cell components (45) 
(see chapter III). Bacterial nitroreductases, globins and peroxiredoxins (see chapter 
III, section 3.3-3.5) that have a protective role on Helicobacter were studied in this 
thesis and are presented in chapters IV and VI. 
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2.1 General characteristics and classification 
The Helicobacter genus belongs to the class Epsilonproteobacteria, order 
Campylobacterales, and family Helicobacteraceae. The genus is composed of 
Gram-negative, microaerobic, non-spore-forming bacteria with curved, spiral or 
fusiform morphology, typically with 0.2 to 1.2 μm diameter and 1.5 to 10 μm long. 
(1). A coccoid form can also occur in some H licobacter spp. upon accumulation of 
toxic compounds in the culture media, by extended incubations periods and other 
ambient stress factors (2-4). The presence of single or multiple flagella confers 
mobility to Helicobacter cells (1). 
Since the discovery of Helicobacter pylori in 1983 (5) several other 
naturally occurring species have been isolated and characterized. The Helicobacter 
genus comprises currently 36 species (http://www.bacterio.net/helicobacter.html), 
with several other proposed new organisms in the process of being characterized. 
Helicobacter spp. are separated into two categories based on the colonization niche: 
the gastric Helicobacter species (GHS), which colonize the gastric mucosa and 
proximal duodenum of mammals and the enterohepatic Helicobacter species (EHS) 
that colonize the intestine and/or the hepatobiliary system of mammals and birds (6, 
7). However, the same organism can be frequently or occasionally found in both 
niches, as is the case of H. aurati and H. bilis, respectively (8). In addition, due to 
the high level of phenotypic and genotypic similarity of several GHS including H. 
suis, H. felis, H. bizzozeronii, H. salomonis, H. cynogastricus, H. baculiformis and 
H. heilmannii, these organisms were grouped as H. heilmannii sensu lato. The name 
H. heilmannii sensu stricto was attributed to the species isolated in 2012 by Smet 
and co-workers (9) that had been previously nominated s H. heilmannii (10). 
Helicobacter species have a relatively small genome of 1.5-2.5 Mb with a 
guanine plus cytosine (G + C) percentage ranging from 30 to 48%. Until now, the 
complete genome sequence of a small number of Helicobacter species was 
described (1, 8). The current known Helicobacter species, respective hosts and 








Table 2.1 Classification of Helicobacter species, respective hosts and genome projects. 
 
Gastric  Enterohepatic 
Helicobacter 
taxon 
Host Genome Project  
Helicobacter 
taxon 
Host Genome Project 
H. acinonychis Cheetah, lion, tiger (11) 
PRJNA58685, 
PRJNA17251 C  
 H. anseris Wild goose (12) NA 
H. baculiformis Cat (13) NA  H. aurati Hamster (14) NA 
H. bizzozeronii 
Human (15), cat (16), 
fox, lynx (17), dog (18), 
cheetah (19)  
PRJNA68141, 
PRJEA65019 C 
 H. bilis 
Mouse (20), dog, cat 
(21), rat (22), human 
(23) 
PRJNA32489 
H. cetorum Dolphin, whale (24) 
PRJNA162217, 
PRJNA97501 C  
 H. brantae Wild goose (12) NA 
H. cynogastricus Dog (25) NA  H. canadensis 





Cat, dog (28), human 
(29) 
PRJNA61409, 
PRJEA61189 C  
 H. canis 





Cat (9), human, fox, 
lynx (17), dog, non-
human primates (33) 
PRJNA182935 
PRJEB367  
 H. cholecystus Hamster (22) NA 
H. himalayensis Marmot (34) NA  H. cinaedi 
Human, hamster, 
dog, cat (35, 36), 
macaque (37) 
PRJDA162219 
PRJDB88 C  
H. mustelae Ferret, mink (38) 
PRJNA46647, 
PRJEA40677 C  
 H. equorum Horse (39) NA 







Table 2.1 Continuation 
Gastric  Enterohepatic 
Helicobacter 
taxon 
Host Genome Project  
Helicobacter 
taxon 
Host Genome Project 
H. pylori 
Human (42), non-human 
primate (43), cat (16), 
sheep (44), dog (45) 
PRJNA57787, 
PRJNA233 C  
 H. ganmani 
Mouse (46), human 
(47) 
NA 
H. salomonis Dog (48), human (33),  NA  H. hepaticus 
Mouse, gerbil (49, 
50) 
PRJNA57737, 
PRJNA185 C  
H. suis Swine (51), human (52) 
PRJNA62531, 
PRJNA43415 




“H. suncus”  House musk shrew (54) NA  H. marmotae 
Prairie dog (55), 
woodchuck, cat (56) 
NA 




   
 H. mesocricetorum Hamster (58) NA 
   
 H. muridarum Mouse, rat (59) 
PRJNA224116, 
PRJNA261711  
   
 H. pametenis Wild bird, swine (60) 
PRJNA224116, 
PRJNA223085  
   
 H. pullorum 
Human, bird (61-64), 




PRJNA251882   
   
 H. rodentium Mouse (69), rat (70) 
PRJNA224116, 
PRJNA234774  
   
 H. trogontum Rat (71) PRJNA261711  
   










Table 2.1 Continuation 
 Enterohepatic 




Host Genome Project 
    H. valdiviensis Bird (72) NA 
   
 “H. apodemus” Mouse (73) 
PRJNA224116, 
PRJNA261711 
   
 
‘‘ Candidatus H. 
bovis’’  
Cattle (74) NA 




Marmoset (75) NA 




Cat (76) NA 
    
“Helicobacter 
jaachi” 
Marmoset (77) (77) 











Wild mouse (79) NA 
       
“H. 
Winghamensis”  
Human (80) PRJNA32491  
 Proposed new species that are currently in processes of validation are represented within quotation marks; c Complete genome 
sequence available; NA: Non-available genome sequence. The genome project number can be accessed in the site: 






2.2 Clinical Relevance of Helicobacter spp. 
Helicobacter spp. have been linked to gastrointestinal and hepatobiliary 
diseases in humans and in animals. Although H. pylori colonizes the stomach of 
more than half of the worldwide human population, the disease development 
depends on the bacterial virulence components, host susceptibility and 
environmental factors. H. pylori causes chronic gastritis and peptic ulcer disease in 
10%-20% of the positive individuals, and gastric carcinoma and mucosa-associated 
lymphoid tissue (MALT) lymphoma in 1%-3% of the hosts. For this reason, in 
1994, H. pylori was classified as a class I carcinogen (82, 83). Although not very 
well documented, H. pylori has been also associated with gastric diseases in 
animals such as felines (84) and in non-human primates (85). 
Non-pylori GHS and EHS have been isolated from animls with gastric 
and enterohepatic diseases. Infection of the GHS H. suis has been associated with 
gastritis in pigs, while infection by H. mustelae, H. aurati and H. acinonychis has 
been related to gastritis and stomach cancer in ferrets, hamsters, and large felines, 
respectively (8). Concerning EHS pathogenicity in animals, H. pullorum may cause 
enteritis and hepatitis in chickens (86-89), and H. hepaticus, H. bilis and H. 
cholecystus gastrointestinal and hepatobiliary diseases in rodents (22, 90-93). In 
mice experimental infections, H. hepaticus was shown to induce a chronic 
inflammation that may develop in hepatitis, consecutive hepatic dysplasia and 
hepatocellular carcinoma (90, 91). Furthermore, H. canis have been associated with 
intestinal and hepatobiliary disease in cats (31) and dogs (32).  
Non-pylori GHS and EHS infections also occur in humans possibly 
through transmission by contact with infected animals or by meat consumption, as 
is the case of H. pullorum and H. suis (8, 94). 
In fact, the GHS H. suis, H. salomonis, H. felis, H. heilmannii sensu stricto 
and H. bizzozeronii (i.e. H. heilmannii sensu lato) shown to colonize the human 
stomach (Table 2.1). Simultaneous infection of two or more of these species or of a 
mixture of H. heilmannii sensu lato and H. pylori have been observed. Although 
prevalence of H. heilmannii sensu lato is very low (0.2% to 6% depending on the 











ulcers and gastric MALT lymphoma in humans (95, 96). Interestingly, the risk of 
developing tumours seems to be higher among patients nfected with H. heilmannii 
sensu lato when compared with those infected by H. pylori (97).  
EHS have shown to colonize the human intestine and hepatobiliary system 
and to be associated with gastrointestinal and hepatobili ry diseases. In particular, 
H. pullorum (61, 98, 99), H. cinaedi (100), H. fennelliae (41, 101), H. canadensis 
(26), H. winghamensis (80), H. canis (30), and H. ganmani (47) have been 
identified in patients with gastroenteritis, suggesting that infection with these 
species may be involved in the development of this disease. H. pullorum, H. 
hepaticus, H. bilis and H. ganmani that are bile-tolerant, have been shown to 
colonize the human hepatobiliary system and are proposed to be associated with 
chronic liver diseases and hepatic cancer (102-106). Furthermore, H. bilis was 
isolated from the human gallbladder and related with the development of 
gallbladder cancer (23, 107). Some EHS, such as H. pullorum (108, 109) and H. 
cinaedi, (110, 111) were shown to translocate into the systemic circulation and 
cause bacteraemia. H. cinaedi is frequently found in immunocompromised patients 
(112) and linked to other secondary infections such as endocarditis (113), cellulitis 
and arthritis (85-87). The observation that the EHS . hepaticus, H. bilis and H. 
cinaedi induce intestinal bowel disease (IBD)-like illness in rodent 
immunodeficient models suggests a possible role of EHS in human IBD aetiology 
(8, 22, 114). Moreover, H. pullorum, H. fennelliae and Helicobacter canadensis 
DNA was detected in a significantly higher number of IBD patients than in 
controls, suggesting an involvement of these species in IBD (115-117).  
Nevertheless, it is highly probable that the frequency of infections with 
non-pylori Helicobacter spp. is underestimated in humans due to the fastidious 
nature of these species, which require nutrient-rich complex media and long 
incubation times. Furthermore, the phenotypic similarity between member species 
of the genera Helicobacter and Campylobacter leads often to a misidentification 






2.3 Helicobacter pylori  
2.3.1 Characteristics and mechanisms of infection 
H. pylori presents curved to S-shaped rod cells, with 4 to 8unipolar or 
bipolar sheathed flagella (Figure 2.1). Biochemically, H. pylori is characterized as 
urease, catalase, alkaline phosphatase, oxidase positive and nitrate reductase 
negative. H. pylori is resistant to antibiotics such as nalidixic acid an  polymyxin B 
and sensitive to cephalothin (8).  
 
Figure 2.1 Electron micrograph image of H. pylori. Bar corresponds to 0.5 μm. 
Image from (8).  
 
H. pylori is unique in its capacity to colonize the human stomach. The 
bacterium resists to gastric acidity through the loca ized concentration of 
ammonium ions produced by its urease enzyme. Also, the bacterium has evasion 
ability by moving across the lumen and the gastric mucus layer by means of its 
flagella (119). Usually H. pylori adheres to cells’ surface-receptors and does not 
cross the gastric epithelial barrier, being classified as an extracellular organism. 
However, H. pylori can be internalized by epithelial cells (120) or penetrate the 
epithelial barrier and be phagocytized (121). In cotrast to the majority of bacterial 
pathogens, which temporarily cause virulent diseases and are then cleared by the 
immune system, H. pylori is able to induce a continuous immune response leading 











inflammatory cells are constantly being recruited to the infectious foci and produce 
high levels of ROS and RNS, that although aim to eradicate H. pylori also cause 
DNA damage and tissue injury in the host. In fact, high levels of ROS and RNS are 
correlated with host histopathological damage and high H. pylori concentration in 
the stomach mucosa (122, 123).  
The activation of innate and adaptive immunity by H. pylori leads to the 
recruitment to the stomach of dendritic cells, macrophages, neutrophils, mast cells, 
T and B cells. H. pylori infection results in a mixed Th1 and Th17 cell response, 
with Th1 cells secreting high levels of INF-γ, and Th17 cells producing IL-17, 
which enhances IL-8 production. Additionally, Th2 cells were reported to occur at 
the infection foci but at a smaller extent. More recently, Treg, which suppress 
effector T cell proliferation and pro-inflammatory c tokine production, were also 
shown to be involved in the response to H. pylori (124).  
When adherent to the gastric epithelium, H. pylori delivers virulence 
factors into the cytoplasm of the host cells. Some of the H. pylori virulence factors 
are particularly important for the induction of the ost inflammatory response 
regarding generation of oxidative and nitrosative stresses. For example, the H. 
pylori virulence factors neutrophil activating protein A (NapA) and urease are 
primarily responsible for the recruitment of neutrophils to the site of infection and 
for the induction of the neutrophil associated oxidative burst (125, 126). Another H. 
pylori virulence factor is the cytotoxin associated gene A (CagA), which is 
delivered by the type-IV secretion system to the epith lial cells, that among several 
cellular functions like cellular growth and motility disruption is responsible for IL-8 
production that is a chemoattractant of neutrophils (123). Urease is a potent inducer 







Figure 2.2 Principal mechanisms that promote H. pylori continuous inflammation 
in the host stomach. The virulence H. pylori factors CagA, NapA and urease 
promote neutrophils recruitment and oxidative burst. Macrophage iNOS is induced 
by urease leading to the production of NO and RNS. Moreover, H. pylori induces 
apoptosis in macrophages via arginase II (Arg2), ornithine decarboxylase (ODC) 
and spermine oxidase (SMOX) up-regulation. H. pylori interaction with dendritic 
cells results in an increased Treg response and a decreased Th1/Th17 priming. 
Image from (123). 
 
2.3.2 Protective mechanisms against the host response  
H. pylori has been developing strategies to escape the pattern recognition 
receptors of the innate immune cells, to avoid phagocytic killing, and to promote 
evasion from adaptive immunity. In particular, the different structure of the 
lipopolysaccharides (LPS) and flagellin of H. pylori contributes to hinder TLR 
recognition. Similarly to other Gram-negative bacteria, H. pylori LPS is composed 
by a hydrophilic polysaccharide moiety, which contai s an O-specific chain, a core 











acylation of the H. pylori lipid A has been demonstrated to confer lower biological 
activity to this LPS. Furthermore, the fucosylated O side chain of H. pylori LPS 
mimics the human Lewis molecules and other blood-group antigens, which 
contributes to elude TLR4 recognition (128). Also, the specific modification in a 
conserved N-terminal motif of H. pylori flagellin A decreases the level of TLR5 
activation (129, 130). Therefore, H. pylori LPS is 100 to 10,000 times less reactive 
than E. coli LPS (131) for TLR4 activation, and H. pylori flagellin is 1000 times 
less reactive than Salmonella enterica serovar typhimurium flagellin for TLR5 
activation (130).  
To escape phagocytic killing, H. pylori interferes with the normal 
endosomal traffic, fusion and maturation of phagosomes within phagocytes. Several 
groups reported that H. pylori promotes the formation of abnormally big 
phagosomes containing several bacteria, called “megasomes”, which have impaired 
interaction with endosomes and therefore lower killing ability (132). 
H. pylori causes macrophage apoptosis by induction of enzymes produced 
by macrophages such as arginase II (Arg2) (133), ornithine decarboxylase (ODC) 
(134) and spermine oxidase (SMOX) (135) enzymes. Host Arg2 produces L-
ornithine and urea from L-arginine, and ODC produces putrescine from L-ornithine 
that is then converted to the polyamines spermidine a d spermine. Once formed, 
spermine is back-converted to spermidine by SMOX with the release of high levels 
of hydrogen peroxide that causes mitochondrial membrane depolarization, 
cytochrome c release, activation of caspases pathway and macrophage apoptosis 
(133, 135) (Figure 2.2).  
H. pylori is proposed to evade the adaptive immunity by interacting with 
dendritic cells, which renders the latter tolerogenic, preferentially inducing Treg 
differentiation instead of Th1 and Th17 effector responses. Strong Treg and weak 
T-effector responses favour immune tolerance and persist nt H. pylori infection 
(136-138) (Figure 2.2). In addition to its cytotoxic functions, the virulence factor 
vacuolating cytotoxin A (VacA) inhibits the activation and proliferation of T-cells, 





production of IL-2, which is a cytokine required for T-cell viability and 
proliferation (124, 139). 
H. pylori has been described to control nitrosative stress imposed by the 
host through the interference with the mammalian iNOS. Arginase enzymes 
compete with mammalian iNOS for the same L-arginine substrate (140). Gobert 
and co-workers reported that wild type strains of H. pylori inhibit NO production 
by activated macrophages at physiologic concentrations of L-arginine, and that the 
inactivation of the gene rocF, encoding arginase in H. pylori, restored NO 
production by macrophages and rendered the mutant strain susceptible to 
macrophage killing (141). Exposure of macrophages to H. pylori resulted in the 
upregulation of host arg2 and arginase inhibition increased NO production and
promoted H. pylori killing. In the same study, primary macrophages of arg2-/- mice 
infected with H. pylori produced higher levels of iNOS, NO and caused more 
bacterial killing than the macrophages of wild type mice (142). Altogether, 
production of bacterial arginase RocF and host argin se Arg2 allow H. pylori to 
evade the immune response by down-regulating eukaryotic NO levels generated by 
mammalian iNOS. 
 
2.4 Helicobacter pullorum 
Helicobacter pullorum is an EHS, which was first isolated by Stanley and
co-workers in 1994, from the faeces of humans with d arrhoea and from the caeca 
of healthy broiler chickens and liver and intestines of laying hens suffering from 
vibrionic hepatitis (61). H. pullorum was isolated from other birds such as turkeys, 
guinea fowls and psittacines (62-64), and more recently it was described to 
naturally colonize rat (67, 68) and mice (65, 66) (Table 2.1).  
Morphologically, H. pullorum cells are slightly curved rods with one 
unsheathed monopolar flagellum (Figure 2.3). The EHS H. rodentium, H. ganmani, 
H. canadensis and H. mesocricetorum also have unsheathed flagella, which is not 
characteristic in other Helicobacter spp. (8). Biochemically, H. pullorum is 











phosphatase negative. In general, H. pullorum strains grow in the presence of 1% 
bile, are sensitive to nalidixic acid and polymyxin B and resistant to the β-lactam 
antibiotics cephalothin and cefoperazone (61). 
The genome of H. pullorum is estimated to have between 1.7 Mb and 2.1 
Mb and approximately 34% of G + C content (94). Until ow, only five draft 
genome sequences of H. pullorum were published (from strains MIT 98- 5489 
(143), 229336/12, 229254/12, 229334/12, and 229313/12 (94)), (Table 2.1). 
 
 
Figure 2.3 Electron micrograph image of H. pullorum from (61). Bar corresponds 
to 1 μm. 
 
H. pullorum seems to adhere to and invade the human intestinal Caco-2 
cells through a flagellum-microvillus interaction, which allows the bacterium to 
anchor onto epithelial cells and penetrate the host cell membrane causing a 
membrane ruffling effect. In addition, the invasion f H. pullorum of Caco-2 cells 
leads to membrane swelling, microvilli degradation and cellular debris release. By 
proteomic analysis, the H. pullorum type-VI secretion system was suggested to 
participate in host invasion (144). H. pullorum expresses a cytolethal distending 
toxin (CDT). CDT is a virulence factor produced by many Gram-negative 
pathogenic bacteria, in which the catalytic subunit, CdtB, is directed to the nucleus 
of the target cell, promotes DNA damage due to its DNase I-like activity, and 
causes cytotoxic effects such as cell cycle arrest, and ultimately, cell death. H. 
pullorum CDT promotes multiple cellular damage in intestinal epithelial cell lines, 





during the G2/M phase, iii) remodelling of the actin cytoskeleton with the 
formation of lamellipodia (membrane protrusions (145)), iv) disturbance of host 
cell adhesion and v) modulation of the cortactin (a F-actin-binding protein (146)) 
expression (147-149). H. pullorum CDT also was shown to induce the expression 
of genes involved in a Th17 inflammatory response and in cancer development 
(150). H. pullorum LPS presents the highest biological activity within the 
Helicobacter genus and induces nuclear factor-κβ (NF-κβ) activation (151). 
Furthermore, Varon and co-workers showed that H. pullorum cells but not filtered 
H. pullorum supernatants induce IL-8 in gastric and intestinal epithelial cell lines, 
also through NF-κβ activation, suggesting that the bacteria-host cell interaction is 
essential for IL-8 production, possible due to the H. pullorum LPS attachment to the 
receptor host cells (152). Recently, Lutay and co-workers described that H. 
pullorum was able to adhere to a J774A.1 macrophage cell lin  (153); however, so 
far, no data is available concerning macrophage internalization, susceptibly to 
macrophage killing and the mechanisms employed by the bacterium against 
mammalian immune system.  
In this work, the characterization of H. pullorum macrophage interactions, 
bacterium susceptibility to nitrosative stress (Chapter V), and enzymatic defences 
against nitrosative and oxidative stress (Chapter VI) were analysed. 
 
2.5 Treatment and antibiotic resistance 
For H. pylori, the current first line treatment consist in one of the following 
therapies: i) a triple therapy that employs a proton pump inhibitor (PPI) and two 
antibiotics, usually amoxicillin and clarithromycin, used for 10-14 days, ii) a 
quadruple therapy, that combines a PPI with bismuth and metronidazole and 
tetracycline, applied for 10-14 days; iii) a sequential therapy that starts with 
amoxicillin plus a PPI during the first five days and is followed by triple therapy 












Treatment failure is mainly associated with bacterial antibiotic resistance 
and is one of the major problems associated with H. pylori. Although antibiotic 
resistance patterns vary by country, the general perspective is that H. pylori 
resistance to metronidazole is prevalent while resistance to clarithromycin, 
amoxicillin and tetracycline is lower (154).  
At the molecular level, antibiotic resistance of H. pylori has been 
associated with point mutations. Mutations in the gyrase A (gyrA) gene, for 
example, are associated with fluoroquinolone resistance (155) and mutations in the 
23S ribosomal RNA are usually seen in H. pylori clarithromycin resistance strains 
(156).  
The antimicrobial action of metronidazole is dependent on its reductive 
activation by a redox system of the target cell, i.e., nitroimidazole needs to be 
converted to cytotoxic forms through reduction of the nitro group to exert its 
antimicrobial effects (157). The oxygen insensitive nitroreductase RdxA, NAD(P)H 
flavin oxidoreductase FrxA and ferredoxin-like FrxB proteins have been linked 
with metronidazole activation (158, 159). While it is generally accepted that 
resistance to metronidazole in H. pylori is attributed to mutations in the rdxA gene 
(160, 161), the involvement of frxA and frxB mutations in metronidazole resistance 
is still not clear (159, 162). The enzymes nitroreductases will be revised in chapter 
III of this thesis, and in chapter IV, the new role f the nitroreductase FrxA of H. 
pylori as a defence mechanism against nitrosative injury will be addressed. 
Concerning non-pylori Helicobacter spp., an optimal treatment regime was 
not yet developed due to the difficulties in the isolation and culture of these 
organisms. Therefore, there are no recommended guidelines for performing 
susceptibility tests nor for the treatment of diagnosed infections with non-pylori 
Helicobacter spp. Nevertheless, the usual treatment currently employed differs 
between GHS and EHS. For the former, the treatment relies on the conventional 
antimicrobial therapy used for H. pylori (96) and, for the latter, various antibiotics 
such as penicillin, aminoglycosides, carbapenem and fluoroquinolone used 
independently or in combination have been used (163-165).  
The prevalence of antimicrobial resistance of non-pylori Helicobacter spp. 
have been poorly documented. However, as reported for H. pylori, point mutations 





antibiotic resistance. In particular, H. pullorum point mutation in codon 84 of the 
gyrA gene, is associated with a resistant phenotype to cipr floxacin (166) and H. 
cinaedi mutations in codon 84 and/or 88 of gyrA gene are associated with 
fluoroquinolones resistance (163). 
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3.1 Bacterial defences against stress 
Bacteria employ several strategies to protect against the toxic effects of 
ROS and RNS, such as the expression of scavenging enzym s, the impairment of 
ROS and RNS production, and the expression of systems for the maintenance of the 
redox cellular homeostasis and for the repair of damaged DNA and proteins. 
The main scavenging enzymes used by bacteria to counteract the toxic effects of 
ROS are superoxide dismutases (Sods), superoxide reductases (Sors), catalases and 
peroxidases.  
Sods catalyse the superoxide dismutation into oxygen and hydrogen 
peroxide (Reaction 3.1). These enzymes are classified in four groups based on their 
metal co-factor: iron Sod (Fe-Sod), manganese Sod (Mn-Sod), copper-zinc Sod 
(CuZn-Sod), and nickel Sod (Ni-Sod) (1). The periplasmic CuZn-Sod, encoded by 
the sodC gene, has been reported to play an essential role upon infection, as 
bacteria having deletions in sodC are more susceptible to phagocytic killing and 
less virulent than their parental strains (2, 3). Bacteria may have three Sods (e.g. 
E.coli), two Sods (e.g. Staphylococcus aureus) or one Sod like H. pylori. In 
particular, the Sod of H. pylori binds iron (Fe-Sod) and is encoded by the sodB 
gene. While aerobic bacteria use Sod to detoxify superoxide, the anaerobic 
microorganisms utilize a cytoplasmic superoxide reductase, Sor, which is an iron 
binding enzyme. Sors catalyse the one-electron reduction of superoxide to give 
hydrogen peroxide, in the presence of two protons and n external reductant to 
provide the electron (Reaction 3.2). Unlike Sod, no oxygen is produced, which is an 
obvious advantage for anaerobic organisms (4).  
 
 Reaction 3.1:  2O2- + 2H+→H2O2 + O2  
 Reaction 3.2:  O2- + 2H+ + 1e-→ 2H2O2 
 
 











Bacterial catalases and peroxidases remove the product f Sod and Sor, i.e. 
hydrogen peroxide. Catalases are ubiquitous enzymes that decompose hydrogen 
peroxide into water and oxygen (Reaction 3.3). The nature of their cofactor 
classifies catalases into haem and manganese (non-haem) catalases, being the less 
widespread. Although catalases typically perform the ydrogen peroxide 
disproportion reaction (Reaction 3.3), some haem catalases have also peroxidatic 
activity, and are therefore referred as bifunctional catalases or catalase-peroxidases. 
In general, bacterial species express more than one catalase. Catalase is usually a 
cytoplasmic protein; however, some studies suggest that bifunctional catalases are 
secreted to the periplasm in some pathogenic bacteri , including H. pylori, 
enterohaemorrhagic E. coli and Legionella pneumophila (5). Deletion of catalase 
genes has been shown to increase the sensitivity of bacterial cells to millimolar 
levels of hydrogen peroxide (6, 7). 
 
 Reaction 3.3  2H2O2→ 2H2O+ O2 
 
Peroxidases reduce hydrogen peroxide and other toxic peroxides through 
the oxidation of a co-subtract (RH2) (Reaction 3.4). The electron donor varies 
within the peroxidase family of proteins and may be glutathione, thioredoxin, 
NAD(P)H, and cytochrome c. The requirement for a reducing donor, which is not 
necessary in the case of catalases, is a limiting factor for the efficiency of 
peroxidases.  
 
Reaction 3.4  RH2 + H2O2 → R + 2H2O 
 
Peroxidases are divided into thiol-based peroxidases that include 
peroxiredoxins (see below, section 3.5), and non-thiol peroxidases, which contain 
selenium or haem in the catalytic centre. Usually, organisms have several genes 





Interestingly, while the wild type E. coli cells are not saturated by even 
millimolar concentrations of hydrogen peroxide (8), the E. coli cells lacking the 
catalases katG and katE scavenge low concentrations of hydrogen peroxide very
effectively but become saturated from 20 μM of hydrogen peroxide. Furthermore, 
the E. coli mutated in both catalases and alkyl hydroperoxide reductase C genes is 
not able to scavenge hydrogen peroxide (9). Therefore, it has been suggested that 
peroxidases are usually the primary scavengers at low concentrations of hydrogen 
peroxide, while catalase activity predominates at higher concentrations of hydrogen 
peroxide, when peroxidases are saturated due to the slowness of electron delivery 
and/or are inactivated by hyperoxidation (5, 9). 
Regarding nitrosative stress protection, the major bacterial NO detoxifying 
enzymes are NO reductases (NORs), nitrite reductases, flavodiiron proteins and 
microbial globins (see below section 3.4). 
NORs are membrane-bound iron-containing enzymes that reduce NO to 
nitrous oxide (Reaction 3.5). NORs are usually active in the denitrification pathway 
of microorganisms. However, some non-denitrifying bacteria also utilize NOR for 
the detoxification of NO produced by macrophages (10). NORs have been reported 
to play an important role in bacterial nitrosative stress protection as the Neisseria 
meningitidis and Pseudomonas aeruginosa nor mutants are more susceptible to NO, 
NO-generating compounds and macrophage killing in comparison to the wild type 
strains (11-13).  
Nitrite reductases are pentahaemic enzymes that promote the six electron 
reduction of nitrite to ammonium (Reaction 3.6), animportant step of the 
denitrification cycle. Some nitrite reductases also detoxify NO, hydroxylamine 
(H2NOH), and nitrous oxide (14). In E. coli and Haemophilus influenza, the nrfA 
mutant strains are more susceptible to anaerobic NO than te wild type (15, 16). 
Also, Campylobacter jejuni NrfA was suggested to be the periplasmic defence 
against nitrosative stress while the globin Cgb is proposed to protect the 
cytoplasmic compartment (17). 
 











 Reaction 3.5  2NO + 2e- + 2H+ → N2O + H2O  
 Reaction 3.6  NO2-+ 6e- + 8H+ → NH4+ + 2H2O 
Flavodiiron proteins are composed of flavin mononucleotide (FMN) and 
di-iron catalytic domains. Several members of this family have extra domains, such 
as flavorubredoxins, which have an additional non-haem mono-iron rubredoxin 
containing region. Although structurally and mechanistically distinct from the 
denitrifying NOR, flavodiiron proteins also catalyse the reduction of NO to nitrous 
oxide (18). The first evidence of NO detoxification by flavodiiron proteins was 
demonstrated in E. coli and attributed to the norV and norW gene products, which 
encode the E. coli flavorubredoxin or NorV and a cognate oxidoreductase that 
transfers electrons from NADH to NorV (19, 20). Furthermore, E. coli cells lacking 
norVW were shown as attenuated for survival in the presence of macrophages (21). 
Subsequent studies in other organisms have confirmed th  role of flavodiiron 
proteins in nitrosative stress protection by direct NO consumption (22, 23).  
Bacteria also control their intracellular generation of ROS and RNS. Water 
soluble NAD(P)H quinone oxidoreductases are able two fully reduce quinone 
molecules, which are components of the respiratory chain. Contrary to the two-
electron reduction, the one-electron reduction of oxidized quinone generates semi-
quinone radicals, which are able to react with oxygen and form superoxide. Some 
NAD(P)H quinone oxidoreductases such as the mammalian DT-diaphorase (24) 
and the bacterial MdaB of H. pylori (25), ChrR of P. putida (26) and MdaB and 
WrbA of P. aeruginosa (27) were reported to protect cells against oxidative stress 
through the two-electron transfer reduction of oxidize  quinone, avoiding the 
formation of the dangerously reactive semi-quinone int rmediates (28, 29). 
Bacteria also employ low molecular weight thiols and thiol-disulfide 
oxidoreductase systems to maintain the reduced state of he cell. Low molecular 
weight thiols include cysteine, glutathione, coenzyme A, bacillithiol (Bacillus and 
Staphylococcus pecies) and mycothiol (Actinomycetes) (30, 31). The thioredoxin 
system is composed of thioredoxin reductase (TrxR) and thioredoxin (Trx). In this 
system, the oxidized TrxR receives electrons from NADPH and reduces Trx, which 





system consists of glutathione reductase, glutathione and glutaredoxin. The enzyme 
glutathione reductase receives electrons from NADPH and reduces the oxidized 
glutathione that transfers electrons to the oxidize glutaredoxin, and the reduced 
glutaredoxin transfers electrons to the terminal thiol substrates. Due to its disulfide 
reductase activity, the two systems present an important role in the defence of 
bacteria against oxidative and nitrosative stress. However, some bacteria, such as H. 
pylori, lack the glutaredoxin system (32). 
Enzymatic mechanisms that repair oxidized DNA and proteins are also 
operative in bacteria. The methionine sulphoxide reductase (Msr) is an example of 
an enzymatic system that repairs oxidized proteins. In most bacteria, this enzymatic 
system is composed by the MsrA and MsrB proteins, which specifically reduce the 
S- and the R-methionine sulfoxide forms of free and protein-containing oxidized 
methionine residues, respectively. However, in some bacteria, such as 
Streptococcus pneumonia, Neisseria gonorrhoeae and H. pylori, the two enzymes 
are fused in a single protein. The msrA mutants of E. coli (33, 34) and 
Saccharomyces cerevisiae (35) are more susceptible to ROS than the parental 
strains, and the E. coli msrA mutant is also more sensitive to GSNO and nitrite (33). 
The MsrAB of N. gonorrhoeae (36) and S. pneumonia (37) mutants have increased 
susceptibility to ROS. In S. pneumonia the msrAB mutant has enhanced uptake by 
macrophages and attenuated virulence in an acute mouse pneumonia model (37).  
 
3.2 Helicobacter defences against reactive oxygen and nitrogen species 
To protect against the deleterious effects of ROS, H. pylori has been 
reported to encode several enzymes that detoxify ROS such as Sod (38), catalase 
(39), alkyl hydroperoxide reductase C (AhpC), bacteriof ritin comigratory protein 
(Bcp), and thiol peroxidase (Tpx) (40, 41).  
The H. pylori strains lacking the Fe-Sod and the bifunctional haem b 
catalase, corresponding to the sodB and katA mutants, respectively, are significantly 
more sensitive to hydrogen peroxide than the wild type (6, 42). Though H. pylori is 
a microaerophilic organism and is usually cultivated between 3 and 10% of oxygen 











(41), the sodB mutant strain was severely inhibited at above 6% of oxygen. 
Furthermore, the sodB gene is up-regulated upon macrophage infection (43). The 
H. pylori katA mutant is hypersensitive to the oxidative burst produced by 
macrophages (6, 42).  
H. pylori defective in alkyl hydroperoxide reductase C (ahpC) strains were 
obtained under low-oxygen conditions and are highly sensitive to oxidative stress 
generated by organic peroxides and paraquat. At oxygen concentrations where the 
wild type strain was able to grow (3% to 12%), the viability of the ahpC mutant 
strains was strongly impaired (44). 
The H. pylori bacterioferitin comigratory protein (bcp) mutant exhibits 
moderate sensitivity to organic peroxides but is not impaired by hydrogen peroxide 
(40, 41). In addition, the H. pylori cells defective in bcp, as well as in ahpC and in 
the double bcp and ahpC mutant, have higher amounts of lipid hydroperoxides, 
which is the main product of lipid peroxidation. This observation suggests a role for 
these enzymes in protection from the oxidative unsaturated fatty acids-mediated 
toxicity (45). 
When compared to the wild type, the H. pylori thiol peroxidase (tpx) 
mutant strain is markedly sensitive to peroxides and paraquat, and is less able to 
growth under 10 to 15 % of oxygen (41, 46). 
Disruption of any of the above genes in H. pylori results in deficiency or 
attenuation of the ability to colonize mice stomach (25, 40, 43, 46, 47), presenting 
the ahpC and sodB mutants the most severe phenotypes (43, 46). 
In addition to the enzymes that directly detoxify ROS, H. pylori also has 
other proteins involved in oxidative stress resistance, such as the neutrophil 
activating protein A (NapA), NADPH quinone oxidoreductase and thioredoxin 
system.  
The H. pylori neutrophil activating protein A, NapA, which is involved in 
the induction of neutrophil oxidative burst (chapter II, section 2.2.1), is a member 





Dps are iron proteins that form DNA complexes, bind free iron and detoxify 
hydrogen peroxide coupled to ferrous iron oxidation (51, 52). 
The H. pylori napA mutant strain is more sensitive to peroxides, paraquat and 
contains higher intracellular content of free iron a d damaged DNA than the wild 
type. The napA mutant does not grow when cultivated among 7 and 15% of 
oxygen, contrary to the wild type strain (48, 50). Wang and co-workers 
demonstrated that H. pylori NapA binds DNA when the protein is loaded to high 
levels of iron (107). Furthermore, the napA gene is up-regulated in response to the 
loss of the major oxidative stress resistance genes in H. pylori such as sodB, katA, 
ahpC and tpx (49). It was suggested that NapA contributes to the survival of H. 
pylori under oxidative stress conditions due to its ability to bind and protect DNA 
against oxidation and by binding iron therefore preventing the harmful hydroxyl 
radical production by Fenton´s reaction, as observed for Dps proteins (48, 50).  
H. pylori expresses a NADPH quinone oxidoreductase, encoded by the 
mdaB gene that is up-regulated when ahpC and napA are absent. H. pylori mdaB 
mutant is moderately sensitive to peroxides and highly susceptible to atmospheric 
oxygen in comparison to the parental strain. Furthermore, while the wild type strain 
usually growths at 10% of oxygen, the growth of the mdaB mutant is significantly 
inhibited under this condition (25). Both the H. pylori napA and mdaB mutants 
showed an attenuated ability for mice colonization (44).  
The thioredoxin system of H. pylori is constituted by thioredoxins Trx1 
and Trx2, and a thioredoxin reductase TrxR (53). Trx1 and TrxR form a reductase 
system for the H. pylori AhpC, Bcp and Msr enzymes, where the role of Trx2 is 
less clear (32). The H. pylori trx1 mutant is more sensitive to hydrogen peroxide 
and paraquat than the wild type strain, and grows poorly under 10% of oxygen. On 
the other side, the H. pylori trx2 mutant grows very poorly under 10% of oxygen 
and is hypersensitive to cumene hydroperoxide (41).  
H. pylori encodes the universal repair system for oxidatively damaged 
DNA and proteins. Gene knockouts followed by oxidative stress susceptibility and 
mice colonization assays revealed that some H. pylori DNA repairing proteins such 
as endonuclease III (Nth), which excises oxidized pyrimidines (54), glycosidase 











MutY, which specifically remove adenines paired with 8-oxoguanine (55), MutS 
that recognizes and repairs 8-oxoguanine (56), and the helicases recB and recN (57, 
58) and endonuclease ruvC (59) involved in the DNA homologous recombination 
process, are important factors for H. pylori ROS protection upon colonization. Like 
for other bacteria, H. pylori MsrAB reduces the R isoform of methionine sulfoxide 
and is up-regulated in response to hydrogen peroxide (60). The H. pylori msrAB 
mutant strain is more susceptible to hydrogen peroxide, paraquat, and 20% of 
oxygen, and presents a higher level of oxidized proteins and a lower ability to 
colonize mice (61).  
H. pylori also encodes enzymes for NO and RNS detoxification. Saraiva 
and co-workers reported that H. pylori expresses a NO reductase (NorH) enzyme 
encoded by the hp0013 gene. NorH inactivation increases the susceptibility of H. 
pylori to the NO donors dipropylenetriamine (DPTA)-NONOate nd GSNO, and 
decreases the NADPH-dependent NO reduction activity of H. pylori cells. 
Accordingly, the recombinant NorH is a NADPH:NO oxidoreductase. The norH 
mutant is more susceptible to macrophage killing and has decreased ability for mice 
colonization. A phylogenetic analysis revealed thatNorH belongs to a novel family 
of enzymes that are widespread among bacteria (62).  
Some of the proteins that protect H. pylori from oxidative stress seem also 
to protect the bacterium from nitrosative injury. In particular, the H. pylori 
peroxiredoxin AhpC was shown to reduce peroxynitrite to nitrite (63). Also, H. 
pylori defective in methionine sulphoxide reductase msrAB gene is more sensitive 
to GSNO than the wild type strain (61). Consistent with these data, H. pylori msrAB 
is up-regulated in response to GSNO and peroxynitrite (61). Trx1 seems also to be 
involved in H. pylori protection against RNS, as growth of H. pylori trx1 mutant is 
impaired in the presence of GSNO and nitroprusside. It is proposed that the 
protective role of H. pylori Trx1 against nitrosative stress could be due to its ability 
in reducing the AhpC and Msr enzymes (41). 
As described in chapter I, H. hepaticus is an EHS that colonizes rodents 





microaerobic organism that presents an optimal growth at 1% oxygen but still 
grows well at an oxygen concentration up to 6%.  
H. hepaticus enzymatic defences against oxidative stress comprise catalase 
and the peroxiredoxin alkyl hydroperoxide reductase, encoded by katA and tsaA, 
respectively, the DNA binding protein from starved cells (Dps), and NADPH 
quinone reductase (MdaB).  
The H. hepaticus katA mutant is more susceptible to hydrogen peroxide 
than the parental strain, suffering severe DNA fragmentation, and does not survive 
to 6% of oxygen (7, 64).  
The H. hepaticus tsaA mutant is more sensitive to organic peroxides, paraquat, have 
higher content of lipid hydroperoxides and at 4% and 6% of oxygen grows less than 
the wild type. However, in the same study, thesaA mutant was shown to be more 
resistant to hydrogen peroxide and exhibited similar abilities for mice colonization 
than the wild type strain, which was proposed to be du  to a compensatory 
upregulation of katA in the tsaA mutant (65).  
In H. hepaticus, katA and tsaA genes are induced by hydrogen peroxide and under 
iron limiting conditions, through the control of the peroxide regulator (PerR) (64). 
PerR belongs to the ferric uptake regulator (Fur) class of metal-responsive repressor 
proteins that is present in several bacteria (e.g. B. subtilis (66), S. aureus (67), and 
C. jejuni (68)). PerR senses hydrogen peroxide and regulates several genes involved 
in peroxide stress response and haem biosynthesis (69). 
In H. hepaticus, the dps and mdaB mutants are more sensitive to peroxides 
than the wild type strain and have impaired growth at 6% oxygen. Furthermore, the 
dps H. hepaticus mutant present a higher percentage of coccoid or lysed cells when 
exposed to oxidative stress (70) and the mdaB mutant up-expresses the superoxide 
detoxifying sod (71).  
Until now, just one enzyme was described to protect the EHS H. cinaedi 
against ROS, the AhpC. Like in other Helicobacter, deletion of ahpC in H. cinaedi 
decreased the resistance to organic peroxides but increased it to hydrogen peroxide. 
The mutant strain is more susceptible to macrophage killing and had significantly 











reduced colonizing ability of mice. Furthermore, the ahpC H. cinaedi mutant 
displayed a diminished ability to induce a Th1 and Th2 immune response in vivo, as 
the concentration of IgG1 and IgG2a detected in the blood of mice, the serological 
markers for the Th2 and Th1 responses, respectively, was lower upon mice 
infection with the mutant than with the wild type strain (72).  
 
3.3 Nitroreductases 
Nitroreductases are FMN and flavin adenine dinucleotid  (FAD) 
containing enzymes that reduce the nitro groups (NO2-) of a variety of 
nitrocompounds, using NAD(P)H as reducing agents. Nitroreductases are classified 
as oxygen insensitive (type I) and oxygen sensitive (type II). The oxygen 
insensitive or type I nitroreductases catalyse the two electron reduction reaction 
from NAD(P)H to the nitro group, generating different intermediary products, 
either in the presence or absence of oxygen. Oxygen s sitive or type II 
nitroreductases perform a one electron reduction frm NAD(P)H to the nitro group 
generating a nitro anion radical that in the presence of oxygen originates superoxide 
and regenerates the parental nitro group (73, 74). Figure 3.1 represents the catalytic 






Figure 3.1 The catalytic mechanism of type I and type II nitroreductases. Type I 
nitroreductases transfer two electrons from NAD(P)H to the substrate (1) resulting 
in the formation of the nitroso (2), hydroxylamino (3) and the amino group (4). 
Type II nitroreductases transfer a single electron o the nitro group, forming a nitro 
anion radical (5), which in the presence of oxygen is reoxidized to the original 
compound with cogeneration of superoxide in a futile redox cycle or can form the 
nitroso intermediate by the addition of another electron. Source (75). 
 
Nitroreductases are widely spread in bacteria and found, to a lesser extent, 
in eukaryotes. Organisms may contain the two types of nitroreductases (75, 76).  
Type I nitroreductases are usually homodimers of approximately 20 to 30 
kDa and structurally composed of five-stranded β sheets surrounded by helices α. 
Each monomer contains a FMN prosthetic group, which is bond to a deep pocket at 
the dimer interface and interacts with residues from both monomers that are 
conserved among nitroreductases (76, 77). These enzymes are divided in groups A 
and B, according to the similarity with E. coli nitroreductase NfsA and NfsB, 
respectively. More recently, a group C that contains proteins phylogenetically 











related to S. aureus nitroreductase NtrA was defined (78, 79). Amino acid sequence 
similarity among the three groups is very low (less than 10%) (79). Functionally, 
group A nitroreductases are usually NADPH-dependent whereas group B and C 
nitroreductases may use both NADH and NADPH as electron donors (76, 79). Most 
bacteria contain more than one type I nitroreductase gene. H. pylori, for example, 
has two type I nitroreductases, FrxA and RdxA that belong to the B group and 
present 39% sequence similarity with E. coli NfsB (79). Yeast S. cerevisiae has also 
two type I nitroreductases, Frm2 and Hbn1 (80). Theonly nitroreductase found in 
mammals is, so far, the type I nitroreductase iodotyrosine deiodinase (YID), which 
catalyses a reductive deiodination of mono- and diiodotyrosine formed during the 
biosynthesis of the thyroid hormone thyroxine that prevents the loss of iodide (81, 
82). Table 3.1 depicts the distribution and classification of the currently 
characterized type I nitroreductases.  
 
Table 3.1 Classification of the characterized type I nitroreductases in group A, 
B and C and respective distribution among different organisms 
Organism 
Type I Nitroreductases Refe- 
Group A Group B Group C rences 
Bacillus amyloliquefaciens YwrO (83) 
Bacillus licheniforms Yfk0 (84) 
Bacillus subtilis NfrA1 (YwcG) (85, 86) 
Clostridium acetobutylicum NitA, NitB (87) 
Enterobacter cloacae NR (88) 
Escherichia coli NfsA NfsB (89, 90) 
Helicobacter pylori RdxA, FrxA (91, 92) 
Klebsiella spp. C1 NTR I (93) 
Lactococcus lactis CinD   (94) 
Pseudomonas putida PnrA PnrB (95) 
Rhodobacter capsulatus NprA, NprB (96) 
Salmonella typhimurium SrnA Cnr (97) 
Staphylococcus aureus NfrA NtrA (78, 98) 
Synechocystis pp. PCC6803 DrgA (99) 
Vibrio fischeri FRase I (100) 
Vibrio harveyi Frp (101) 
Homo sapiens YID (82) 
Saccharomyces cerevisiae Frm2, Hbn1 (80) 





Type II nitroreductases occur in bacteria such as E. coli (73) and 
Clostridium strains (102), and their study remains largely unaddressed.  
Nitroreductases seem to have several physiological functions. Their main 
function is the reductive degradation of potentially toxic nitrocompounds, with 
several nitroreductases degrading a variety of nitroheterocyclic and nitroaromatic 
substrates. It has been speculated that these compounds are not the nitroreductases 
original substrates, and that nitroreductases have acquired the capacity to reduce 
nitroheterocyclic and nitroaromatic compounds released to the environment by 
human activities. Due to these characteristics, nitroreductases have a 
biotechnological interest for industrial applications such as for the biodegradation 
and bioremediation of environmentally toxic nitrocompounds (75, 76). 
Nitroreductases also play an essential role in the activation of 
nitroaromatic antibiotics, such as nitrofurans and nitroimidazoles. The bactericidal 
activation of these compounds have been attributed to the high cytotoxicity of 
hydroxylamine intermediates produced upon reduction of their nitro groups by 
nitroreductases (75, 76). Therefore, bacterial resistance to nitrofurans and 
nitroimidazoles has been associated with mutations i  genes encoding 
nitroreductases, as is the case of nfsA and nfsB of E. coli (103) and rdxA and frxA of 
H. pylori (104).  
Nitroreductases have also biomedical potential for anticancer therapies. 
Nitroaromatic prodrugs, such as CB1954 [5-(aziridin-1-yl)-2,4-dinitrobenzamide] 
are biologically inert compounds that are converted to potent cytotoxic agents when 
reduced by nitroreductases. In gene or in enzyme-directed prodrug therapy, 
nitroreductase are delivered specifically to tumour cells before the administration of 
a nitroaromatic prodrug. The compound can then be activated into a cytotoxic drug 
at the tumour site and destroys the cancer cells. The E. coli NfsA and NfsB 
enzymes, which activate CB1954, have been the most studied nitroreductases for 
anticancer prodrug therapy (105); however, other nitroreductases and new prodrugs 
have also been investigated (106). 
Roldán and co-workers suggested that because of the ni roreductases 
versatility, genetic events such as duplications, lateral gene transfer and mutations 
have created a set of nitroreductase-like proteins that acquired new physiological 
roles with or without the loss of the previous activities (76). For example, the 











nitroreductase BluB of Sinorhizobium meliloti (107) and the mammalian YID (81, 
82) have been implicated in the biosynthesis of vitam n B12 and in the reductive 
dehalogenation of iodinated tyrosine residues during the thyroid hormone synthesis, 
respectively. An additional role for nitroreductases is the maintenance of cellular 
metal homeostasis as is the case of E. coli NfsA and NfsB and V. harveyi FRP, 
which reduce cromate (Cr6+) to less soluble and toxic Cr3+ (108, 109). Moreover, 
the DrgA nitroreductase of the cyanobacterium Synechocystis showed ferric 
reductase activity when ferric iron was bounded to iron chelator compounds such as 
EDTA (99). Some nitroreductase-like proteins, such as V. fischeri FRaseI and V. 
harveyi FRP are also involved in the bioluminescent process by catalysing the 
reduction of FMN by NAD(P)H, with the reduced flavin being used as substrate for 
the luciferase enzyme (100, 101). 
Interestingly, some nitroreductases were also shown to be involved in 
cellular protection against oxidative and nitrosative stress. In Lactococcus lactis, 
mutants of the nitroreductase cinD gene are more sensitive to oxidative stress than 
the wild type, and the purified CinD protein exhibits catalase activity (94).  
The Bacillus subtilis nitroreductase NfrA1 has catalase activity (85), and 
the nfrA1 encoding gene is induced by paraquat and hydrogen peroxide (110). 
Similarly, the nitroreductase genes nf A of E. coli, snrA of S. typhimurium and nprA 
of Rhodobacter capsulatus are induced by paraquat (96, 111, 112). 
In S. aureus, the nfrA transcription is strongly induced by the thiol-specific 
oxidant diamide and nitrofurantoin, which upon activa ion generates superoxide, 
and is slightly induced by high concentrations of hydrogen peroxide. Furthermore, 
S. aureus NfrA exhibits disulfide reductase activity, proposed to contribute to the 
transfer of electrons to oxidized proteins under oxidative stress conditions (98).  
Saraiva and co-workers reported that the S. aureus strain defective in 
another nitroreductase gene, ntrA, has greater susceptibility to GSNO killing than 
the wild type strain, and that ntrA is induced by GSNO. Furthermore, S. aureus 
NtrA detoxifies GSNO besides reducing nitrofurans (78). Hence, S. aureus NtrA 
seems to play two different roles in vivo: promotion of nitrofuran activation and 
protection of the cell against nitrosative stress as GSNO reductases (78, 98).  
The studies concerning the regulatory mechanisms of nitroreductases are 





superoxide regulator and sensor (SoxRS) system, which responds to superoxide by 
inducing the expression of scavenger proteins and enzymes that repair damaged 
proteins and DNA (69). The E. coli nfsB expression was shown to be regulated by 
the multiple antibiotic resistance (MarRA) system, in which the MarA protein binds 
to a mar box located in the promoter region of the nfsB gene (113). The MarRA 
system controls the response of E. coli and other bacteria to different antibiotics and 
environmental pollutants. MarR is the repressor of the marRAB operon that directly 
interacts with salicylic acid and 2,4-dinitrophenol among other chemicals, leading 
to MarA synthesis, which directly regulates the transcription of the Mar regulon 
(114, 115). 
In R. capsulatus, the expression of the nitroreductase nprB gene is 
proposed to be constitutive, whereas the nitroreductase nprA gene expression is 
inducible by a wide range of nitroaromatic and heterocyclic compounds, including 
several dinitroaromatics, nitrofuran derivatives, 2-aminofluorene, benzo[a]pyrene, 
salicylic acid, and paraquat. The identification of two putative mar/sox boxes in the 
possible promoter region of the nprA gene and the induction of nprA expression by 
the above mentioned compounds suggest a role of MarRA nd SoxRS regulatory 
systems in the regulation of R. capsulatus nprA (96). 
 
3.4 Globins 
Globins are a widespread group of enzymes that occur in all kingdoms of 
life. These molecules are defined by a characteristic globin fold that is composed by 
helices α surrounding a haem b group. Globins are divided in three classes: 
flavohaemoglobins, single domain haemoglobins and truncated haemoglobins 
(116). Flavohaemoglobins are sub-divided in type I and type II (117, 118), and 
truncated haemoglobins in groups I, II and III or N, O and P, respectively (119, 
120). Different classes of haemoglobins can co-exist in the same organism, and 









Table 3.2 Distribution and number of flavohemoglobins (FHbs), ingle domain haemoglobins (SHbs) and truncated 
haemoglobins (TrHbs) in bacteria 
Organism   
FHbs  SdHbs 
 
TrHbs 
Type I Type II  
 
Group I (N)  Group II (O) Group III (P) 
Bacillus subtilis   1           1   
Campylobacter jejuni         1       1 
Escherichia coli   1               
Helicobacter hepaticus                 1 
Mycobacterium avium     1       1 1 1 
Mycobacterium bovis     1       1 1   
Mycobacterium leprae               1   
Mycobacterium smegmatis   1 1      1 1   
Mycobacterium tuberculosis     1       1 1   
Pseudoalteromonas haloplanktis   1         1 2   
Pseudomonas aeruginosa   1     1         
Salmonella typhimurium   1               
Staphylococcus aureus   1           1   
Synechococcus spp. PCC 7002       1   
Vibrio cholerae 
 
1     1         
Vitreoscilla stercoraria         1         






The flavohaemoglobins are present in bacteria, yeast and fungi. These 
enzymes present a unique two domain structure composed of an N-terminal 
haemoglobin domain fused with a highly conserved C-terminal oxidoreductase 
domain that binds NADPH and FAD. The N-terminal domain of flavohemoglobins 
has the classical 3-on-3 haemoglobin fold surrounding the haem centre (Figure 3.2) 
(123, 124).  
  
Figure 3.2 Structure of E. coli flavohaemoglobin. The N-terminal classical globin 
domain of flavohaemoglobin is represented in red, while the FAD and the NADPH-
binding modules of the C-terminal oxidoreductase domain are represented in cyan 
and green, respectively. Adapted from (125). 
Type I flavohaemoglobins have been shown to protect s veral bacteria 
against nitrosative stress by direct NO consumption, ncluding E. coli (126), V. 
cholerae (127), P. aeruginosa (128), S. aureus (129, 130), B. subtilis (131), and S. 
typhimurium (132). 
In aerobic conditions, type I flavohaemoglobins catalyse the conversion of NO to 
nitrate, through a NO dioxygenase or a NO denitroxylase mechanism (Reaction 
3.7).  
 
 Reaction 3.7 2NO + 2O2 + NADPH → 2NO3- + NADP+ + H+ 










In the dioxygenase mechanism, the reaction starts with the binding of the 
oxygen to the ferrous haem and the formation of a ferrous-oxy complex, which 
reacts with NO to form a transient ferrous-ONOO- intermediate that undergoes a 
rapid isomerization and releases nitrate with the concomitant oxidation of the 
ferrous to ferric haem. The ferrous haem is then resto d by transfer of an electron 
from NADH to FAD, and to the ferric haem.  
In the denitroxylase mechanism, NO first binds ferrous haem to form a ferrous-
nitrosyl species, followed by the electron transfer from the ferrous haem of the 
ferrous nitrosyl species to generate a ferric-nitroxyl species, which in turn reacts 
with oxygen to form nitrate. The oxidoreductase domain supports the one-electron 
reduction of the ferric to ferrous haem, thus completing the catalytic cycle. The 
higher affinity of ferrous flavohaemoglobin to NO when compared with oxygen and 
the fact that bacteria face high concentrations of NO generated by macrophages in 
low oxygen environments suggests that the denitroxylase mechanism predominates 
over the dioxygenase mechanism under physiological conditions (123, 129).  
Under anaerobic conditions, type I flavohaemoglobins convert NO to 
nitrous oxide, but this reaction occurs at approximately 1% of the aerobic reaction, 
which suggests that flavohaemoglobins operate mainly u der aerobic conditions 
(133).  
Under anaerobic conditions, flavohaemoglobins also reduce hydroperoxides (e.g. t-
butyl hydroperoxide, cumene hydroperoxide and linoleic acid hydroperoxide), and 
may therefore protect the cells from these toxic peroxides (134).  
The expression of type I flavohaemoglobin is increased by: i) NO and NO 
related compounds; ii) the decrease of iron (132, 135); iii) limitation of oxygen 
(129); iv) by paraquat; and v) in the stationary cell growth phase (136). Its 
regulation involves several transcription factors that may vary within bacteria. For 
example, the NO sensitive repressor (NsrR) regulates the flavohaemoglobin 
response to NO donors, acting as repressor in Salmonella typhimurium (132), B. 
subtilis (137) and E. coli (138), under aerobic and anaerobic conditions. NsrR i  a 
NO sensor that contains a 2Fe-2S cluster whose nitrosylation results in the loss of 





The global fumarate nitrate reduction (FNR) transcription factor also regulates the 
expression of the flavohaemoglobin gene (hmp) in E. coli (135). FNR is able to 
sense oxygen and NO via its labile 4Fe-4S cluster. FNR becames inactive in 
response to the increase in oxygen levels through oxidation of the 4Fe-4S to 2Fe-2S 
and the loss of the cluster. As the oxygen levels dcrease, the FNR cluster is loaded 
again and the protein is activated (139). Under anaerobic conditions, when FNR is 
in its holo form, the E. coli hmp expression is repressed (135) but when the bacteri 
are exposed to NO under anaerobic conditions, the 4Fe-4S became nitrosylated 
leading to a decrease in the affinity of FNR to thehmp promoter and to a de-
repression of the hmp transcription (140).  
More recently, a new type of flavohaemoglobins have be n identified in 
Mycobacteria and in other Actinomycetes. These proteins were classified as type II 
flavohaemoglobins and, unlike the conventional type I, its haem group displays an 
hexa-coordinated form in both ferric and ferrous states, and the C-domain lacks 
several of the conserved residues involved in FAD and NADH binding in type I 
flavohaemoglobins (117). Type II flavohaemoglobins may also co-exist with 
truncated haemoglobins and type I flavohaemoglobins (Table 3.2). While type I 
Mycobacteria flavohaemoglobin detoxifies NO (118), the type II flavohaemoglobin 
do not performs NO detoxification; instead, it oxidizes D-lactate, which may 
accumulate during membrane lipid peroxidation under oxidative stress conditions, 
by transferring electrons from D-lactate to the haem via FAD. In vitro, the type II 
flavohaemoglobin gene of M. tuberculosis is up-regulated by hydrogen peroxide 
and in vivo during macrophage infection (141). 
 
3.4.2 Single domain haemoglobins 
Single domain haemoglobins exhibit the classical 3-on-3 α-helical 
myoglobin fold, characterized by a haem group surrounded by eight helices α
(Figure 3.3) (116). This class of enzymes is present in bacteria such as C. jejuni, 
Pseudomonas aeruginosa and Vibrio cholerae (Table 3.2), and in eukaryotes (142). 
The structure and amino acid sequence of bacterial sing e domain haemoglobins are 










closely related to the 3-on-3 eukaryotic globins (e.g. myoglobin, neuroglobin and 
cytoglobin) (121).  
 
Figure 3.3 Structure of the single domain haemoglobin Cgb of C. jejuni. The figure 
depicts the 3-on-3 α-helical fold of Cgb surrounding the haem cofactor. Helices are 
represented in different colours and labelled from A to H. Image from (143). 
 
The role of bacterial single domain haemoglobins have been studied in 
Vitreoscilla and in C. jejuni.  
Vitreoscilla is a Gram-negative obligate aerobic bacterium that grows in low 
oxygen environments (144), and has a unique haemoglobin belonging to the single 
domain globin class that was named Vhb (or Vgb). The expression of the vhb gene 
in its natural host (145) and its heterologous expression in E. coli, when vhb is 
cloned together with its natural promoter (146), is strongly induced by hypoxic 
conditions through the global transcription regulator Fnr (147). In addition, the 
heterologous expression of Vitreoscilla vhb in E. coli and in other organisms 
resulted in improved cell growth and protein production under microaerobic 
conditions (148, 149). These observations had led to suggest a role for Vitreoscilla 
Vhb in oxygen binding (particularly at low concentrations) and its delivery to the 
terminal respiratory oxidase enzymes to enhance ATP production, which would 
enable Vitreoscilla to survive under hypoxic conditions (150). Alternatively, it was 
suggested that Vhb may act as a terminal oxidase itself (148). 
The expression of Vitreoscilla Vhb in several hosts has become a widely used 





stimulate bioremediation, and increase the growth yield and survival of engineered 
organisms (151). 
In addition to the role in oxygen metabolism, other protective functions have been 
proposed for Vitreoscilla Vhb. In particular, it was reported that the heterologous 
expression of Vhb in Enterobacter aerogenes reduces the hydrogen peroxide 
toxicity (152), and that Vitreoscilla Vhb possesses peroxidase activity (153). The 
heterologous expression of Vitreoscilla vhb in E. coli resulted in the induction of 
the antioxidant genes katG (catalase G) and sodA (superoxide dismutase A), and 
conferred significant protection to E. coli from oxidative stress. This protective 
effect of Vitreoscilla Vhb was mediated through the E. coli oxidative stress 
regulator OxyR and Fnr (154). OxyR is a transcriptional regulator that senses 
hydrogen peroxide through a sensory cysteine residu and regulates the response of 
several bacteria to oxidative stress (69). Vitreoscilla Vhb was shown to directly 
bind to E. coli OxyR, and to promote OxyR oxidation, which may had result in the 
up-regulation of katG, sodA and possibly of other genes that are part of the OxyR 
regulon (154). 
A role for Vhb in nitrosative stress protection has al o been proposed. A chimeric 
protein comprising Vhb fused with a flavoreductase domain of the Ralstonia 
eutropha FHb was described to consume NO and to provide E. coli protection 
against nitrosative stress (155). It was proposed that a flavoreductase (NADH-
methemoglobin reductase) that co-purifies with Vhb may act as the reducing 
partner (156), even though, the overall mechanism of NO detoxification by 
Vitreoscilla remains unknown. 
In contrast to Vitreoscilla Vhb, there is no evidence that the single domain 
globin Cgb of the microaerophilic C. jejuni plays a role in oxygen delivery. The C.
jejuni cgb mutant strain exhibited markedly inhibition of the a robic respiration and 
hypersensitivity to NO and other nitrosating agents (157-159). Cgb is strongly up-
regulated by nitrosative stress through NssR as the disruption of nssR abolished the 
inducible expression of cgb. The nitrosative stress sensing regulator (NssR) belongs 
to the cAMP receptor protein (Crp)-Fnr superfamily of transcription regulators and 
is commonly encoded in ε-proteobacterial genomes (160). Furthermore, C. jejuni 










Cgb has been shown to detoxify NO (161), but its partner reductase remains 
unknown, and it is speculated that Cgb may associate with host reductases or use 
bacterial small molecules (e.g. GSH) as a source of electrons for NO (162). 
Therefore, it is well established that resistance against nitrosative stress is linked to 
the presence of Cgb in C. jejuni. 
 
3.4.3 Truncated haemoglobins 
The truncated haemoglobins are widely distributed in bacteria, unicellular 
eukaryotes and plants (163). As their name indicates, truncated haemoglobins are 
20 to 40 residues shorter than single domain haemoglobins. Furthermore, truncated 
haemoglobins present a distinctive 2-on-2 α-helical fold in which the conserved 
helix pairs B/E and G/H are arranged in an antiparallel way surrounding and 
protecting the haem group from the solvent (Figure 3.4).  
Sequence identity among the truncated haemoglobins belonging to groups 
I, II and III is very low (~ 20% identity). The main structural differences among 
these groups are the A-helix that can be either very short or absent (as in group III) 
and the variation in the length of F and H-helices (Figure 3.4) (119, 120).  
 
Figure 3.4 Structure of the three classes of truncated haemoglobins. Truncated 
haemoglobins (TrHbs) of groups I (N), II (O) and III (P) are represented by 
Paramecium caudatum HbN, M. tuberculosis HbO and C. jejuni Ctb, respectively. 





the sperm whale globin. Helices are shown as cylinders and labelled. The helices 
structurally conserved within 3-on-3 and 2-on-2 folds are shown in grey. The haem 
is shown in a stick representation. Adapted from (164). 
 
The role of the truncated haemoglobins belonging to roup I and II was 
studied in the cyanobacterium Synechococcus pp. PCC 7002, in Mycobacterium 
species, and in Pseudoalteromonas haloplanktis. 
The Synechococcus pp. PCC 7002 haemoglobin (glbN) is encoded by GlbN that 
belongs to the group I truncated haemoglobins. High levels of nitrate, used as the 
nitrogen source, and exposure to NO were better tolated by the wild type strain 
than by the glbN mutant. Furthermore, the cellular contents of ROS and RNS were 
elevated in the glbN mutant under nitrosative stress conditions and were 
significantly attenuated upon GlbN overproduction. Therefore, the authors 
proposed that GlbN protects cells from RNS that could be naturally encountered 
during growth on nitrate or under denitrifying conditions (165). 
M. tuberculosis and M. bovis have two truncated haemoglobin encoding genes, 
glbN and glbO, corresponding to the proteins HbN and HbO, which belong to the 
truncated haemoglobin group I and group II, respectiv ly (119) (Table 3.2). M. 
tuberculosis truncated haemoglobin HbN presents NO activity. Furthermore, the 
over-expression of M. tuberculosis glbN affords protection against NO toxicity in 
an E. coli hmp mutant (166). In S. typhimurium hmp deficient cells expressing glbN 
and glbO, the glbN gene but not glbO improved bacterial survival within activated 
macrophages. Under aerobic conditions, the NO uptake activity of a S. typhimurium 
hmp mutant was significantly improved upon expression of M. tuberculosis glbN 
and glbO. While under low oxygen levels, HbN efficiently remove NO, the HbO 
does not, suggesting a predominant role of M. tuberculosis HbN over HbO in NO 
detoxification (167).  
 
M. bovis HbN detoxifies NO into nitrate, and the glbN mutant strain does not 
metabolize NO and has decreased NO respiration rates (119).  










M. leprae group II truncated haemoglobin (HbO), the only globin apparently 
present in the genome, was shown to be involved in hydrogen peroxide, NO and 
peroxynitrite scavenging (168-170). Since it is apparently the only globin in M. 
leprae, it has been suggested that the bacterium has lost HbN during evolution and 
HbO may have acquired the ability to detoxify NO (169). 
P. haloplanktis Ph-2/2HbO, which is encoded by PSHAa0030 gene and is 
one of the group II truncated haemoglobins of the marine cold-adapted 
psychrophile P. haloplanktis, was shown to catalyse peroxynitrite isomerization in 
vitro. In addition, Ph-2/2HbO was shown to confer P. haloplanktis resistance 
against oxidative and nitrosative stresses and to protect the growth and cellular 
respiration of an E. coli hmp mutant under nitrosative stress conditions (171, 12).  
Among group III, the truncated haemoglobins from C. jejuni (Ctb) and H. 
hepaticus (HbP) (173) are the best biochemically characterized proteins, but their 
physiological role was so far only investigated for Ctb.  
Although its expression is elevated when exposed to NO and RNS, via the action of 
the NO-responsive regulator NssR (158), mutation of the ctb gene in C. jejuni does 
not confer an NO-sensitive phenotype (174). The C. jejuni ctb mutant has a slower 
growth rate during the stationary phase under microaer bic conditions when 
compared with the wild type strain, suggesting a role f r Ctb in oxygen transfer. 
However, under oxygen-limited conditions, the C. jejuni ctb mutant showed similar 
growth levels than the parental strain (174).  
 
3.5 Peroxiredoxins  
Peroxiredoxins are thiol-dependent peroxidases that detoxify hydrogen 
peroxide, peroxynitrite and organic peroxides.  
Peroxiredoxins are characterized by a conserved thioredoxin fold 
consisting of seven strands β and five helices α. Their active centre is structurally 
conserved, containing a highly conserved catalytic cysteine residue referred as the 
peroxidatic cysteine (CP). When present, a second cysteine residue which is 





terminal helix or in other distinct positions (in helix α2, α3, α5 or between β1and β2 
strands). In general, peroxiredoxins can exist as mono ers; dimers or assemble into 
active decameric and dodecameric structures (175, 176). All peroxiredoxins share a 
common catalytic cycle, in which the thiolate group of the CP attacks a peroxide 
substrate. This cysteine is then oxidized to sulfenic acid with the release of the 
corresponding water or alcohol when hydrogen peroxide or larger peroxides are 
used as substrates, respectively. Subsequently, the oxidized CP forms a disulfide 
linkage with the CR and the disulfide is reduced by a thiol protein, regenerating the 
CP and CR residues (Figure 3.5) (175, 177).  
 
 
Figure 3.5 Catalytic cycle of peroxiredoxins. The peroxidatic cysteine thiolate (CP-
S-) attacks a peroxide substrate (ROOH) and is oxidized to a sulfenic acid (CP-
SOH) (1). The resolving cysteine (CR-SH) forms a disulfide with the CP-SOH (2), 
and the disulfide is reduced by a thiol protein (RSH) regenerating the CP-S- and the 
CR-SH (3). Image adapted from (175, 177). 
 
Peroxiredoxins were originally classified as typical 2-Cys, atypical 2-Cys 
and 1-Cys according to the number and location of the catalytic cysteines. In 
general, the 2-Cys peroxiredoxins are homodimeric enzymes that contain one CP 
and one CR per subunit. In the family of the 2-Cys peroxiredoxins, the CR is found 
in the C-terminal helix and forms an intersubunit disulfide with the CP of the other 
subunit. In the atypical 2-Cys peroxiredoxins, the CR is not located in the C-



























intrasubunit disulfide. Given the absence of the CR, the 1-Cys peroxiredoxins form 
a disulfide with a cysteine of another thiol protein such as thioredoxin, glutaredoxin 
or glutathione (175, 177, 178).  
Since this classification system only informs about the catalytic mechanism of each 
enzyme, a more recent classification of peroxiredoxins based on sequence 
similarities was proposed. This new classification divides peroxiredoxins into: i) 
peroxiredoxin 1/alkyl hydroperoxide reductase C (Prx1/AhpC); ii) 
bacterioferitin/peroxiredoxin Q (Bcp/PrxQ); iii) thiol peroxidase (Tpx); iv) 
peroxiredoxin 6 (Prx6); v) peroxiredoxin 5 (Prx5); and vi) alkyl hydroperoxide 
reductase E (AhpE) (179). Most organisms have several classes of peroxiredoxins 
coexisting in the genome. Table 3.3 gives examples of the distribution of the six 











Prx1/AhpC Bcp/PrxQ Tpx Prx6 Prx5 AhpE 
Bacteroides fragilis  1 1 1 (180, 181) 
Brucella abortus  1 1 1 (182) 
Campylobacter jejuni 1 1 1 (183) 
Desulfovibrio vulgaris 
Hildenborough  
1 1 1 
   
(184, 185) 
Enterococcus faecalis 1 1 (186), 
Escherichia coli 1 1 1 (175) 
Francisella tularensis  1 1 1 (187) 
Helicobacter pylori 1 1 1 (41) 
Mycobacterium 
tuberculosis 





1 1 1 
   
(189) 
Staphylococcus aureus  1 1 1 (190, 191) 
Streptococcus pyogenes 1 (192) 
Giardia intestinalis 2 (193) 
Homo sapiens 4 1 1 (175) 
Saccharomyces 
cerevisiae  2 1 1 1 (194) 
Trypanosoma cruzi 2 (195) 
Xylella fastidiosa 1 1 (196) 
 
The members of the Prx1/AhpC subfamily are typical 2-Cys proteins and 
are widely distributed in all kingdoms of life. This subfamily is the best studied one 
and includes the yeast thiol-specific antioxidant (TSA) proteins, several plant 
peroxiredoxins, the bacterial AhpC (named as such due to the alkyl hydroperoxide 
reductase activity demonstrated by the first bacterial nzyme found of this class) 
and the human PrxI, PrxII, PrxIII and PrxIV (175, 176). The members of this 
subfamily are typically dimeric proteins and undergo a redox-sensitive dimer-
decamer or a less usual dimer-dodecamer transition, n which the oxidized protein 
favours catalytic dimers while the reduced AhpC dimers preferentially assemble in 
a doughnut-like structure. The main structural difference of the Prx1/AhpC 
compared with other peroxiredoxin subfamilies is the CR present at the C terminal 
helix and a C-terminal extension of 50 to 80 residues (175). Some bacteria such as 










E. coli (197) and S. typhimurium (198) have a cognate flavoreductase, AhpF, that 
specifically reduces AhpC. In other bacteria, like H. pylori (199), AhpC is also 
present but its reducing partner, AhpF, is absent. Ins ead, the latter bacterium uses 
the thioredoxin/thioredoxin reductase system, or other thiol proteins, to reduce 
AhpC. The Prx1/AhpC peroxiredoxins play an essential role in protecting 
organisms against oxidative and nitrosative damage by directly detoxifying toxic 
peroxides. These enzymes are able to detoxify a wide peroxides such as hydrogen 
peroxide, t-butyl hydroperoxide, cumene hydroperoxide and lipoic acid 
hydroperoxide, but with different substrate affinities that depend on the organism 
(200). Furthermore, AhpC from the S. typhimurium, M. tuberculosis, and H. pylori 
(63), and Prx1/AhpC members from higher organisms such as S. cerevisiae Tsa1 
and Tsa2 (201), Plasmodium falciparum TPx1 (202), Trypanosoma brucei and 
Trypanosoma cruzi TXNPx (203) and human Prx2 (204) efficiently reduce 
peroxynitrite. Phenotypic studies reported that the Listeria monocytogenes (205), 
Porphyromonas gingivalis (206) and Brucella abortus (182) ahpC mutants are 
more sensitive to hydrogen peroxide relatively to the wild type strain. On the 
contrary, the ahpC deletion mutants of bacteria such as S. aureus (207), H. 
hepaticus (65), H. cinaedi (72), M. tuberculosis (208), C. jejuni (209), 
Streptococcus pyogenes (192), Streptococcus mutans (210) and E. coli (9) showed 
little or no sensitivity to hydrogen peroxide. However, it was shown that this lack of 
susceptibility is due to a compensatory upregulation of catalase levels, which 
detoxifies hydrogen peroxide in the absence of AhpC.  
Several bacterial strains with ahpC inactivated gene are sensitive to organic 
peroxides. In particular, C. jejuni (209), H. cinaedi (72), H. hepaticus (65), H. 
pylori (44) and S. typhimurium (211) ahpC mutants have diminished resistance to 
cumene hydroperoxide. H. cinaedi (72), H. hepaticus (65) and H. pylori (44) ahpC 
mutants have increased susceptibility to t-butyl hydroperoxide. Hence, AhpC seems 
to have a role as a scavenger of organic peroxides. Also, an accumulation of lipid 
hydroperoxides was observed in the H. hepaticus tsaA (65) and H. pylori ahpC (45) 
mutant strains.  
In bacteria such as L. monocytogenes (205), M. tuberculosis, M. smegmatis (212), 





the resistence to peroxynitrite or to peroxynitrite g nerators. Furthermore, the S.
typhimurium ahpC mutant showed increased susceptibility to peroxynitrite, GSNO 
and sodium nitrite, a defect that was complemented by M. tuberculosis AhpC (211). 
Also, the deletion in S. cerevisiae of tsa1 and tsa2 genes rendered the strain 
hypersensitive to peroxynitrite and sodium nitroprusside (214).  
AhpC seems to be an important mechanism for bacteril survival within 
macrophages. In particular, the ahpC mutants of H. cinaedi, M. tuberculosis and F. 
tularensis have decreased survival upon macrophage infection (72, 212, 213). 
Furthermore, S. typhimurium (215, 216) and E. coli (217) ahpC and ahpF 
expression is induced upon intracellular growth in mouse macrophages and in 
response to phagocytosis by human neutrophils, respectively.  
AhpC was also shown to be an important virulence fator upon mice infection, as 
the ahpC mutants of H. pylori (46) presented a severe deficiency for mice 
colonization. Moreover, the mutants of the ahpC homologous genes in H. cinaedi 
(72) and L. monocytogenes (205) have diminished virulence.  
The regulatory mechanism of ahpC varies among organisms. H. pylori seems to 
lack the homologs of the major peroxide regulatory systems such as OxyR and 
PerR (200), and the regulation of ahpC is linked to the post-transcription 
aconitaseB, which is a 4Fe-4S protein. AconitaseB cluster is oxidized under high 
oxygen levels or disassembled under low iron conditions, rendering apo-aconitaseB 
that is able to bind to the transcript of ahpC, and provides RNA stability and 
subsequently increase of ahpC expression (218). In E. coli (219), S. typhimurium 
(215), P. aeruginosa (220), Mycobacteria (221), P. gingivalis (222), Bacteroides 
fragilis (223) and Streptomyces coelicolor (224) the ahpC gene is regulated by 
OxyR in response to hydrogen peroxide. PerR has also been identified as the 
regulator of peroxide-inducible ahpC expression in B. subtilis (66), C. jejuni (68), 
H. hepaticus (64), and S. aureus (191). 
C. jejuni oxidative stress regulator (CosR) also shown to positively control the 
expression of ahpC. CosR is present in other ε-Proteobacteria such as H. pylori, H. 
hepaticus and Wolinella succinogenes. In response to paraquat, the level of CosR 










decreases together with the expression of ahpC, which suggests that AhpC may 
contribute to the detoxification of peroxides and not of superoxide (225).  
The hydrogen peroxide regulator (HypR) is a new oxidative stress regulator that 
was isolated and characterized in the enteric bacterium Enterococcus faecalis. 
HypR is a member of the LysR family of positive transcriptional regulators and was 
shown to be involved in the activation of E. faecalis ahpCF in response to hydrogen 
peroxide (226).  
Some eukaryotic Prx1/AhpC enzymes shown to be inactivated at high intracellular 
hydrogen peroxide levels by hyperoxidation of the CP, which is then reversed by 
sulfiredoxins and sestrins reduction. However, and contrary to eukaryotes, the 
majority of the bacterial peroxiredoxins are highly resistant to inactivation by 
hyperoxidation, even at millimolar peroxide concentrations, which permits bacteria 
to survive high levels of ROS and RNS produced by mam alian macrophages 
(175, 227, 228). Finally, some Prx1/AhpC enzymes were r ported to function under 
stress conditions as molecular chaperones in organisms from different kingdoms of 
life, as is the case of H. pylori AhpC, cyanobacterial Anabaena 2-Cys 
peroxiredoxin alr4641 and P. aeruginosa PaPrx (229). 
Although the majority of the Bcp/PrxQ members occur in bacteria, these 
proteins are also present in archaea and eukaryotes. Bcp was originally identified in 
E. coli as a protein that co-migrated with bacterioferritin n SDS gels (230). The 
Bcp/PrxQ is structurally and functionally the most diverse peroxiredoxin subfamily. 
Known members vary in its oligomeric state, existing as monomers or dimers, as 
well as in the presence and location of the C
R
, having 1-Cys or 2-Cys mechanisms 
(175). The Bcp/PrxQ proteins are able to detoxify a wide range of peroxides, but 
with activity rates lower than the bacterial AhpC proteins (231). Interestingly, the 
E. coli Bcp protein demonstrated a higher affinity for reducing linoleic acid 
hydroperoxide (Km = 10 μM) than for hydrogen peroxide (Km = 50 μM) or t-butyl 
hydroperoxide (Km = 40 μM) (232). Similarity, the H. pylori Bcp showed 
preference for linoleic acid hydroperoxide, suggesting that the reduction of fatty 
acids hydroperoxides might be one of the main roles f Bcp (45). In plants, Xylella 





function was so far observed in bacterial Bcps. Phenotypical studies showed that 
the Burkholderia cenocepacia (233), E. coli (232) and P. gingivalis (234) bcp 
mutants are more sensitive to hydrogen peroxide than the wild type strains. 
Furthermore, the E. coli bcp mutant is hypersensitive to organic peroxides (232). 
The expression of the bcp gene of P. gingivalis (234) and B. fragilis (181) restored 
the hydrogen peroxide resistance of an E. coli bcp defective mutant. In C. jejuni, 
the single bcp and tpx mutants had no major alteration in their phenotype when 
exposed to peroxides, superoxide, or nitrosative str s  agents. Nevertheless, a 
double mutation in the bcp and tpx genes rendered the strain hypersensitive to all of 
these agents, suggesting that Bcp and Tpx are partially redundant in this organism 
(183). In H. pylori, the bcp mutant was only slightly sensitive to oxidative stre s 
(40). Yet, Bcp was shown to protect H. pylori from lipid peroxidation and to 
contribute to virulence during mice infection (see above section 3.2) (40).  
Although the studies of bcp regulation are scarce, in S. aureus, PerR was shown to 
induce the transcription of bcp in response to hydrogen peroxide (191). 
The Tpx like proteins are only present in bacteria. This subfamily was 
named as such for its first discovered member thiolperoxidase of E. coli. Relatively 
to the other peroxiredoxin subfamilies, Tpxs have an additional N-terminal β 
hairpin loop in their structure. Tpxs are obligate dimers, with almost all identified 
Tpx functioning as 2-Cys and about 1% as 1-Cys peroxiredoxins (175). The Tpx 
family members have a broad substrate specificity (235, 236) that varies among 
organisms. For example, E. coli Tpx reduces hydrogen peroxide, t-butyl 
hydroperoxide, cumene hydroperoxide and linoleic acid hydroperoxide more 
efficiently than AhpC and shows a distinct preference for cumene hydroperoxide 
(Km = 9 μM) over hydrogen peroxide (Km = 1.7 mM) (236). M tuberculosis Tpx 
also presents a higher affinity for cumene hydroperxide over the referred 
peroxides but cannot reduce linoleic acid hydroperoxide. Furthermore, M. 
tuberculosis Tpx reduces peroxynitrite (237). Phenotypical studies showed that the 
tpx mutant strains of E. coli (235, 238), E. faecalis (186), S. typhimurium (239) and 
Streptococcus gordonii (240) lose resistence to hydrogen peroxide. The E. coli tpx 
mutant was more sensitive to organic peroxides and p raquat, suffered higher levels 
of protein oxidation, and accumulated a higher concentration of lipid peroxides 










when compared to the wild type (235, 238). Interestingly, the level of sensitivity to 
peroxides was higher for the E. coli and S. typhimurium tpx mutants relative to the 
E. coli ahpC and bcp, and S. typhimurium ahpC and tsaA mutants (239), suggesting 
a predominant role of this protein in oxidative stre s protection. As referred above, 
Tpx is able to protect H. pylori against oxidative stress (section 3.2, (41, 46)) and in 
C. jejuni, both Tpx and Bcp proteins were shown important to combat oxidative and 
nitrosative stresses (183). The M. tuberculosis strains lacking tpx failed to grow and 
survive in activated macrophages (241). The S. Typhimurium tpx mutant has a 
lower intracellular proliferation in activated macrophages than the wild type strain 
(239). E. faecalis Tpx mediates a higher survival rate inside macrophages in 
comparison to AhpC (186). Altogether, Tpx have shown to be important in vivo for 
macrophage infection. The Tpx mutants of H. pylori (46), M. tuberculosis (241) 
and E. faecalis (186) were attenuated upon mice infection. Expression of S. 
gordonii tpx was up-regulated in the presence of oxygen and paraqu t (240) and the 
tpx of E. coli was slightly induced by aeration (235). In Mycobacterium bovis, tpx is 
induced in response to thiol stress generated by exposure to diamide (242).  
The Prx6 subfamily is present in archaea, bacteria and eukaryotes and their 
members are mainly 1-Cys peroxiredoxins, such as the P. aeruginosa LsfA (243) 
and the mammalian Prx6. Their principal structural t it is a C-terminal extension 
that is 15-40 residue longer than the characteristic C-terminal extension of 
Prx1/AhpC enzymes. All known Prx6 subfamily members a e dimers and some 
form decamers (175). So far, the physiological role f bacterial Prx6 subfamily 
members was only studied for P. aeruginosa LsfA. The P. aeruginosa lsfA mutant 
strain is more sensitive than the wild type to hydrogen peroxide but not to organic 
peroxides. A redox sensitive fluorescent probe was more oxidized in the lsfA 
mutant-infected macrophages than in macrophages infected with the wild type 
strain, suggesting a role of LsfA in ROS protection. In an acute pneumonia model, 
mice infected with the lsfA mutant had increased cytokine release, neutrophil 
recruitment and increased survival compared to mice infected with the wild-type, 
which suggests that LsfA is able to downregulate the host innate immune response 





The Prx5 subfamily members occor in bacteria, fungi, plants and 
mammals. This subfamily of proteins that includes Haemophilus influenzae Prx5 
(244) and the mammalian Prx5, usually form dimers independently of the redox 
state. Only approximately 17% of the known Prx5 subfamily members are 2-Cys 
and 20% of the proteins are fused with a glutaredoxin domain, which suggests that 
the glutaredoxin domain acts as the electron donor for the peroxiredoxin domain of 
these proteins (244). Interestingly, the human Prx5 e hibits peroxynitrite activity 
(245), but so far, the role of bacterial Prx5 members in oxidative and nitrosative 
stress protection was not studied. 
The AhpE is the smallest peroxiredoxin subfamily, only present in 
Mycobacteria and other Actinomycetes. AhpE members are 1-Cys peroxiredoxins, 
form dimers, and have an extended loop at the N-terminus in relation to the other 
peroxiredoxin subfamilies (175). M. tuberculosis AhpE was reported to have 
peroxynitrite activity, reducing peroxynitrite by two orders of magnitude faster than 
hydrogen peroxide (246).  
Table 3.4 summarizes the phylogenetic distribution, the main structural 















Location of CR 
Prx1/AhpC 
Archaea, bacteria, 








plants, and fungi (not 
animals) 
Monomers/dimers Extended helix α5 
Helix α2 (61%) Helix 
α3 (6%) 
Tpx Bacteria Dimers 
N-terminal β 
hairpin 
Helix α3 (>95%) 
Prx6 
Archaea, bacteria, 





No CR (41%) 
Prx5 
Bacteria, plants, and 
other eukaryotes (not 
archaea) 
Dimers 
Fused with a 
glutaredoxin 
domain (~20%) 
Helix α5 (21%) 
Between β1 and β2 of 
N-terminus (17%) 
AhpE Bacteria Dimers 
Extended loop at 
N-terminus 
Helix α2 (67%). No 
CR (19%) 
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Helicobacter pylori is a pathogen that infects the gastric mucosa of a large 
percentage of the human population worldwide, and pre isposes to peptic ulceration 
and gastric cancer. Persistent colonization of humans by H. pylori triggers an 
inflammatory response that leads to the production of reactive nitrogen species. 
However, the mechanisms of H. pylori defence against nitrosative stress remain 
largely unknown. In this study, we show that the NADH-flavin oxidoreductase FrxA 
of H. pylori, besides metabolizing nitrofurans and metronidazole, has S-
nitrosoglutathione reductase activity. In agreement with this, inactivation of the 
FrxA-encoding gene resulted in a strain that was more sensitive to S-
nitrosoglutathione. FrxA was also shown to contribute to the proliferation of H. pylori 
in macrophages, which are key phagocytic cells of the mammalian innate immune 
system. Moreover, FrxA was shown to support the virulence of the pathogen upon 
mouse infection. Altogether, we provide evidence for a new function of FrxA that 
contributes to the successful chronic colonization ability that characterizes H. pylori. 
 
4.1 Introduction 
Helicobacter pylori is a human pathogen responsible for multiple gastric 
pathologies that, when untreated, may result in gastric cancer. The bacterium causes 
chronic infections of the gastric mucosa, owing to its ability to withstand exposure to 
harmful chemicals, such as the nitric oxide (NO) produced by the mammalian 
inducible NO synthase (iNOS) and derived from the nitrite present in the acidic 
stomach environment. Expression of iNOS is triggered by pathogen invasion of the 
phagocytic cells of the mammalian innate immune system, namely macrophages and 
neutrophils (1, 2). NO impairs the function of several bacterial metalloproteins by 
directly binding to metal centres, such as iron haem and iron-sulphur centres. 
Moreover, NO reacts rapidly with superoxide, produced by the mammalian NADPH 
oxidase, generating the potent oxidant HOONO (peroxynitrite), which also damages 
proteins and DNA. NO binds to thiol groups of cysteines of proteins to form S-
nitrosothiols; this represents a form of reversible post-translational damage of cellular 





generated inside cells by the univalent oxidation of NO to nitrosium ion, promoted 
by intracellular free or protein-bound metals, and further ligation to glutathione (3-
5). 
In several bacteria, the enzymatic removal of NO is performed by the 
flavodiiron NO reductases and flavohaemoglobins (6, 7), which are apparently absent 
in the genome of H. pylori. Recently, we reported that H. pylori uses a new type of 
NO reductase, NorH, that is present in all of the so far known Helicobacter species. 
These proteins constitute a new family of NO detoxifiers that occur in several 
microorganisms, including bacteria that contain the canonical enzymes (8). 
Bacteria also alleviate the detrimental effects of nitrosative stress by 
reversing the S-nitrosylation process. In particular, the enzymatic reduction of GSNO 
to glutathione disulfide and ammonia, via a glutathione N-hydroxysulfenamide 
intermediate, is a reaction that allows control of the cellular S-nitrosothiol levels and 
protection from nitrosative stress (9). Endogenous GSNO reductase (GSNOR) 
(formally glutathione-dependent formaldehyde dehydrogenase) activity has been 
observed in Escherichia coli (10) and Neisseria gonorrhoeae (11). Also, glutathione-
dependent class III alcohol dehydrogenases have been shown to catalyse GSNO 
reduction in Neisseria meningitides (11), Hemophilus influenza (12), and 
Streptococcus pneumoniae (13). Moreover, in E. coli (14) and Mycobacterium 
tuberculosis (15), the thioredoxin system, comprising thioredoxin, thioredoxin 
reductase, and NADPH, has emerged alongside GSNOR as a physiologically 
important denitrosylase. Likewise, both thioredoxins from H. pylori (thioredoxin 1 
and thioredoxin 2) have been suggested to play a role in resistance to GSNO stress, 
owing to the increased susceptibility to GSNO of thioredoxin-deficient strains (16). 
Treatment of H. pylori is achieved by double or triple antibiotic-based 
therapies that include the prodrug metronidazole. The drug belongs to the 
nitroimidazole family of antibiotics, and is activated by the microbial nitroreductases 
(17). H. pylori contains at least two nitroreductases, the oxygen-independent NADPH 
nitroreductase RdxA, and the NADH-flavin oxidoreductase FrxA (18-21). 
Although there is general agreement that RdxA is involved in metronidazole 
activation, the correlation of metronidazole resistance with mutations in frxA is still 










under debate, and the physiological role of the protein remains elusive. In this study, 
we tested whether H. pylori FrxA metabolizes other substrates, namely reactive 
nitrogen species. We produced recombinant FrxA, and characterized its enzymatic 
activity for reduction of nitrofurans, metronidazole, 3-nitrotyrosine, S-nitrocysteine, 
and GSNO. Furthermore, we generated a nonpolar H. pylori frxA mutant to determine 
the effect of frxA depletion on H. pylori survival in vitro, and in macrophages and 
mice. The results revealed new aspects of the function of FrxA as a GSNOR, and 
demonstrated the contribution of FrxA to macrophage infection and mouse 
colonization by H. pylori. 
 
4.2 Results 
FrxA reduces nitrofurans, metronidazole, and GSNO 
To investigate the role of H. pylori FrxA, the protein was produced in E. coli 
cells and characterized. To this end, the H. pylori frxA gene was amplified by use of 
the oligonucleotides outlined in Table 1, and cloned into pET28a; the recombinant 
plasmid was then transformed into E. coli BL21-Gold (DE3). Cell growth and protein 
purification were performed as described in 'Experim ntal procedures'. Purified His-
FrxA had an apparent molecular mass of ~ 26 kDa in SDS/PAGE (Figure 4.1a, inset), 
which agrees with the molecular mass derived from the gene sequence. The protein 









Table 4.1 Oligonucleotides used in this study 
 
 
Figure 4.1 Biochemical characterization of H. pylori FrxA nitroreductase. (a) UV–
visible spectra of H. pylori FrxA as isolated (dashed line) and after incubation with a 
Description Oligonucleotide sequence (5’→3’) 
frxA gene deletion  
 upstream flanking region 
 frx1 CGCTCAAAAACCCCAAACATGC 
 frx2 TTATTCCTCCTAGTTAGTCATTTAATGTTCTCCTTTTTC 
 downstream flanking region 
 frx3 TACCTGGAGGGAATAATGAGAATAAAAACGCTGTTAGC 
 frx4 TCTGAATACCTGAAAGGGCG 
Real Time qRT-PCR  
 ppk (hp1010) 
 ppkRT5 GCGCGTTAGTCGTTTATGGCGTTT 
 ppkRT3 AGCGCTCAAAGGGTTGTAATTGCC 
 frxA (hp0642) 
 frxART5 GGCTTGAACCATGGAAAATGC 
 frxART3 GGCTTGAACCATGGAAAATGC 
Expression of FrxA 
 FrxAndeI CCTAAAGAATACTCGAGTGTGTTG 
 FrxAxhoI GGAGAACATTCATATGGACAGAG 










two-fold excess of FMN, i.e. containing one FMN per monomer (full line). Inset: 
SDS/PAGE with purified H. pylori FrxA (left lane) and a protein molecular mass 
marker (lane M). (b) Analytical gel filtration profile of H. pylori His-tagged FrxA. 
Inset: correlation between the molecular mass and retention time of protein standards 
(triangles); FrxA was eluted with an approximate molecular mass of 52 kDa (circle). 
(c) Dependence of the metronidazole-specific activity H. pylori FrxA (0.5 μM) on 
the FMN bound to the protein. The FMN content was determined as described in 
“Experimental procedures”, and is depicted as the FMN bound/protein monomer 
ratio. Linear regression, R2 = 0.97; and slope of 418.3 ± 22.2 nmol·min−1·mg−1 
protein. Activities were assayed with metronidazole (0.15 mM) and 0.2 mM 
NADPH, and are represented as nmol·min−1·mg−1 protein. Two independent protein 
samples were assayed in triplicate. (d) Cells of wild type H. pylori 26695 (white bar) 
and the frxA (black bar) and rdxA (striped bar) mutants were left untreated and 
exposed for 1 h to 200 μM GSNO. GSNOR activity was determined in bacterial 
suspensions, prepared as described in 'Experimental procedures', with 200 μM 
NADPH and 400 μM GSNO. Values are means ± standard deviations of three 
biological cultures. Units represent 1 μmol of GSNO and NADPH consumed per 
minute. ***P < 0.001 (two-way ANOVA and Tukey's multiple comparison test). 
 
The purified protein was yellow, and its UV-visible spectrum showed two bands in 
the 300-500-nm region, as is typical for flavin-contai ing proteins (Figure 4.1a). 
Treatment of FrxA with SDS induced the release of a cofactor, whose free form 
showed a visible spectrum with an absorbance maximum at 446 nm, which is 
characteristic of FMN molecules. The as-purified FrxA containing 0.2 FMN 
molecules per FrxA polypeptide chain, and incubation of the protein with an 
approximately two-fold concentration of FMN yielded a protein with one FMN per 
monomer. 
The substrate specificity of FrxA for several nitro-substituted compounds, 
namely nitrofurantoin, nitrofurazone, metronidazole, and 3-nitro-L-tyrosine, was 
studied. FrxA showed NADPH-dependent activity for nit ofurans that varied from 





observed for nitrofurazone; these activities are within the range of values found for 
other bacterial nitroreductases (22). 
 
Table 4.2 Kinetic parameters of H. pylori FxrA enzyme activity for nitro-









kcat/K m        
(M -1.s-1) 
Metronidazole  621 ± 38 22.4 ± 5.2 0.6 2.5 x 104  
Nitrofurantoin  538 ± 67 42.3 ± 12.1 0.5 1.1 x 104  
Nitrofurazone  1122 ± 83 14.3 ± 3.9 1.0 7.1 x 104  
3-nitrotyrosine 190 ± 16 62.6 ± 13.7 0.1 2.7 x 103 
GSNO  575 ± 24 4.1 ± 1.1 0.5 12.6 x 104  
S-nitrosocysteine 716 ± 35 7.2 ± 2.0 0.6 8.9 x 104 
 
FrxA had a metronidazole activity of 621 nmol·min−1·mg−1 protein, which is 
comparable with the activities measured for nitrofuan compounds (Table 2). As the 
metronidazole activity of FrxA was lower than that reported for H. pylori RdxA (20), 
we tested whether the activity of FrxA was a function of the flavin content of the 
protein. It was observed that metronidazole activity of the isolated protein containing 
0.2 FMN molecules per polypeptide chain accounted for ~ 20% of the activity of the 
full FMN-loaded FrxA, and that the catalytic activiy ncreased with the FMN content 
of FrxA (Figure 4.1c). 
Interestingly, FrxA was catalytically active towards 3-nitro-L-tyrosine (Table 2). This 
compound is a biologically relevant substrate that results from the damage induced 
in proteins by nitrosative stress and that is widely used as a marker of this type of 
stress. 
Additionally, FrxA was able to reduce GSNO and S-nitrosylated cysteine with 
comparable kinetic parameters (Table 2). These activities were determined in the 
presence of NADPH, and reactions were initiated by the addition of the enzyme and 
monitored following the oxidation of NADPH and S-nitrosothiols. FrxA showed 
GSNOR activity of 575 nmol·min−1·mg−1 protein; although this value is of the same 
order of magnitude as the values determined for other tested substrates, the lower Km 










and higher Kcat/Km values for GSNO suggest that S-nitrosothiols may be the preferred 
substrates of H. pylori FrxA. 
Altogether, the data revealed that, despite being a typical member of the 
nitroreductase family of homodimeric flavoproteins, FrxA shows significant GSNOR 
activity. 
 
The frxA mutants are defective in GSNOR activity 
As recombinant FrxA is a GSNOR, we evaluated its contribution to the 
GSNO reduction rate of H. pylori cells. To this end, the H. pylori 26695 strain 
carrying a deletion in frxA was constructed and its GSNOR activity was determined. 
For comparison purposes, an H. pylori line with inactivation of rdxA was also 
constructed and analysed. GSNOR activity was evaluated in mixtures containing cell 
extracts, which were prepared as described in 'Experimental procedures', buffer, and 
NADPH. The reaction was initiated by addition of GSNO. The GSNOR activities of 
H. pylori cells of wild type and mutant strains unexposed to stress showed no 
significant differences. However, whereas upon exposure to GSNO the rdxA mutant 
showed GSNOR activity comparable to that of the wild type, the frxA mutant showed 
lower GSNOR activity (Figure 4.1d). 
 
The frxA mutants are hypersensitive to GSNO 
Next, we tested whether FrxA contributes to the cellular GSNO resistance 
of H. pylori (Figure 4.2). Liquid cultures of H. pylori 26695 wild type and frxA 
mutant strains were inoculated and subjected to GSNO stress. In the absence of stress, 
the viability of the frxA-deficient strain was comparable to that of the parental strain, 
but for cells treated with GSNO the frxA mutant showed lower viability than the wild-
type (Figure 4.2a). Interestingly, susceptibilities of the frxA mutant and parental 







Figure 4.2 FrxA affords protection to H. pylori against nitrosative stress. (a) Cell 
viability of wild type H. pylori 26695 (triangles) and the frxA mutant (squares) 
cultivated in BHI medium supplemented with 10% fetal bovine serum in the absence 
(filled symbols) and in the presence (open symbols) f 200 μM GSNO. (b) Cell 
viability of wild type H. pylori B128 (triangles) and the frxA mutant (squares) 
cultivated in BHI medium supplemented with 10% fetal bovine serum in the absence 
(filled symbols) or presence (open symbols) of 300 μM GSNO. (c) Survival of the H. 
pylori B128 frxA mutant strain transformed with the empty vector pILL2157 (open 
bar) and with pILL2157 expressing frxA (filled bar), cultivated in BHI medium 
supplemented with 10% fetal bovine serum and 1 mM IPTG, after 24 h of exposure 
to 300 μM GSNO. Values are means ± standard deviations of three independent 
cultures. *P < 0.05, **P < 0.01 (t-test). 
 
To substantiate the results, the frxA gene deletion was introduced into 
another H. pylori strain, namely H. pylori B128, that has the ability to colonize mice 
(23). Identical growth assays were performed, and the results revealed that deletion 
of frxA impaired the resistance of H. pylori B128 to GSNO (Figure 4.2b). In addition, 
complementation experiments showed that expression of FrxA from the inducible 










plasmid pILL2157-frxA was sufficient to rescue the phenotype of H. pylori B128 
wild type (Figure 4.2c). 
Interestingly, the H. pylori B128 frxA mutant proved to be more resistant to GSNO 
than H. pylori 26695, which may be attributable to a different genetic background, 
as high genetic variability is usually observed among H. pylori isolates. 
 
Transcription of frxA is induced by nitrosative stress 
The mRNA abundance of frxA was examined, with quantitative real-time 
RT-PCR, in cells of wild-type H. pylori treated with NO donors, namely GSNO and 
spermine-NONOate. The data showed that frxA expression underwent fold increases 
of 3.5 ± 0.6 and 5.0 ± 1.3 when cells were exposed to GSNO and spermine-NONOate, 
respectively. 
 
The frxA mutant has reduced survival in macrophages 
The decreased resistance of the frxA mutant to GSNO as compared with the 
parent strain led us to study the role of FrxA in the survival of H. pylori during 
interaction with macrophages (Figure 4.3a, b). A lower number of viable bacterial 
cells were recovered from macrophages infected withthe H. pylori 26695 frxA 
mutant (Figure 4.3a) than from macrophages infected with the parental strain, which 






Figure 4.3 FrxA confers in vivo protection to H. pylori. (a) Survival of wild type H. 
pylori 26695 (open bar) and the frxA mutant (filled bar) after 24 h of infection of 
RAW264.7 macrophages (left) and after 24 h of infection of RAW264.7 
macrophages treated with the iNOS inhibitor L-NMMA. Values are means ± standard 
errors (n = 9). **P < 0.01 (one-way ANOVA). (b) Infection of RAW264.7 
macrophages with wild type H. pylori B128 (white bar), the frxA mutant harbouring 
the empty vector pILL2157 (black bar), and the frxA mutant complemented with the 
vector pILL2157 expressing frxA (grey bar). Values are means and standard errors of 
the average values (n = 3). *** P < 0.0001 (ANOVA and Bonferroni test). In all 
assays, macrophages were seeded at 5 × 105 in 24-well plates and infected at a 
multiplicity of infection of 100. (c) Colonization of C57BL/6J mice with wild type 
H. pylori B128 (circles) and the frxA mutant (triangles). Mice were inoculated orally 
with a 1:1 mixture of wild-type H. pylori B128 and the frxA mutant (2 × 108 bacteria), 
and the stomach bacterial load was evaluated after 15 days of infection. Each data 
point corresponds to a single mouse (n = 16); the horizontal bar represents the mean, 
and the dashed line indicates the detection limit of CFUs per gram of stomach. (d) 
Competition index of the H. pylori frxA mutant strain upon coinfection of 15 mice. 
Each data point corresponds to a value calculated from the colonization level depicted 
in (c). 










In order to correlate the lower resistance of the frxA mutant strain with an 
impaired capacity to withstand iNOS-dependent NO stres , experiments were 
repeated in the presence of an iNOS inhibitor. Macrophages incubated with NG-
monomethyl-L-arginine (L-NMMA) that do not produce NO, were less efficient at 
eliminating H. pylori. Moreover, no differences were seen between the survival of 
the wild-type strain and that of the mutant strain (Figure 4.3a). 
Infection assays performed with the H. pylori B128 frxA-deficient strain also showed 
that the mutant was killed more efficiently by macrophages to a degree comparable 
to that observed for the H. pylori 26695 frxA mutant (Figure 4.3b). Furthermore, 
complementation assays performed with the inducible plasmid pILL2157-frxA 
revealed that expression i  trans of FrxA in the H. pylori B128 frxA mutant strain 
restored the survival of H. pylori in macrophages to levels resembling those observed 
for the wild type (Figure 4.3b). 
These results demonstrate that FrxA deficiency impars the proliferation of H. pylori 
in macrophages by promoting pathogen clearance. 
 
FrxA protects H. pylori during mouse infection 
To further evaluate the contribution of FrxA to successful infection by H. 
pylori, we determined the mouse colonization efficiency of the frxA mutant during 
competition with the wild type strain. C57BL/6J mice were infected orally with an 
inoculum consisting of a 1:1 mixture of viable cells of the frxA mutant and wild type 
strains. The level of gastric colonization was analysed in 16 mice at the peak of 
infection (15 days), which is characterized mainly b  the infiltration of innate 
immune cells. At this time, mice were killed and the stomach homogenates were 
plated for viability determination. For each mouse, th  competition index of the frxA 
mutant versus the wild type was calculated. 
The results showed displacement of the mutant strain, which was almost completely 
eliminated after 15 days of infection (Figure 4.3c) Furthermore, the competition 





data revealed that inactivation of frxA made H. pylori less proficient in colonizing the 
stomachs of mice. 
 
4.3 Discussion 
The level of the H. pylori FrxA nitroreductase activity determined in this 
study is similar to that reported previously (~ 0.5μmol·min−1·mg−1 protein), and is 
consistent with the observation that overexpression of H. pylori FrxA confers 
nitrofurantoin and nitrofurazone reductase activity to a nitroreductase-deleted E. coli 
strain (19). Here, we have also shown that H. pylori FrxA catalyses the reduction of 
3-nitrotyrosine, a compound that is formed upon protein tyrosine nitration. To the 
best of our knowledge, such activity has so far only been tested for E. coli 
nitroreductases NsfA and NfsB, but neither was ableto metabolize this substrate (24). 
Despite the general agreement that the oxygen-independent NADPH 
nitroreductase RdxA and the NADH-flavin oxidoreductase FrxA of H. pylori are 
involved in metronidazole resistance, until now the m tronidazole activity of FrxA 
could not be evaluated. In this study, we successfully measured this activity, and 
showed that the FMN-containing H. pylori FrxA has a metronidazole activity of 0.6 
μmol·min−1·mg−1 protein. It is possible that the lack of metronidazole activity 
previously reported for H. pylori FrxA (19) was attributable to the urea denaturation 
protocol utilized for purification, which may have led to the loss of the flavin cofactor 
required for the catalytic activity of FrxA. 
H. pylori FrxA shows a metronidazole activity (0.6 μmol·min−1·mg−1 
protein) that is lower than that reported for the RdxA nitroreductase of H. pylori (9 
μmol·min−1·mg−1 protein) (19). In accordance with this observation, the H. pylori 
frxA mutant showed a lower level of metronidazole resistance than the rdxA-deficient 
strain (18). 
It is noteworthy that our work also provides the first evidence that FrxA 
plays a role in protection of H. pylori against reactive nitrogen metabolites, as the 
protein has significant GSNOR activity (0.6 μmol·min−1·mg−1 protein). In particular, 
FrxA shows a Km for GSNO (4 μM) that is higher than that of the E. coli 










formaldehyde-dependent GSNOR (700 μM) (10), indicating a higher affinity of FrxA 
for this substrate. 
We previously reported that the Staphylococcus aureus NtrA nitroreductase 
has GSNOR activity (22); this dual activity of the two enzymes is consistent with 
several studies showing that nitroreductases may accept a wide range of substrates 
(25). However, it is interesting that neither protein shows activity towards NO gas, 
indicating specificity for GSNO. 
Microbial nitroreductases are usually classified into classes A and B, 
typified by the E. coli enzymes NfsA and NfsB, respectively, and class C, which 
includes S. aureus NtrA (22). H. pylori FrxA has a high degree of amino acid 
sequence similarity with E. coli NfsB (18% identity; 41% similarity) and only 7% 
identity and 18% similarity with S. aureus NtrA. Hence, the bifunctional character of 
a nitroreductase and, in particular, its involvement in itrosative stress defence cannot 
be inferred from the class in which the enzyme is included. Hence, it is possible that 
other bacterial nitroreductases may play an equivalent role in nitrosative 
detoxification. 
Transcription of frxA is increased in cells exposed to GSNO and spermine-
NONOate, which are compounds commonly utilized as NO donors. Induction of 
transcription of the FrxA-encoding gene by nitrosative stress is compatible with the 
reduced viability and GSNO reduction capability of H. pylori frxA mutant cells. This 
result is in agreement with the general observation hat S-nitrosothiols elicit a 
transcriptional response of gene products involved in nitrosative protective functions, 
even of gene products that do not detoxify NO directly (26-28). 
Although H. pylori lacks the machinery to synthesize glutathione, it was 
reported to utilize the host's glutathione pool andto contain free cysteine (29, 30). 
Hence, the capacity of FrxA to reduce both GSNO andS-nitrosocysteine may 
represent an advantageous adaptation for survival in environments that contain the 
two compounds. 
Our results show that the growth of H. pylori is significantly inhibited by 





previous studies (16). S-nitrosylation of a number of proteins of H. pylori has been 
implicated in the susceptibility of the bacterium to NO. These include alkyl 
hydroperoxide reductase and the urease α- ubunit, and the latter was shown to be 
reversibly inhibited by GSNO in a concentration-dependent manner (31). Owing to 
its GSNOR activity, FrxA is expected to contribute to the protection of urease and to 
the in vivo survival of H. pylori. Indeed, deletion of frxA is herein shown to decrease 
the resistance of the bacterium during macrophage infection and to compromise the 
pathogen´s ability to sustain mouse stomach colonization. Although this was not an 
expected result, considering the canonical function of nitroreductases as activators of 
metronidazole, the demonstrated GSNOR activity of FrxA allows clarification of its 
association with a susceptible phenotype upon mouse colonization (32). The data also 
explain the rare occurrence of FrxA mutations in metronidazole-resistant clinical 
strains, as inactivation of its activity is expected to be detrimental to H. pylori 
survival. Therefore, it may be speculated that targetin  FrxA with drugs or antibodies 
could constitute an adjunct to the existing antibiocs by facilitating host-dependent 
clearance of the pathogen. 
In summary, the findings of this study have revealed  novel mechanism for 
the metabolism of S-nitrosothiols by H. pylori, a poorly understood aspect of this 
pathogen. We demonstrate that, despite the fact that FrxA seems to be similar to other 
nitroreductases in relation to nitrofuran reduction, it is distinct in its ability to reduce 
GSNO. We have proved that FrxA contributes to the survival of H. pylori during 
macrophage infection and mouse gastric colonization. He ce, FrxA constitutes an H.
pylori defence against the S-nitrosothiol stresses imposed by the host mammalian 
immunity to which the pathogen is exposed during its lifelong colonization. 
 
4.4 Experimental procedures 
Reagents, bacteria, culture conditions, and plasmids 
All reagents were acquired from Sigma, unless otherwis  stated. H. pylori 
26695 and B128 were used as wild type strains, and were routinely cultivated at 37 °C 
in a microaerobic atmosphere (6% O2, 7% CO2, 3.5% H2, and 83.5% N2) (Anoxomat 
Mart, Drachten, The Netherlands), in horse blood agar (BA) composed of Blood Agar 










Base no. 2 (Oxoid, Basingstoke, UK) with 10% (v/v) defibrinated horse blood 
(Probiológica, Lisbon, Portugal), or brain heart infusion (BHI) broth (Oxoid) 
supplemented with 10% (v/v) decomplemented fetal bovine serum (Gibco-
Invitrogen, Paisley, Scotland, UK). All media were supplemented with an 
antibiotic/antifungal mix composed of 0.3 mg·L−1 polymyxin B, 12.5 mg·L−1 
vancomycin, 6 mg·L−1 trimethoprim and 5 mg·L−1 amphotericin B, and, when 
required, 20 μg·mL−1 kanamycin and 4 μg·mL−1 chloramphenicol. H. pylori grown 
for 24 h in BA plates was utilized to inoculate liqu d precultures (25-cm2 cell culture 
flasks filled with 10 mL of BHI + fetal bovine serum medium) at a OD600 of 0.05 that 
were grown for 16 h at 37 °C and 150 r.p.m. (final OD600 of ~ 1). The resultant cells 
served as inocula in all subsequent studies. 
Plasmid manipulations were performed in E. coli XL2-Blue and E. coli 
MC4100. The triparental conjugation was performed with E. coli GC7 (pBRK2013), 
and E. coli BL21 Gold (DE3) served as host cells for expression of the recombinant 
protein. All E. coli cells were grown on LB medium that, when required, was 
supplemented with 30 μg·mL−1 kanamycin, 10 μg·mL−1 tetracycline, and 30 μg·mL−1 
chloramphenicol. 
GSNO and S-nitrosocysteine were freshly prepared by mixing equimolar 
amounts of sodium nitrite and reduced glutathione ad cysteine, respectively, under 
acidic conditions (0.05 M HCl), and neutralized with NaOH (33). 
Liquid precultures of H. pylori 26695 and B128 wild type strains and their 
corresponding frxA (hp0642 in H. pylori 26695) mutants were transformed with the 
empty plasmid pILL2157 and pILL2157 containing the frxA gene. Assays were 
performed in 24-well plates containing 1.2 mL of BHI + fetal bovine serum medium 
and, when indicated, supplemented with isopropyl thio-β-D-galactoside (IPTG). 
Plates were inoculated with the precultures to an initial OD600 of 0.05, and 
immediately exposed to 200 μM and 300 μM GSNO or left untreated (control). The 
number of viable cells [colony-forming units (CFUs)·mL−1] was monitored after 12 
h and 24 h by serial dilution of the cultures in BHI medium and plating on BA plates. 
The percentage survival represents the ratio of the number of viable cells determined 





Construction of the H. pylori nonpolar frxA-deficient mutant 
Nonpolar inactivation of rxA and rdxA in H. pylori 26695 and B128 was 
performed by allelic exchange after transformation of H. pylori with a three-fragment 
assembly product that carried frxA flanking regions of the target gene and the 
kanamycin aphA-3 cassette, with the primers shown in Table 1. Generation of the 
product and its introduction into H. pylori were performed essentially as previously 
described (8). Inactivation of rdxA was achieved by transforming H. pylori with a 
previously constructed suicide plasmid that carries the kanamycin cassette flanked 
by 500-bp regions upstream and downstream of rdxA (34). The presence of the 
desired mutations in the H. pylori chromosomal DNA was confirmed by PCR 
analysis. 
For the complementation assays, frxA was amplified from the H. pylori 
26695 genomic DNA with primers FrxAndeI and FrxAxhoI (Table 1), digested with 
NdeI/XhoI, and cloned into NdeI/XhoI-digested pILL2157 (35) to give recombinant 
pILL2157-frxA. pILL2157 and pILL2157-frxA were introduced by triparental 
conjugation into H. pylori B128 frxA with E. coli GC7 (pRK2013) as mobilizer (36). 
 
Production and purification of recombinant FrxA 
The frxA gene was PCR-amplified from the H. pylori 26695 genomic DNA 
with primers FrxAndeI and FrxAxhoI (Table 1), and cloned into NdeI/XhoI pET28a 
(Novagen, Nottingham, UK) to produce a protein with a poly-histidine tail fusion at 
the N-terminal region. The resulting vector, pET28-frxA, was introduced into E. coli 
BL21 Gold (DE3), which was grown aerobically at 37 °C in LB medium 
supplemented with 50 μM riboflavin. When they had reached a OD600 of 0.3, cells 
were treated with 500 μM IPTG and grown for a further 6 h at 20 °C. Cells were then 
harvested by centrifugation (8000 g, 10 min at 4 °C), disrupted in a French pressure 
cell, and ultracentrifuged for 2 h at 100,000 g and 4 °C. The soluble fraction was 
loaded into a Ni2+ -chelating Sepharose Fast Flow resin (GE Healthcare, Little 
Chalfont, UK) previously equilibrated with 20 mM Tris/HCl (pH 7.5), 500 mM NaCl, 
and 10% (v/v) glycerol, and FrxA was eluted with 500 mM imidazole. After 










overnight dialysis against 20 mM Tris/HCl (pH 7.5) containing 10% (v/v) glycerol, 
the protein purity was evaluated by SDS/PAGE with the Roti-Mark protein molecular 
mass marker (Carl Roth). The protein concentration was determined with the 
bicinchoninic acid assay (37). 
The quaternary structure of FrxA was determined in a Tricorn Superdex 200 
(10/300) GL column (GE Healthcare), equilibrated in 20 mM Tris/HCl (pH 7.5), 150 
mM NaCl, and 10% (v/v) glycerol, with catalase (230,00 Da), myoglobin (17,000 
Da), haemoglobin (64,000 Da), γ-globulin (140,000 Da), horse cytochrome c (13,700 
Da) and albumin (66,000 Da) as standards. 
Incorporation of FMN was achieved by incubating thepurified H. pylori 
FrxA (20 μM) with 10-40 μM FMN for 20 min at room temperature under light-
protective conditions. Unbound FMN was removed by passing the sample through a 
Biospin P-6 column (Biorad, Munich, Germany). The type and content of flavin was 
determined after incubation of FrxA (~ 20 μM) with SDS 0.2% (w/v) for 20 min, by 
measuring the absorbance at 446 nm [ε446 nm (FMN) = 12,000 M−1·cm−1] (38). 
 
Enzymatic assays 
H. pylori cultures grown for 24 h on BA plates were resuspended in BHI 
medium supplemented with 0.2% (v/v) β-cyclodextrin to a OD600 of ~ 0.4, and left 
untreated or exposed to 100 μM GSNO for 1 h at 37 °C. Cells were then collected, 
washed, and resuspended in reaction buffer, and lysates were prepared by incubating 
cells with 0.1 mg·mL−1 lysozyme and 0.02% sodium deoxycholate for 15 min at 37 
°C. Reaction mixtures containing the cell lysate, 20 mM Tris/HCl (pH 7.5), 0.2 mM 
NADPH and 0.4 mM GSNO were used to determine GSNOR activity by monitori g 
the combined consumption of NADPH and GSNO at 340 nm [ε340 nm (NADPH + 
GSNO) = 7.04 mM−1·cm−1) (8). In all cases, NADPH consumption of reaction 
mixtures lacking the cell lysate was evaluated and subtracted from that obtained for 
the respective reaction mixtures containing all comp nents. Activities are defined as 
units (μmol GSNO consumption·min−1·mg total protein−1). At least three biological 





The enzymatic activity of purified H. pylori FrxA (0.5 μM) was determined 
for the indicated substrates (2.5-200 μM) and evaluated in reaction mixtures that 
contained 50 mM Tris/HCl buffer (pH 7.5) and 200 μM NADPH; the reaction was 
initiated by the addition of FrxA, which was previously incubated with a two-fold 
molar excess of FMN. Metronidazole activity was determined with FrxA previously 
incubated with the indicated amounts of FMN, as described above. Values were 
corrected for the activity of the reaction between NADPH and the corresponding 
substrate. 
The following substrates were assayed: nitrofurazone, itrofurantoin, 
metronidazole, and 3-nitrotyrosine. GSNO and S-nitrosocysteine, freshly prepared 
from reduced glutathione or cysteine, as described above, were also tested as 
substrates. All assays were performed in 96-well plates (200 μL per well) in a 
Multiskan Go microplate spectrophotometer (Thermo Scientific, Dreieich, 
Germany). The following extinction coefficients were used: ε(nitrofurazone, 400 nm) = 12.96 
mM−1·cm−1 (39); ε(nitrofurantoin, 420 nm) = 12.0 mM−1·cm−1 (20), ε(3-nitrotyrosine, 420 nm) = 4.40 
mM−1·cm−1 (40), ε(NADPH, 340 nm) = 6.22 mM−1·cm−1, ε(metronidazole, 320 nm) = 9.0 mM−1·cm−1 
(20), and ε(GSNO/CysNO, 334 nm) = 0.907 mM−1·cm−1 (33). Two independent batches of 
protein were assayed in triplicate, and data were fitt d to the Michaelis-Menten 
equation with GraphPad Prism 5. 
 
Quantitative real-time RT-PCR analysis 
An overnight culture of H. pylori 26695 was utilized to inoculate fresh BHI 
+ fetal bovine serum medium to a OD600 of 0.05. Cells were grown to a OD600 of 0.5, 
and cultured for 1 h in the absence and in the presence of 150 μM spermine-NONOate 
or 200 μM GSNO. After collection of the cells by centrifugation (8000 g, 10 min at 
4 °C), the total RNA was isolated with the Qiagen RNeasy kit (Qiagen, Hilden, 
Germany), and residual DNA was removed by treatment with Turbo DNA-free 
(Ambion, Madrid, Spain). RNA was quantified in a NanoDrop spectrophotometer, 
and its integrity was confirmed by agarose gel electrophoresis. cDNA was prepared 
by the use of total RNA (2 μg), random hexamers (100 ng; Roche, Mannheim, 
Germany), and Superscript II Reverse Transcriptase (Invitrogen, Paisley, Scotland, 










UK). The quantitative real-time RT-PCR reactions were prepared with the 
LightCycler FastStart DNA Master SYBER Green I kit, with 20 ng of cDNA and 
oligonucleotides frxART5 and frxART3 (Table 1), and performed in a LightCycler 
instrument (Roche Applied Science). The frxA transcript level was normalized to the 
mRNA abundance of the constitutive ppk gene (polyphosphate kinase; hp1010) 
determined with the oligonucleotides ppkRT5 and ppkRT3 (Table 1). Three 
biological samples were analysed in duplicate. 
 
Macrophage assays 
Murine macrophage RAW264.7 cells (ATCC Tib71) were cultured in 
DMEM with 4.5 g·L−1 glucose and glutamax supplemented with 10% (v/v) fetal 
bovine serum, 1 mM sodium pyruvate, 70 units·mL−1 penicillin and 70 μg·mL−1 
streptomycin in a humidified 5% CO2/95% air atmosphere. Macrophages were 
seeded on 24-well plates (5 × 105 cells per well), and after 24 h the medium was 
replaced with infection medium, namely DMEM (Gibco) supplemented with 1 mM 
sodium pyruvate and 0.4 mM L-arginine, and, when required, 0.8 mM L-NMMA. 
Wild type and respective frxA mutants of H. pylori 26695 and B128 previously 
transformed with pILL2157 and pILL2157-frxA were grown for 24 h in BA plates 
and used to prepare bacterial suspensions, which were added to the macrophages at 
a multiplicity of infection of 100. The plates were then centrifuged at 1500 g for 5 
min, and incubated for 24 h in the presence of 1 mMIPTG. For bacterial survival 
determination, cells were scraped from wells, diluted in BHI medium, and added to 
BA plates, which were next incubated under microaerbic conditions at 37 °C. 
Aliquots of the supernatants were taken to evaluate the nitrite concentration by means 
of the Griess reaction method (41); the standard sodium nitrite solution was prepared 
in infection medium. 
 
Mouse colonization assays 
Animal handling and experiments were carried out in strict accordance with 
institutional guidelines prescribed by the committee of Hygiène Sécurité et Protection 
de l'Environnement (Protocol 98-223; Institut Pasteur) and the European Union 





used for scientific purposes. Our laboratory has the administrative authorization for 
animal experimentation (Permit Number 75-1554). Allefforts were made to 
minimize suffering. Mice were killed with CO2. 
For mouse infection, bacterial suspensions of H. pylori B128 and the derived 
frxA mutant were independently prepared in physiological saline solution with, as 
inocula, cultures of H. pylori cultivated in BA plates for 24 h. Infection was 
performed orally by feeding 5-week-old female wild-type C57BL/6J mice with a 
bacterial suspension consisting of a mixture (1:1) of the H. pylori wild type and 
mutant strains (2 × 108 bacteria per mouse). 
The numbers of viable cells of wild-type and frxA mutant H. pylori in the 
inoculation mixtures were assayed by plating serial d lutions of the cultures in 
kanamycin-selective and nonselective plates. After 15 days of infection, mice (n = 
16) were killed with CO2, and their stomachs were weighed before being ground in 
peptone broth and serially diluted in peptone broth. The viability of each H. pylori 
strain was evaluated from the CFUs·mL−1 obtained upon plating of the stomach 
homogenates on BA medium containing 200 μg·mL−1bacitracin and 10 μg·mL−1 
nalidixic acid. Selection of the frxA mutant was achieved by further supplementation 
of the medium with 20 μg·mL−1kanamycin. Plates were incubated for 8 days at 37 
°C in a microaerobic atmosphere. The competition index of frxA was calculated from 
the following formula: 
 
competition index = CFU CFU 	  
CFU
CFU   
 
Statistical analyses were performed with GraphPad Prism 5 (GraphPad 
Software, San Diego, CA, USA) and one-way ANOVA, followed by a Bonferroni 
multiple comparison test; for the t-test, a significance threshold at P < 0.05 (95% 
confidence level) was used. 
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Helicobacter pullorum is an avian enterohepatic species that, more recently, 
has also been found as a naturally acquired infection in mice and rats, and isolated 
from patients with gastrointestinal and hepatobiliary diseases. In this work, the 
interaction between H. pullorum and murine macrophages was examined. Firstly, the 
impact of nitric oxide, which is an antimicrobial produced by mammalian 
macrophages, on H. pullorum 6350-92 viability and morphology was studied by 
colony-forming assays and light microscopy, respectiv ly. Exposure to nitric oxide 
lowered H. pullorum viability, in a growth-phase-dependent manner, and decreased 
the mean cell size. However, the number of coccoid forms remained low, contrasting 
with what has been observed for other Helicobacter species. Confocal microscopy 
showed that H. pullorum is internalized by murine macrophages, triggering nitric 
oxide production that promotes phagocytosis and killing of the pathogen. Interaction 
between H. pullorum and macrophages stimulated secretion of pro-inflamm tory 
cytokines, such as TNF-α, IL-1β, IL-6 and MIP-2. These results show that H. 




Helicobacter pullorum is an enterohepatic Gram-negative and 
microaerophilic non-spore-forming bacterium that presents slightly curved rod cells 
and an unsheathed monopolar flagellum. H. pullorum was first described in the caeca 
of asymptomatic poultry and the livers and intestinal contents of laying hens 
suspected of having vibrionic hepatitis (1). H. pullorum was also shown to colonize 
turkeys, guinea fowls, psittacine birds and, more recently, rats and mice (2-8). 
Moreover, H. pullorum is considered an emergent human foodborne pathogen 
implicated in several intestinal pathologies (9). In particular, H. pullorum has been 
found in patients with diarrhoea, gastroenteritis, inflammatory bowel disease, 





H. pullorum adheres to and invades human intestinal Caco-2 cells, possesses 
a type-VI secretion system (17) and expresses a cytolethal distending toxin (CDT) 
(18-20). The bacterium presents LPS with the highest biological activity within the 
genus Helicobacter, capable of inducing NF-κβ activation (21). In gastric and 
intestinal epithelial cell lines, H. pullorum triggers the production of IL-8 via NF-κβ, 
probably due to its LPS involvement (22). 
As sentinel cells of the human body, macrophages ar activated by several 
signals, including cytokines (e.g. gamma interferon, INF-γ) and microbial 
compounds (e.g. LPS). In primed macrophages, a variety of pro-inflammatory 
cytokines, such as IL-1β and TNF-α mediate the expression of the inducible nitric 
oxide synthase (iNOS) (23). 
The mammalian iNOS enzyme produces nitric oxide (NO), a highly reactive 
molecule that combines with oxygen species, produce by activated macrophages 
and neutrophils, to generate species like nitrosonium (NO+), nitroxyl (NO−), 
peroxynitrite (ONOO−) and nitrite (NO2−). Most of these reactive nitrogen species 
damage several bacterial components, such as DNA, lipids, protein metal centres and 
the amino acid residues of proteins, causing inactiv tion of key metabolic functions 
and ultimately leading to microbial clearance (24-26). 
In spite of the potential pathogenicity of this bacterium, the mechanisms of 
H. pullorum infection remain poorly understood. For example, th re is still a gap in 
the knowledge on how H. pullorum behaves when facing antimicrobials produced by 
the host immune system and regarding the response of phagocytes to H. pullorum. In 
this work, we have evaluated the viability and morphological modifications of H. 
pullorum when exposed to nitrosative stress generated by different NO donors 
applied at different stages of bacterial growth. The interaction of H. pullorum with 
murine macrophages was studied by confocal microscopy and through the analysis 
of the cytokines stimulated upon H. pullorum infection. 











5.2 Experimental procedures 
Bacterial strain manipulation 
H. pullorum 6350-92 (CCUG 33838), which was isolated from a stool 
sample of a patient with gastroenteritis and hepatitis (27), was used as the reference 
strain. The strain was routinely cultivated on blood agar (BA) plates, which are 
composed of solid medium blood agar base no. 2 (Oxoid) supplemented with 10% 
(v/v) defibrinated horse blood (Probiológica) and an ntibiotic/antifungal mix 
containing 6.3 g vancomycin L− 1 (Roth), 3.1 g trimethoprim L− 1 (Sigma) and 2.5 g 
amphotericin B L− 1 (Roth). Cells were incubated in closed jars, at 37 °C, under a 
microaerobic atmosphere (7% CO2, 6 % O2, 3.5 % H2 and 83.5 % N2) generated by 
an Anoxomat system (Mart Microbiology). Bacteria were taken as fully grown after 
culturing on BA plates for a total of 5 days, during which bacteria were twice 
transferred to fresh BA medium. 
 
Viability tests 
The viability of H. pullorum under nitrosative stress conditions was 
determined by exposing cells to the following nitrosative stress generators: spermine-
NONOate (Sigma; t1/2 ∼ 40  min; (28)), dipropylenetriamine (DPTA)-NONOate 
(Cayman; t ½ ∼ 3  h) and S-nitrosoglutathione (GSNO; t1/2 ∼ 50  min; (29)). GSNO 
was freshly prepared by mixing equimolar amounts of odium nitrite and reduced 
glutathione under acidic conditions (0.05  M HCl) (28). For these assays, fully grown 
bacteria were inoculated in 25 cm2 cell culture flasks (Nunc) filled with 10  mL 
medium, at an initial optical density at 600 nm (OD600) of 0.1-0.2, in brain heart 
infusion (BHI) broth (Oxoid) plus 10% (v/v) defibrinated FCS (Gibco-Invitrogen) 
(BHI-FCS) and grown for 19  h at 150  r.p.m. These cells were used to inoculate BHI 
medium supplemented with 0.2% (w/v) β-cyclodextrin (Sigma) (BHI-βCD) at an 
OD600 of 0.05, and distributed into 24-well plates. The stress generators were added, 
at concentrations ranging from 50 to 500 μM, at different stages of H. pullorum 
growth: immediately after inoculation (OD600 ∼ 0.05, lag phase), after 12  h (OD600 ∼ 





number of viable cells was monitored at 12  h intervals up to 48  h after the stress 
application. The number of CFU·mL− 1 was evaluated by serially diluting each 
sample in BHI medium and plating on antibiotic/antifungal cocktail containing BA 
plates, which were incubated for 48  h. 
 
Morphological studies 
H. pullorum morphology under nitrosative stress was studied in cells grown 
in BHI-FCS, as described above for the viability tests, and exposed to spermine-
NONOate (10, 50 and 100 μM). Cells prepared similarly but not exposed to anystress 
were also visualized. After 24  h incubation, cell suspensions were pelleted by 
centrifugation (5  min at 2400 g ), resuspended in 10-50 μl PBS and mounted onto 
1.7% (w/v) agarose-coated glass slides. Images were acquired with a 
iXonEMCCD+885 cooled camera (Andor Technology) attached to a DMR600 
Microscope (Leica), with × 64/1.6 NA magnification, and treated with ImageJ 
software (30). The percentage of bacilli versus cocci forms and the cell size were 
evaluated by counting and measuring manually a total of 100 cells per condition using 
Metamorph software version 4 (Molecular Devices). 
 
Infection assays with murine macrophages 
Murine macrophages J774A.1 (ATCC TIB-67) were cultured in Dulbecco's 
modified Eagle's medium (DMEM) with high glucose, GlutaMAX supplement, 
pyruvate (GIBCO), 10% (v/v) FCS and 100 μg penicillin/streptomycin mL− 1 (Sigma) 
(DMEMc medium), and incubated in a humidified 5% CO2-air-controlled 
atmosphere at 37 °C. For the infection assays, J774A.1 macrophages were 
resuspended in Roswell Park Memorial Institute 1640 medium (RPMI), GlutaMAX 
supplement (Gibco) containing 10% (v/v) FCS and 100 μg penicillin/streptomycin 
mL− 1 (RPMIc medium), and seeded for 3 h in 24-well plates at a density of 5 × 10 
5cells per well. Macrophages were left untreated (non-activated macrophages), or 
activated overnight with 0.3 μg INF-γ mL− 1(Sigma) and 1 μg LPS mL− 1 (Sigma) 
(activated macrophages). When required, murine iNOS activity was inhibited by NG-
monomethyl-L-arginine acetate salt (L-NMMA; Sigma; 800 μM), which was added 











simultaneously to INF-γ and LPS. After 12 h of incubation, the macrophage medium 
was exchanged by infection medium that consisted of RPMI GlutaMAX plus 10% 
FCS (RPMIi) and, where indicated, supplemented with800 μM L-NMMA. 
For macrophage infection assays, fully grown bacteria were cultured on BA 
plates for another 24 h. These bacteria were used to inoculate, at an OD600 ∼ 0.1-0.2, 
Brucella broth liquid medium (BB; Gibco) containing 5% FCS (BB-FCS), and the 
H. pullorum was grown for 15 h. Bacilli were then pelleted (10 min, 8740 g , 4 °C) 
and resuspended in RPMIi at an OD600 of 0.2, and the bacterial viability determined 
by CFU counting prior to incubation within macrophages (time 0 of infection). 
Bacteria were used to infect macrophages, at a MOI of 100, for 5 and 10 h. For each 
time point, the H. pullorum-infected macrophages were collected and bacteria present 
in the supernatant, adherent to the surface of the macrophages and localized inside 
the macrophages were platted together, and the CFU count of viable H. pullorum 
bacilli was determined following incubation under microaerobic conditions. At the 
same time points of infection, the amount of NO produced by macrophages as the 
nitrite accumulated in the supernatants of the macrophage cell cultures was 
quantified. Nitrite production by macrophages that were not infected or infected with 
H. pullorum, and in the presence and in the absence of INF-γ/LPS/L-NMMA, was 
also analysed. The nitrite content was determined by microtitre plate colorimetric 
assay (Multiskan GO; Thermo Scientific), which consisted of readings of the 
absorbance at 540 nm of the 1:1 mixtures of supernatant (100 μL) and Griess reagent 
(1%, (w/v), sulfanilamide/0.1% (w/v) naphthylethylene diamine dihydrochloride/2% 
(v/v), phosphoric acid). Sodium nitrite was used as st ndard. 
 
Confocal experiments 
For the confocal experiments, J774A.1 macrophages (1 × 10 6 cells per well) 
were seeded in 6-well plates containing submerged glass coverslips and cultivated in 
DMEMc for 12 h. Macrophages were left untreated (non-activated macrophages) or 
activated for 5 h with 0.15 μg INF-γ mL− 1 and 0.5 μg LPS ml− 1 (activated 
macrophages); where indicated, the inhibition of the NO production was achieved by 





H. pullorum bacilli grown in BB-FCS for 15 h, as described above for the 
macrophage assays, were washed with PBS, resuspended i  DEMEM without 
antibiotics (DMEMi) and DMEMi plus 800 μM L-NMMA at an OD600 of ∼ 0.2 and 
viability was determined by CFU counting, and the cells were then used to infect 
macrophages at a MOI of 100. After 30 min and 2 h of infection, each well was 
washed three times with PBS to remove non-adherent bacteria, the cells were fixed 
with 4% (w/v) formaldehyde, washed again (three times in PBS), stained with 2 μM 
HCS CellMask red (Molecular Probes) for 30 min at room temperature and PBS 
washed three times. The coverslips were mounted onto microscopy slides and 
confocal Z-stacks were acquired on a Leica SP5 confocal microscope, using a 
× 63/1.3 NA oil immersion objective, a 568 nm laser line and the spectral detection 
adjusted for the emission of the Alexa 568 fluorochme. Stained macrophages that 
were activated by INF-γ and LPS, and incubated in DMEMi for 2 h, were also 
examined, and served as internal controls. For quantitative assessment, adherent and 
intracellular bacteria of 100 random macrophages per condition were counted and 
images treated with ImageJ software. Two separate exp riments were performed and 
cell counting was validated by two independent observers. 
In parallel experiments, the viability of the adherent and intracellular H. 
pullorum bacilli was determined upon infection of macrophages for 30 min and 2 h. 
Each well was washed three times with PBS to remove bacteria present in 
supernatants, macrophages lysed with 2% (w/v) saponin and their bacterial content 
evaluated by CFU counting. 
 
Analysis of cytokine gene expression 
Expression of TNF-α, IL-1β, IL-6 and macrophage inflammatory protein 2 
(MIP-2), which is the mouse homologue of the mammalian IL-8 (31), was quantified 
in mRNA extracted from J774A.1 macrophages seeded, for 3 h, in 24-well plates 
(5 × 105 cells per well) containing RPMIc medium. H pullorum bacilli prepared in 
RPMIi, as described above for the macrophage assays, were incubated with 
macrophages at a MOI of 100, for 6  h. For comparison purposes, expression of 
cytokines in macrophages non-infected, non-activated nd activated only with INF-











γ (0.15 μg·mL− 1) and LPS (0.5 μg·mL− 1) was also measured. After incubation, the 
wells were washed with cold PBS and the total RNA was isolated with a High Pure 
RNA isolation kit (Roche). Residual DNA was digested using the enzymes of the 
Turbo DNA-free kit (Ambion). For each sample, 200 ng RNA was converted to 
cDNA using the anchored-oligo-dT primers and the Transcriptor High Fidelity 
cDNA synthesis kit (Roche). Semiquantitative reverse transcriptase PCR reactions 
contained 40 ng cDNA μL− 1, 2.5 U Taq DNA polymerase (BioLabs), 200 μM dNTPs 
(Nzytech) and 0.5 μM of each primer (Table 5.1), in 50 μL final volume. The reverse 
transcriptase PCR conditions were: 1 cycle of denaturation at 95 °C (30 s-2 min), 
followed by 30 cycles at 95 °C for 45 s, 50-55 °C for 30-45 s and 68 °C for 1 min, 
followed by a final cycle at 68 °C for 5 min. Bio-Rad Quantity One software was used 
in order to perform three steps that allowed the determination of the relative 
quantification of the cytokine expression: (i) image background subtraction; (ii) 
estimation and integration of all the pixels present in the DNA bands to an estimated 
area; and (iii) the area obtained for the gene band of interest, under the different 
conditions tested, was divided by the area estimated for the constitutive gene band, 
the murine glyceraldehyde 3-phosphate dehydrogenase (gapdh) gene, in the 
respective condition. These estimated relative quantifications enabled the 
establishment of comparisons of differences in cytokine expression upon 
macrophage infection with H. pullorum. Two independent biological samples were 
analysed in quadruplicate. Statistical analyses were p formed by Student's unpaired 
t-test using GraphPad Prism software. 
Table 5.1 Oligonucleotides used in this study 


























Effect of nitrosative stress agents on H. pullorum viability 
The viability of H. pullorum 6350-92 under NO stress was analysed by 
exposing cells to different sources of NO. Two NONOates, spermine-NONOate and 
DPTA-NONOate, which differ in NO releasing rates, and GSNO, which typifies S-
nitrosothiols and donates a nitroso functional group to another thiol via a 
transnitration reaction (33), were used. Hence, the bacterial phenotype responses to 
NONOates and GSNO are expected to be different. 
H. pullorum grown to lag phase (OD600 ∼ 0.05), early exponential phase 
(OD600 ∼ 0.2) and stationary phase (OD600 ∼ 1) (Figure 5.1), in Supplementary 
Material) was treated with nitrosative stress-generating agents in concentrations that 
ranged between 50 and 500 μM, and viability was evaluated at several intervals of 
time up to 84 h (Figure 5.2). 
 
 
Figure 5.1 Growth of H. pullorum cultured under conditions similar to those used in 
this study. Data are presented as means ± standard deviations of the measured values 
























Figure 5.2 Effect of nitrosative stress on H. pullorum viability. (a) H. pullorum at lag 
phase (T = 0  h), (b) early exponential phase (T = 12  h) and (c) stationary phase 
(T = 48  h) was exposed to several concentrations of spermin -NONOate (SP), 
DPTA-NONOate (DPTA) and GSNO. Nitrosative stress agents were tested at 50 μM 
(white bars), 100 μM (light grey bars), 250 μM (medium grey bars) and 500 μM (dark 
grey bars), and black bars depict non-stressed cells. Numbers within squares indicate 
the time of addition of the NO donor. Data are presented as the mean ± standard 
deviation of one biological sample with three replicates. 
 
Addition of NONOates to cells at the lag phase caused a viability decrease 
for all tested concentrations (Figure 5.2a). When clls were treated with the same 
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that of spermine-NONOate, which is most probably reated to the longer half-life of 
the former. Nevertheless, in both cases recovery of viability occurred 48 h after NO 
exposure, except for the highest NONOate concentration used (500 μM). Different 
growth behaviour was observed when the stress was applied to H. pullorum at the 
early exponential phase: for the same concentration, he addition of NONOates to 
cells at the early exponential phase caused a smaller decrease in viability when 
compared to cells treated at the lag phase. Moreove, growth recovery to levels 
similar to untreated cells was observed in a shorter in rval of time (Figure 5.2b). The 
results also showed that no viability impairment occurred when NONOates are 
applied to H. pullorum cells that had reached the stationary phase (Figure 5.2c). 
Exposure of lag phase-grown cells of H. pullorum to GSNO led to a decrease 
of viability, but only for high concentrations of GSNO (250 and 500 μM) (Figure 
5.2a). The inhibitory effect persisted over time as after 24 h treatment the cells 
exposed to 250 and 500 μM GSNO still displayed very low viability. However, H. 
pullorum did not suffer substantial viability impairment when GSNO was supplied 
to cells at the early exponential and stationary phases (Figure 5.2b, c). Altogether, it 
was concluded that NO donors have an antimicrobial action against H. pullorum only 
when cells are at the initial growth phase. 
 
H. pullorum cell size decreases under NO stress 
To investigate the morphological alterations caused by nitrosative stress on 
H. pullorum, cells were treated with spermine-NONOate (10-100 μM) and examined 
by light microscopy. The majority of the H. pullorum NO-exposed cells exhibited a 
bacillary form similar to that observed for untreated cells. Cells with U, V, C and S 
shapes were also observed, mainly in samples exposed to 50 and 100 μM of 
spermine-NONOate (Figure 5.3a), as these usually occur when bacteria are changing 
from bacilli to coccoid form (34-36). Interestingly, exposure of H. pullorum to NO 
stress caused alterations in the cell size, as judged by a decrease in the mean cell size 
of ∼ 25% upon exposure to 50 and 100 μM spermine-NONOate. Moreover, the cell 
size shortening was accompanied by a decrease in length heterogeneity (Figure 5.3a, 
b). 












Figure 5.3 Morphology of H. pullorum NO-treated cells. (a) Phase-contrast 
microscopy images, and percentage of coccoid and bacillary forms, of H. pullorum 
cells exposed to the indicated concentrations of spermine-NONOate. Images are 
representative of the most common morphological phenotype observed for each 
condition. Morphological forms are indicated as follows: cocci (full arrows) and U/C 
shape (dashed arrows). Bar, 5 μm. (b) Mean cell length of H. pullorum untreated 
(white bar), and exposed to 10 μM (black bar), 50 μM (light grey bar) and 100 μM 
(dark grey bar) of spermine-NONOate (SP) for 24 h. Data are presented as the mean ± 
standard error of the mean. **, P < 0.01; ***, P < 0.0001 (t-test). The percentage of 
bacillary/coccoid forms and the mean length were det rmined by manually analysing 
100 cells per condition in two independent biological samples. 
 
H. pullorum viability is lower in NO-producing murine macrophages 
H. pullorum viability upon infection of J774A.1 murine macrophages was 
evaluated. When incubated with non-activated macrophages, H. pullorum suffered a 
decrease in survival of less than one log after 5 h, and approximately one log after 
10 h. When in contact with INF-γ/LPS-activated macrophages, H. pullorum viability 
dropped significantly by approximately three logs after 5 h, and more than four logs 
after 10 h. Addition to macrophages of the mammalian iNOS enzyme inhibitor L-
NMMA (37, 38) rescued H. pullorum viability to levels comparable to those observed 
within non-activated macrophages (Figure 5.4a). Since the release of NO by 





macrophages upon infection. The results show that H. pullorum activates the 
mammalian iNOS as the nitrite content declined to zero when infection occurred in 
the presence of the iNOS inhibitor L-NMMA (Figure 5.4b). Furthermore, H. 
pullorum viability was inversely related to the amount of NO generated by 
macrophages as a higher number of H. pullorum colonies was observed when lower 
nitrite contents were present in the supernatants (Figure 5.4). Hence, H. pullorum 
triggers the mammalian innate immune system inducing the iNOS enzyme and the 
NO generated acts as a bactericidal agent against th s pathogen. 
 
 
Figure 5.4 H. pullorum survival in murine macrophages and nitrite content derived 
from the NO produced by macrophages. (a) H. pullorum viability in J774A.1 murine 
macrophages: non-activated (black bars), stimulated with INF-γ/LPS (grey bars) and 
activated in the presence of the iNOS inhibitor L-NMMA (white bars). Bacterial 
viability was evaluated immediately before infection (time 0), and at 5 and 10 h post-
infection. (b) NO produced by macrophages was evaluated in the form of nitrite in 
the presence (+) and the absence (−) of the indicated components. At least three 
replicates were analysed for each condition. Data are presented as the 



























































































H. pullorum is phagocytized by murine macrophages 
H. pullorum loads in J774A.1 macrophages were quantified by analysis of 
fluorescent images obtained with confocal microscopy. INF-γ/LPS-activated 
macrophages that were not infected with bacteria confirmed that stained macrophage 
cells could be distinguished from stained bacterial cel s (Figure 5.5a, b). Bacteria 
were considered as either internalized or adherent to macrophages based on the 




Figure 5.5 Confocal images of macrophages J774A.1 Maximum-intensi y 
projections of whole Z-stacks of (a) non-activated and (b) INF-γ/LPS activated 
macrophages. In c) orthogonal single planes from a confocal stack of H. pullorum 
infected macrophages is shown. Bacteria location was confirmed by inspection of 
three planes simultaneously. Bacteria appearing at the surface on, at least 2 
orthogonal planes were considered extracellular. Bacteria were treated as internalized 
when visualized within the cytoplasm in all three orth gonal planes. The dashed and 
full arrows indicate adherent and internalized bacteria, respectively. Scale bar 
corresponds to 10 μm. 
 
Phagocytosis of H. pullorum by non-activated, activated and iNOS-inhibited 





H. pullorum cells were found to adhere to macrophages and to be internalized. The 
percentage of macrophages with phagocytized bacteri was 70% after 30 min and 
86% after 2 h infection. The highest number of bacteria phagocytized per macrophage 
was observed for activated macrophages, i.e. when macrophages were producing 
significant quantities of NO (Figure 5.6a, c). Concmitantly, suppression of NO 
production led to a decrease in the number of bacteri  per macrophage. In parallel 
experiments, the viability of H. pullorum within macrophages was determined under 
conditions that replicated those used for confocal microscopy experiments. These 
results also showed that H. pullorum survival was lower in activated macrophages 
when compared to non-activated and iNOS-inhibited macrophages (Figure 5.6c). 
 











Figure 5.6 Phagocytosis of H. pullorum by murine macrophages. (a) Confocal 
images of H. pullorum adhered and internalized by J774A.1 macrophages that were 
non-activated, or INF-γ/LPS treated in the absence and presence of L-NMMA, and 
visualized after 30 and 120 min post-infection. (b) Amplified images of H. pullorum 
before and after 30 and 120 min post-infection of INF-γ/LPS-treated macrophages. 
Confocal images (a, b) are maximum-intensity projections of the whole Z-stacks and 
representative of the most common morphological form bserved for each condition 
for two independent biological replicates. Bars, 10 μm. (c) Mean number of 
internalized bacteria per macrophage (i), counted from the Z-series confocal stacks 
of a total of 200 macrophages evaluated in two independent biological experiments; 
and the correspondent macrophage nitrite content (ii) and H. pullorum viability (iii) 
in non-activated (black bars), or INF-γ/LPS-activated macrophages in the absence 
(grey bars) and presence of L-NMMA (white bars). Data re presented as the 
mean ± standard error of the mean. *, P < 0.05; **, P < 0.01; ***, P < 0.0001 (t-test).  
Prior to infection in macrophages, H. pullorum cells presented a bacillary 
shape (Figure 5.6b, before). Upon incubation in macrophages, internalized bacteria 
exhibited coccoid and shorter bacillary forms (Figure 5.6b, 30 and 120 min). 
Altogether these results indicate that the production of NO by macrophages increases 
the phagocytosis of H. pullorum cells, which upon internalization acquire a coccoid 
or shorter bacilli shape. 
 
H. pullorum induces the expression of cytokines in macrophages 
J774A.1 macrophages were incubated with H. pullorum and the level of 
gene expression of TNF-α, IL-1β, IL-6 and MIP-2, which has been reported to be 
linked to iNOS activation (39, 40), was determined. Infection of macrophages with 
H. pullorum for 6 h resulted in the production of IL-1β, TNF-α, IL-6 and MIP-2 
cytokines, in relation to non-infected and non-activated macrophages. H. pullorum 
induced the expression of IL-1β, TNF-α, IL-6 and MIP-2 at levels similar to those 






Figure 5.7 Induction of host cytokines by H. pullorum. The expression of TNF-α, 
IL1-β, IL-6 and MIP-2 was quantified, by semiquantitative PCR, in INF-γ/LPS-
activated and H. pullorum-infected J774A.1 macrophages. For each condition, 
expression values were quantified by band pixel intnsity obtained for the cytokine 
and normalized to the correspondent band pixel intensity of the constitutive gapdh 
gene. Fold change was determined by dividing values by the normalized cytokine 
expression in non-infected and non-activated macrophages. Values are presented as 
the mean ± standard error of the mean of two independent biolog cal samples with at 
least four technical replicas. 
 
5.4 Discussion 
H. pullorum is an emerging human pathogen with zoonotic potential (9), 
whose mechanisms of pathogenesis and resistance to immunity remain largely 
unknown. In this work, we have analysed the behaviour of H. pullorum when exposed 
to NO, which is an important antimicrobial chemical weapon of the mammalian 
immune system. H. pullorum is shown to be killed by several NO donors, namely 
spermine-NONOate, DPTA-NONOate and GSNO, in a growth phase-dependent 
way. The nitrosative stress strongly impaired H. pullorum viability when NONOates 
were added at the initial growth phase. On the contrary, the nitrosative stress toxicity 
was negligible for cells that were already at the early exponential and stationary 
phases. This behaviour was observed even when usingvery high concentrations of 
DPTA and spermine-NONOate, i.e. at concentrations that completely impair growth 
when added at the initial growth phase. GSNO is a less efficient bactericide in 
comparison with NONOates. When H. pullorum is at the initial growth phase, GSNO 
































pullorum exhibits a higher resistance to NO stress than Helicobacter pylori since it 
was previously reported that GSNO and DPTA-NONOate significantly impair the 
growth of H. pylori at much lower concentrations (100 and 150 μM, respectively) 
(41). 
Our morphological studies indicated that non-stressed cells of H. pullorum 
grown for 24 h retained the bacillary form, with only approximately 1% of the cells 
presenting a coccoid form. Therefore, coccoid forms of H. pullorum seem to occur at 
latter stages, a result which agrees with previous data showing that after 2 days 
growth in BHI liquid broth, only 20% of the H. pullorum cells exhibited a coccoid 
form, and that conversion of all cells to the coccoid f rm occurred after 4 days (42). 
The bacillary form of H. pullorum cells was not significantly altered upon 
exposure to nitrosative stress generated by spermin-NONOate at concentrations up 
to 100 μM. This behaviour of H. pullorum apparently contrasts with that of H. pylori, 
as the latter was reported to undergo a rapid conversion from bacillary to the coccoid 
form when exposed to NO donors (34, 43). 
Although NO did not induce the appearance of coccoid f rms in H. 
pullorum, the stress led to a decrease in the mean length of the bacteria. A decrease 
in bacterial size due to environmental factors is not a very common phenomenon, but 
it was reported for Escherichia coli when entering the stationary phase and for marine 
bacteria during starvation. For marine bacteria, cell size shortening has been 
proposed to represent a survival mechanism that facilitates nutrient acquisition (44). 
Incubation of H. pullorum with NO-generating murine macrophages 
lowered the viability of the bacterium, and the macrophage-killing ability was 
dependent on the NO produced as treatment of macrophages with an iNOS inhibitor 
increased the survival of internalized H. pullorum cells. The NO-producing murine 
macrophages phagocytized a higher number of H. pullorum cells that rapidly became 
non-viable. Interestingly, H. pylori was reported to increase the expression of iNOS 
by stimulating the number of macrophages and lymphocytes in the gastric mucosa, 
and nitrosative stress killed the bacterium (45, 46). However, to the best of our 
knowledge, the increase of phagocytized cells by NO-producing murine 





Our work indicates that H. pullorum adheres to murine macrophages, as also 
noted by (47). Furthermore, we report, for what is believed to be the first time, that 
H. pullorum is internalized in murine macrophages and induces th  secretion of the 
pro-inflammatory cytokines TNF-α, IL-1β, IL-6 and MIP-2. Similarly, H. pylori and 
Helicobacter hepaticus infections have been reported to induce IL-1β, TNF-α and 
IL-6 (48-50). Moreover, our observation that in murine macrophages H. pullorum 
increases the expression of MIP-2, the IL-8 homologue ene, is consistent with 
previous studies of H. pullorum done in human gastric and intestinal epithelial 
infected cell lines showing IL-8 induction (22). 
The induction of NO and pro-inflammatory cytokines in macrophages by H. 
pullorum observed in this study may be associated with the interaction of macrophage 
receptors with H. pullorum LPS, possibly through activation of NF-κβ, similarly to 
the activation of IL-8 by H. pullorum previously observed in epithelial cells (22). 
Furthermore, the ability here shown to elicit inflammatory responses in a mammalian 
host suggests that H. pullorum can be pathogenic for humans. 
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Helicobacter pullorum is an enterohepatic species infecting animals and 
humans that stimulates the mammalian innate immunity to produce antimicrobial 
reactive nitrogen species. The genome of H. pullorum was examined and two 
haemoglobins and three peroxiredoxin-like genes putatively involved in nitrosative 
stress defence were identified. The expression of these genes was analysed under 
nitrosative stress conditions. Strains deleted in these genes were constructed and 
growth and viability was evaluated upon exposure to nitrosative stress. The 
contribution of these systems to the H. pullorum infection of murine macrophages 
was assessed. All proteins were recombinantly produce  and characterized. 
We show that H. pullorum contains a single domain and a truncated haemoglobin 
that are induced by the nitric oxide donor nitrosogluthatione and complement the 
nitrosative stress sensitive phenotype of an E. coli flavohaemoglobin mutant. The 
H. pullorum single domain globin provided in vitro resistance to nitrosative stress 
and improved the ability of H. pullorum to survive when contacting host 
mammalian cells, such as macrophages. Deletion of the H. pullorum truncated 
globin did not change the sensitivity to nitrosative stress and macrophage killing. 
The purified single domain and a truncated haemoglobins contain haem b as its 
cofactor, and present, respectively, a low-spin and a high-spin iron in its ferric state.  
The peroxiredoxin-like genes of H. pullorum, named as peroxiredoxins one, two 
and three (prx1, prx2 and prx3), are homologs of the bacterial peroxiredoxins 
bacterioferritin comigratory protein, alkyl hydroperoxide reductase and thiol 
peroxidase, respectively. Prx2 was shown to be induce  in response to peroxynitrite 
and Prx3 in response to hydrogen peroxide. Whereas the prx1 mutant did not show 
increased sensitivity to oxidative and nitrosative str sses and to macrophage killing, 
the prx2 mutant presented a growth defect even under normal growth conditions. 
The construction of the prx3 mutant was not possible, which suggests that the gen
has an essential role in H. pullorum. The three recombinant H. pullorum 
peroxiredoxin proteins were shown to detoxify peroxynitrite, having Prx3 the 





Altogether the results show that the single domain globin and the peroxiredoxins 
contribute to the nitrosative stress protection of H. pullorum. 
 
6.1 Introduction 
Helicobacter pullorum is an enterohepatic Helicobacter species that 
colonizes the gastrointestinal tract of birds (1-4), mice (5, 6), rats (7, 8) and humans 
(1, 9, 10). The bacterium has been described as a potential human pathogen due to 
its isolation from human with digestive disorders and bacteraemia (1, 9-14). H. 
pullorum infection is suggested to occur via a type-VI secretion system (15), and 
the induction of the host cell cytotoxicity is mediated by the bacterial cytolethal 
distending toxin (CDT) activity (16-18). H. pullorum was reported to trigger the 
host immunity, since the bacterium induces IL-8 secretion through the NF-κβ 
pathway on epithelial cells (19, 20) and H. pullorum CDT was shown to induce the 
expression of genes involved in a Th17 inflammatory response (20). We have 
shown that H. pullorum internalizes and activates murine macrophages, and 
stimulates the expression of pro-inflammatory cytokines TNF-α, IL-1β, IL-6 and 
MIP-2. Additionally, the nitric oxide (NO) produced by mammalian macrophages 
was seen to decrease H. pullorum viability (Chapter V). Release of NO and 
superoxide by mammalian inducible nitric oxide synthase (iNOS) and NADPH 
oxidase (NOX) enzymes, respectively, is a mechanism of the innate immunity for 
bacterial clearance. Within the phagolysosome the pathogen is exposed to these 
compounds and their derivatives that known as reactive oxygen and nitrogen 
species (ROS and RNS), which include, for example, hydrogen peroxide and 
peroxynitrite (21). In H. pullorum, the systems used to avoid the damage caused by 
these toxic molecules remain to be elucidated. 
In general, the resistance of bacteria to NO and RNS has been related to the 
presence of flavodiirons and haemoglobins (22-38). Haemoglobins are a diversified 
group of globin-like haem proteins that includes flavohaemoglobin, single domain 
haemoglobin, and truncated haemoglobin. Flavohaemoglobins present a two-
domain structure composed by a N-terminal haem-globin fused with a C-terminal 










reductase domain that binds NADPH and FAD. In a large number of bacteria, 
flavohaemoglobin is a major NO-detoxifying enzyme that protects against 
nitrosative stress, under aerobic and anaerobic conditi s (22). Single domain 
haemoglobins lack the reductase domain, present in flavohaemoglobins and their 
role in NO protection has been studied in Vitreoscilla stercoraria (Vhb) and C. 
jejuni (Cgb) (26, 28, 30, 39). A chimeric protein comprising Vhb fused with a 
flavoreductase domain of the Ralstonia eutropha flavohaemoglobin was described 
to detoxify NO, and provided to E. coli protection against nitrosative stress (30). 
The C. jejuni cgb mutant strain exhibited markedly inhibition of the aerobic 
respiration and hypersensitivity to NO and other nitrosating agents (26, 28, 39).  
Truncated haemoglobins, or 2-on-2 haemoglobins, are 20-40 residues shorter than 
single domain haemoglobins and have a different α-helical fold. Truncated 
haemoglobins are divided in three groups, I, II andIII, or N, O and P, respectively. 
Although the function of truncated haemoglobins is not fully understood, the 
proteins have been proposed to be involved in oxygen and NO metabolism (40). In 
particular, the role of the truncated haemoglobins elonging to groups I and II was 
studied in the cyanobacterium Synechococcus pp. PCC 7002, Mycobacterium 
species and Pseudoalteromonas haloplanktis. The group I truncated haemoglobin 
GlbN of Synechococcus pp. PCC 7002 protects the bacterium against NO and high 
levels of nitrate (41). M. tuberculosis group I truncated haemoglobin HbN, 
encoding glbN gene, presents NO activity and enhances the heterologous survival 
of S. typhimurium within macrophages (31). The expression of the M. tuberculosis 
glbN in an E. coli flavohaemoglobin (hmp) mutant, under aerobic conditions, 
restored the resistance to NO (32). In M. bovis, HbN detoxifies NO to nitrate, and 
the glbN mutant strain has impaired ability to metabolize NO and lower NO 
respiration rates (23). M. leprae group II truncated haemoglobin (HbO), the only 
haemoglobin apparently present in the genome, was shown to be involved in both 
hydrogen peroxide, NO and peroxynitrite scavenging (33-35). As for M. leprae 
HbO, the group II truncated haemoglobin Ph-2/2HbO of P. haloplanktis, encoded 
by the PSHAa0030 gene, was reported to catalyse peroxynitrite, n vitro. In 





nitrosative stresses and restored the growth and cellular respiration of an E. coli 
hmp mutant under nitrosative stress conditions (36, 37).  
Whitin group III, the truncated haemoglobin from C. jejuni (Ctb) and H. hepaticus 
(HbP) are the best biochemically characterized proteins (42-44), but their 
contribution to NO protection was so far only investigated for Ctb. Data showed 
that even though ctb is up-regulated in response to nitrosative stress, the protein 
seems not to contribute to C. jejuni NO protection (38, 45). 
Peroxiredoxins are a group of ubiquitous proteins that are usually 
described to confer resistance to oxidative stress. These enzymes detoxify hydrogen 
peroxide and a wide range of organic hydroperoxides (46-52). In H. pylori, M. 
tuberculosis and S. typhimurium, peroxiredoxins were described to contribute to 
peroxynitrite reduction (53-55). Peroxiredoxins are classified into typical 2-Cys, 
atypical 2-Cys, and 1-Cys based on the number and location of their catalytic 
cysteines. More recently, peroxiredoxins were divided into six subfamilies, based in 
their amino acid similarity (56, 57), being the alkyl hydroperoxide-reductase 
(AhpC)/Prx1 (46, 50, 51, 53, 54, 58, 59), thiol peroxidase (Tpx) (48-50, 54) and the 
bacterioferritin comigratory protein (Bcp)/PrxQ (47, 48, 52) the most studied 
peroxiredoxin subfamilies in the bacterial kingdom. All peroxiredoxins share the 
same basic catalytic mechanism, in which an active-s te cysteine (the peroxidatic 
cysteine, CP) is oxidized to a sulfenic acid by the peroxide substrate forming a 
disulfide with another cysteine residue (the resolving cysteine; CR) (57). 
Although the increasing evidence for the potential proinflammatory and 
pathogenic roles of H. pullorum in humans, the molecular mechanisms of this 
bacterium to fight host defences remain unaddressed. The aim of this work was to 
study homologs of haemoglobins and peroxiredoxins in H. pullorum and elucidate 
whether they contribute to protect this emergent pathogen against oxidative and 
nitrosative stresses. 
 










6.2 Materials and Methods 
Analysis of H. pullorum genome 
Search of H. pullorum genes encoding homologs of bacterial 
haemoglobins and peroxiredoxins were done on the genom  of the H. pullorum 
MIT 98-5489 (available at the gene bank, assembly accession GCA_000155495.1, 
project ABQU00000000.1). Protein-protein BLAST algorithm at NCBI BLAST 
was used for amino acid sequence similarities studies, and alignments were 
performed with Clustal X 2.1 version and edited with the Genedoc software.  
 
Bacterial strains, plasmids and growth conditions 
All strains and plasmids used in this study are listed in Table 6.1. 
Helicobacter pullorum 6350-92 (CCUG 33838), isolated from a stool sample of a 
patient with gastroenteritis and hepatitis (60), was used as the wild type strain. Cells 
were routinely cultivated at 37 °C in a microaerobic atmosphere (6% O2, 7% CO2, 
3.5% H2, and 83.5% N2) generated by the Anoxomat system (Mart Microbiology), 
in horse blood agar (BA) composed of Blood Agar Base no. 2 (Oxoid) with 10% 
(v/v) defibrinated horse blood (Probiológica), supplemented with an antibiotic-
antifungal mix composed by 6.3 g·L−1 vancomycin (Roth), 3.1 g·L−1 trimethoprim 
(Sigma) and 2.5 g·L−1 amphotericin B (Roth), and, when required, 20 µg·mL−1 of 
kanamycin or 5 µg·mL−1 of gentamicin. Bacteria were taken as fully grown hen 
cultured in BA plates for 5 days, with two intermediate plating passages.  
E. coli pre-cultures were grown overnight at 37 ºC and 150r.p.m. on 
Luria-Bertani (LB) medium that, when required, were supplemented with 





Table 6.1 Strains and plasmids used in this study 
 
Strain or plasmid Genotype or relevant characteristics Source 
Strains   
H. pullorum 6350-92 Parental strain (60) 
 
∆trHb  HPMG_00979 deletion mutant; Kmr This study 
 
∆sdHb  HPMG_00954 deletion mutant; Kmr This study 
 
∆trHb∆sdHb 
HPMG_00979 and HPMG_00954 deletion 
mutant; Kmr Gmr 
This study 
 
∆prx1 HPMG_00817 deletion mutant; Gmr This study 
 
∆prx2 HPMG_00739 deletion mutant; Kmr This study 
 
∆prx1∆prx2 
HPMG_00817 and HPMG_00739 deletion 
mutant; Kmr Gmr 
This study 
    E. coli   
 
K-12 ATCC 23716 Parental strain ATCC 
 
∆hmp LMS2552; K-12 hmp mutant; Kmr (61) 
 XL1-Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacIq Z∆M15 Tn10 ]; Tetr 
Agilent 
Technologies 
 BL21 Gold (DE3)  
F- ompT hsdS(rB- mB- ) dcm+  galλ endA Hte; 
Tetr 
Stratagene 
    
Plasmids   
pFLAG-CTC 
Vector for protein expression under the 
influence of the tac promoter; Ampr 
Sigma 
pFLAG-CTC-trHb 
pFLAG-CTC carrying the trHb gene 
subcloned into NdeI and XhoI sites; Ampr 
This study 
pFLAG-CTC-sdHb  
pFLAG-CTC carrying the sdHb gene 
subcloned into NdeI and XhoI sites; Ampr 
This study 
 
Real-time qRT-PCR analysis 
Fully grown H. pullorum cells were inoculated in 25 cm2 cell culture flasks 
(Nunc) filled with 10 mL Brain Heart Infusion (BHI) broth (Oxoid) plus 10% 
defibrinated Fetal Calf Serum (FCS, Gibco-Invitrogen) (BHI-FCS), to an initial 
optical density at 600 nm (OD600) of 0.1-0.2. Cells were grown for 19 h, at 150 
r.p.m. in microaerobic conditions, and these cultures were used to inoculate in fresh 
BHI medium supplemented with 0.2% (v/v) β-cyclodextrin (Sigma), (BHI-βCD) at 
an OD600 of 0.1. When cells reached an OD600 of ~ 0.5, 100 µM of the nitrosative 
stress generator S-nitrosogluthatione (GSNO), which was freshly prepared by 
mixing equimolar amounts of sodium nitrite and reduced glutathione under acidic 
conditions (0.05 M HCl) (62), or 50 µM of hydrogen peroxide (Panreac) were 










added. After 30 min or 1 h of incubation with hydrogen peroxide and GSNO, 
respectively, a mixture of ethanol:phenol (95:5) was added to stabilize the RNA and 
cells were collected by centrifugation (10 min, 8000 g, 4 ºC). As peroxynitrite 
reacts quickly with BHI medium, H. pullorum was firstly grown as described above 
but using Brucella Broth (Oxoid, BB) containing 5% FCS instead of BHI-FCS and 
BHI-βCD and treated with 50 µM peroxynitrite (Cayman), for 15 min. 
Total RNA was then isolated with the High Pure RNA Isolation kit (Roche), and 
the residual DNA was removed by treatment with Turbo DNA-free (Ambion). 
RNA was quantified in a NanoDrop spectrophotometer (Thermo Scientific), and its 
integrity confirmed by agarose gel electrophoresis. For each sample, 200 ng RNA 
was converted to cDNA using the anchored-oligodT prime s and the Transcriptor 
High Fidelity cDNA Synthesis kit (Roche).  
Real-time PCR experiments were done according to the manufacturer’s instructions 
in a LightCycler Instrument using LightCycler FastStart DNA Master SYBER 
Green I Kit (Roche Applied Science). The amplificaton reactions were carried out 
with equal amounts of cDNA (300 ng) as initial template, and each reaction 
contained 0.5 μM of the specific primers (Table 6.2), 4 mM of MgCl2, and the hot-
start PCR reaction mix from Roche Applied Science. The expression ratio of the 
target gene was determined relatively to a reference gene, the H. pullorum DNA 
gyrase subunit A gene (gyrA, HPMG_00492) (63) that does not change expression 
under these conditions. At least two biological samples were analysed in duplicate.  
 




  Oligonucleotide Sequence (5’ to 3’) 









































































Construction of H. pullorum mutants 
The nonpolar truncated haemoglobin (trHb), single domain haemoglobin 
(sdHb), peroxiredoxin 1 (prx1) and peroxiredoxin 2 (prx2) single deletion mutants 
(∆trHb, ∆sdHb, ∆prx1 and ∆prx2; Table 6.1), were constructed by inactivation of 
the H. pullorum HPMG_00979, HPMG_00954, HPMG_00817 and HPMG_00739 
genes, which was achieved by allelic exchange aftertransformation of H. pullorum 
with a three-fragment assembly product that consisted of the flanking regions of the 
target gene and the kanamycin aphA-3 or the gentamycin aac(3)-IV (64) cassettes. 
To this end, a region upstream of each target gene was PCR amplified with Phusion 
polymerase (Thermo Scientific) and oligonucleotides A1/A2 (Table 6.2), a region 
downstream of each target gene was amplified with ol gonucleotides B1/B2 (Table 
6.2), using the genomic DNA of H. pullorum 6350-92 as template, while the 
resistance cassettes previously cloned in pUC18 were amplified with primers 
C1/C2 (Table 6.2). Then, the three DNA fragments were assembled by PCR using 
oligonucleotides A1 and B2.  
The three-fragment DNA assembly products were introduced into H. pullorum 
6350-92 by electroporation (65). Briefly, H. pullorum cells were harvested from 
two fully grown BA plates, resuspended in 2 mL ice-cold washing buffer (270 mM 
sucrose, 15% glycerol), and 3 times washed (10 min, 10,000 g, 4 ºC) and 
resuspended in 1/10 volume of washing buffer. 50 mL of a cell suspension were 
electroporated with 1-2 µg DNA, using a MicroPulser (Bio Rad) at 1.80 kV, 200 V, 
and 25 F. Immediately after electroporation, 200 µL recovery broth (BHI, 10% 
glycerol, 10% FCS) was added and cells were plated on non-selective BA plates 
containing the antibiotic cocktail (above described). After an overnight incubation, 
cells were plated on selective BA plates with 20 µg·mL−1 kanamycin or 5 µg·mL−1 
gentamicin. The presence of the desired mutations in the H. pullorum chromosomal 
DNA was confirmed by PCR analysis.  
The trHb and sdHb double deletion mutant (∆trHb∆sdHb; Table 6.1), was 
constructed by the introduction of the three-fragment assembly product mentioned 
above, which carried the gentamycin cassette and the upstream and downstream 





(∆prx1∆prx2; Table 6.1) was constructed by electroporation of the three-fragment 
assembly product that carried the kanamycin cassette wi hin the flanking fragments 
of prx2 in the ∆prx1 H. pullorum strain. 
 
Growth assays 
H. pullorum wild type and haemoglobin mutants were exposed to GSNO, 
and the wild type and the peroxiredoxin mutants were xposed to hydrogen 
peroxide and peroxynitrite, or left untreated (contr l).  
To this end, 19 h grown cultures prepared as described above for the Real-time 
PCR protocol were reinoculated in BHI-βCD medium to an OD600 of 0.1. When 
cells reached an OD600 ~ 0.4, 100 µM GSNO was added. For the hydrogen 
peroxide susceptibility experiments, the 19 h grown cultures were reinoculated in 
BHI-βCD to an OD600 of 0.1 and distributed into 24-well plates, with or without the 
addition of 1 and 5 mM of hydrogen peroxide. Growth as measured by measuring 
OD600 for 10 or 24 h.  
For the peroxynitrite assays, H. pullorum cells firstly grown as described before 
immediately above but using BB plus 2.5% FCS (instead of BHI-FCS and BHI-
βCD) and reinoculated in 10 mL medium to an OD600 of 0.05. Peroxynitrite (50 
µM) was added to the cultures and growth and viability was monitored after 2, 7 
and 11 h by measuring the OD600 and by serial diluting each sample in BHI and 
plating on antibiotic-antifungal cocktail containing BA plates. The number of viable 
cells (colony-forming units (CFU·mL-1) was evaluated upon incubation in BA 
plates, for 48 h.  
 
Macrophages assays 
Murine macrophages J774A.1 (ATCC TIB-67) were routinely cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) with high glucose, GlutaMAX™ 
Supplement, pyruvate (GIBCO), 10% FCS and 100 μg·mL-1 penicillin/streptomycin 
(Sigma), and incubated in a humidified 5% CO2-air controlled atmosphere, at 37 ºC.  










Fully grown H. pullorum was used to inoculate fresh BA plates that grown for 24 h, 
which were next used to inoculate, at an OD 0.1-0.2, BB medium containing 5% 
FCS, and grown for 15 h. Immediately before infection, H. pullorum cells were 
pelleted (10 min, 8740 g, 4 ºC), resuspended in the infection medium Roswell Park 
Memorial Institute 1640 Medium (RPMI), with GlutaMAX™ Supplement 
(GIBCO) containing 10% FCS (RPMIi) at an OD600 of 0.2, and the bacterial 
viability determined by CFU counting prior to the incubation within macrophages 
(time zero of infection). 
For the infection assays with H. pullorum wild type and the mutant strains, 
macrophages were seeded overnight in 24-well plates at a concentration of 2 x 105 
cells/well. Macrophages were then activated for 5 hwith 0.15 μg·mL−1 gamma 
interferon (INF-γ, Sigma) and 0.5 μg·mL−1 lipopolysaccharides (LPS, Sigma). 
When required, murine iNOS activity was inhibited with 800 μM L-NMMA, which 
was added simultaneously to INF-γ and LPS. Immediately before infection, the 
macrophage medium was changed to the infection medium RPMIi and, where 
indicated, supplemented with the L-NMMA inhibitor. Macrophages were infected 
with H. pullorum wild type and the mutant strains at a multiplicity of infection 
(MOI) of 100. After 2 and 6 h of incubation the supernatants were collected for the 
quantification of nitrites by the Greiss method (66). Each well was washed three 
times with PBS, and macrophages were lysed with 2% saponin (w/v) and their 
bacterial content evaluated by CFU counting.  
 
Complementation assays 
For over-expression of each of the H. pullorum haemoglobins in the E. coli 
flavohaemoglobin mutant LMS2552 (∆hmp) (61), the HPMG_00979 and 
HPMG_00954 genes were PCR amplified with Phusion polymerase from the 
genomic DNA of H. pullorum 6350-92, using the primer pairs 
TrHb_NdeI/TrHb_XhoI and SdHb_NdeI/SdHb_XhoI (Table 6.2). The resultant 
DNA fragments were cloned in digested NdeI/XhoI plasmid pFLAG-CTC, yielding 
the pFLAG-trHb and pFLAG-sdHb plasmids. Competent cells of E. coli wild type 





For the mutant strain, the positive transformants were selected on LA medium 
containing 100 µg·mL−1 ampicillin plus 25 µg·mL−1 kanamycin, while for the E. 
coli wild type selection was done with ampicillin (100 µg·mL−1). Positive colonies 
were screened by PCR using the primers N26 and C24 from Sigma (Table 6.2). 
Overnight pre-cultures of E. coli wild type and ∆hmp carrying the empty 
pFLAG, pFLAG-trHb and the pFLAG-sdHb were grown in LB supplemented with 
the respective antibiotics and 1 mM IPTG, and used to inoculate fresh LB medium 
supplemented with 12 µM FeCl3, 1 mM aminolevulinic acid and 1 mM IPTG to an 
initial OD600 of 0.05. Cells were grown aerobically for 8 h, untrea ed or exposed to 
200 µM GSNO, and OD600 was monitored at 1 h intervals. 
 
Production of recombinant haemoglobins and peroxiredoxins of H. 
pullorum 
Haemoglobins and peroxiredoxins homolog genes of H. pullorum 6350-92 
were amplified with Phusion polymerase and primers ba ed on flaking sequences 
that generated NdeI and XhoI restriction products (Table 6.2) with 436 bp (trHb), 
563 bp (sdHb), 506 bp (prx1), 628 (prx2) and 535 (prx3) bp. These genes were 
cloned into NdeI/XhoI digested expression vector pET28a+ (Novagen) to produce 
proteins with a poly-histidine tail fusion (His-tag) at the N-terminal region, and 
transformed in E. coli XL1 Blue. Positive recombinant plasmids were select d from 
kanamycin (30 μg·mL−1) resistant colonies in Luria-Bertani Agar (LA) medium, 
and the integrity of the genes was confirmed by gene sequencing. 
Over-expression of the recombinant proteins was achieved in E. coli Bl21Gold 
(DE3), which was grown aerobically in LB supplemented with 30 μg·mL−1 
kanamycin at 37 ºC and 150 r.p.m. For the over-expression of haemoglobins, the 
broth was also supplemented with 8 mg·L−1 Fe (in the form of FeSO4.7H2O). When 
cells reached OD600 of 0.8, 400 μM IPTG was added and cells were further 
incubated overnight at 20 ºC and 150 r.p.m. Cells were harvested by centrifugation 
(10 min, 8000 g, 4 ºC), resuspended in Tris-HCl 20 mM, disrupted in a French 
pressure cell, and ultracentrifuged at 100,000 g and 4 °C for 2 h. The soluble 










fractions were loaded into a charged nickel-IMAC Sepharose HP column (GE 
Healthcare) equilibrated with buffer Tris-HCl 20 mM (pH 7.5) and 500 mM NaCl 
and eluted in the same buffer that contained 500 mM i idazole. After overnight 
dialysis of the peroxiredoxins against 20 mM Tris-HCl (pH 7.5) and 150 mM NaCl, 
and of the haemoglobins against 20 mM Tris-HCl (pH 7.5), 250 mM NaCl and 20% 
glycerol, the protein size and purity was evaluated by SDS/PAGE with the Roti-
Mark protein molecular mass marker (Carl Roth). The protein concentration was 
determined with the biocinchoninic acid assay (67). Haem quantification and 
determination was done by the pyridine haemochrome method (68). 
 
UV–Visible spectroscopy and EPR  
UV–Visible absorption spectra of H. pullorum proteins were acquired at 
room temperature using a Shimadzu UV-1700 spectrophot meter. Electron 
paramagnetic resonance (EPR) spectra of H. pullorum haemoglobins were obtained 
on a Bruker EMX spectrometer, equipped with an Oxford Instruments continuous 
flow helium cryostat. The EPR spectra were recorded at 12 K, at 9.4 GHz, 
microwave power of 2 mW and modulation amplitude of 1 mT.  
 
Peroxynitrite assays 
The reaction of peroxynitrite (ONOO−, ε302 nm = 1.67 x 103 M−1·cm−1) 
with the reduced proteins Prx1, Prx2 and Prx3 from H. pullorum was investigated 
by time-resolved spectroscopy, using a thermostated stopped-flow instrument 
(DX.17MV, Applied Photophysics) equipped with a 1-cm path length observation 
chamber. Experiments were carried out according to the ‘initial rate approach’ (69). 
The proteins were reduced by a 2 h incubation with 10 mM dithiothreitol (DTT) at 
room-temperature. Prior to the experiments, the excess DTT was removed and the 
buffer exchanged to 100 mM phosphate buffer pH = 7.0 plus 0.2 mM 
diethylenetriamine pentaacetic acid (DTPA) by concentration/dilution cycles. 
Afterwards, the proteins were gently degassed and anaerobically mixed in a 1:1 





µM peroxynitrite in 10 mM NaOH. The reaction was investigated at 5 °C. The 
initial rate of peroxynitrite decomposition (Vo) was obtained from the absorption 
decrease measured at 310 nm, using ε = 1.6 x 103 M−1·cm−1 (69). The kinetic traces 
were analysed from 4 ms on, because a small artifactual signal was invariantly 
observed over the very first millisecond after mixing. Given the rate law Vo = k 
[ONOO−]0 [Prx]0, the second-order rate constant (k) of the reaction was estimated 
by linear regression analysis of the dependence of the measured initial rates on 
protein concentration, and dividing the fitted slope by the initial peroxynitrite 
concentration ([ONOO−]0). The concentration of the three proteins was obtained 
using the following 280 nm extinction coefficients predicted by Bioinformatics 
Resource Portal of the Swiss Institute of Bioinformatics (http://www.expasy.org/): 




H. pullorum genome contains two haemoglobin-like encoding genes 
Analysis of the H. pullorum genome revealed DNA regions coding for two 
putative haemoglobin-like proteins (HPMG_00954 and HPMG_009791). Their 
amino acid sequences include the highly conserved histidine residue that 
participates in haem binding and is present in the position eight of helix F (F8) of 
all known haemoglobins. Also, other highly conserved r sidues involved in haem 
stabilization were found conserved (40, 70) (Figure 6.1).  
A more detailed analysis revealed that the coding region of HPMG_00954 
shares (56% I/74% S) and (50% I/69% S) amino acid sequence identity/similarity 
with the single domain haemoglobins C. jejuni Cgb and V. stercoraria Vhb, 
respectively. H. pullorum single domain haemoglobin (SdHb) shares between 42-
48% I/60-67% S with Staphylococcus aureus, Pseudomonas aeruginosa and E. coli 
flavohaemoglobins. Figure 6.1, highlights the conserved residues of H. pullorum 
                                                          
1 These genes are also nominated as HPMG_RS04780 and HPMG_RS03725. 
 










SdHb when compared with the bacterial single domain haemoglobins and the 
globin-like domain of flavohaemoglobins. 
The H. pullorum HPMG_00979 gene product (TrHb) shares amino acid 
sequence identity and similarity with: i) group III C. jejuni Ctb (64% I, and 78% S) 
and H. hepaticus HbP (66% I and 82% S); ii) group I M. tuberculosis HbN (29% I 
and 39% S); and iii) group II HbO (17% I and 35% S) truncated haemoglobins. H. 
pullorum TrHb exhibits several conserved amino acid residues with bacterial group 
III truncated haemoglobins (Figure 6.1).  
 
 
Figure 6.1 Amino acid sequence comparison of H. pullorum haemoglobins 























































































































































haemoglobins. Protein single domain haemoglobin sequences of H. pullorum 
(Hpu_SdHb), C. jejuni (Cj_Cgb) and V. stercoraria (Vs_Vhb); flavohemoglobins of 
S. aureus (Sa_Hmp), P. aeruginosa (Pa_Fhp) and E. coli (Ec_Hmp); group III 
truncated haemoglobins of C. jejuni (Cj_Ctb), H. pullorum (Hpu_TrHb) and H. 
hepaticus (Hh_HbP); group I truncated haemoglobin of M. tuberculosis (Mt_HbN) 
and group II truncated haemoglobins of M. tuberculosis (Mt_HbO) and P. 
haloplanktis (PSHAa0030 gene, Ph_HbO) were aligned using the Clustal X 
algorithm. Amino acids residues conserved in all single domain haemoglobin and 
flavohemoglobin sequences are shaded in black and amino acid residues conserved in 
all group III truncated haemoglobins are marked in grey. The histidine F8 is shaded 
in red and the other highly conserved residues in blue. The amino acid sequences of 
flavohemoglobin are not complete.  
 
Expression of the haemoglobins and phenotypic analysis of the H. 
pullorum haemoglobin mutants  
The expression of trHb and sdHb genes in H. pullorum treated with 100 
µM GSNO was examined through quantitative real-time RT-PCR. The data showed 
that under these conditions the trHb and sdHb expression underwent a fold increase 
of 1.7 ± 0.6 and 3.4 ± 1.3, respectively. 
The growth of the ∆trHb, ∆sdHb and the ∆trHb∆sdHb deletion mutants 
exposed to 100 µM GSNO was analysed. The ∆sdHb and double ∆trHb∆sdHb 
mutant strains displayed higher sensitivity to nitrosative stress than the wild type 
strain. In the presence of GSNO, the growth of the ∆trHb mutant was not 
significantly different from that of the parental strain (Figure 6.2). 
 











Figure 6.2 H. pullorum wild type and haemoglobin mutants under nitrosative 
stress. Growth of H. pullorum wild type (full circles), ∆trHb mutant (open squares), 
∆sdHb mutant (open triangles) and ∆trHb∆sdHb double mutant (open diamons) 
exposed to 100 µM GSNO. Percentage of growth represnts the ratio of the OD600 
of stress exposed versus untreated cells. Values are presented as means ± standard 
error of the mean of four independent experiments.  
 
H. pullorum TrHb and SdHb protect E. coli hmp mutant from 
nitrosative stress 
Complementation studies were conducted to test whether H. pullorum 
TrHb and SdHb proteins would be able to replace E. coli flavohemoglobin. Hence, 
E. coli ∆hmp mutant was transformed with pILL2157 plasmid expressing either 
trHb or sdHb gene. The E. coli ∆hmp strain transformed with the empty pILL2157 
plasmid showed more susceptibility to 200 µM GSNO than the wild type strain 
transformed with the empty vector and the mutant strains expressing the TrHb and 
SdHb proteins (Figure 6.3). This shows that the expr ssion of TrHb and SdHb from 
the inducible plasmid pILL2157-trHb and pILL2157-sdHb rescued the phenotype 
of E. coli, indicating that both H. pullorum TrHb and SdHb have the ability to 




















Figure 6.3 Complementation of the E. coli ∆hmp mutant with the H. pullorum 
TrHb and SdHb in the presence of nitrosative stress. Growth of E. coli wild type 
and ∆hmp mutant strains transformed with the empty vector pILL2157 (circles and 
squares respectively), and E. coli ∆hmp expressing the TrHb (triangles) or SdHb 
proteins (diamonds), in the absence of stress (full symbols) and in the presence of 
200 µM GSNO (open symbols).  
 
Survival of H. pullorum haemoglobins mutants in murine 
macrophages  
The viability of the H. pullorum ∆trHb and ∆sdHb mutant strains were 
tested in murine J774A.1 macrophages. After 2 h of infection, no major differences 
in the survival of H. pullorum wild type and the mutants were observed. However, 
after 6 h of infection, while the ∆trHb mutant showed no major differences in 
macrophage survival in comparison with the wild type, the ∆sdHb and the double 
∆trHb∆sdHb mutants were less resistant to activated macrophages (Figure 6.4a). In 
addition, ∆sdHb and ∆trHb∆sdHb mutants recovered their viability to the level of 
the ∆trHb mutant strain when in macrophages with the iNOS inhibited (Figure 
6.4b). The viability of the double ∆trHb∆sdHb mutant was slightly higher than that 
of ∆sdHb.  
 


























Figure 6.4 Survival of H. pullorum wild type and haemoglobin mutant strains upon 
macrophage infection. Activated (a) and iNOS inhibited (b) J774A.1 macrophages 
were infected with H. pullorum wild type (black bars), ∆trHb (light grey bars), 
∆sdHb (dark grey bars) and ∆trHb∆sdHb (white bars), at a MOI of 100. Viable 
counts were determined after 2 and 6 h of infection. Values are means ± standard 
error of the mean of at least two independent experiments analysed in duplicate. 
 
Biochemical characterization of H. pullorum haemoglobins 
The purified H. pullorum TrHb and SdHb have an apparent molecular 
mass of ~ 17 and 19 kDa respectively, which agrees with the molecular mass 
derived from the gene sequence plus the His-tag. TrHb and SdHb exhibit the typical 
features of haem containing proteins with Soret bands at 414 and 410 nm, 
respectively (Figure 6.5a and b). Furthermore, the redox spectra of the pyridine 
haemochrome of the H. pullorum TrHb and SdHb showed a band at 555 nm, with a 
ratio of contained 0.7 and 0.6 haem per protein, respectively, confirming the 
presence of haem b in both proteins. 
The EPR spectra of the purified H. pullorum TrHb presents resonances 
characteristic of a high-spin haem, with g = 5.92. In agreement, a broad band in the 
UV-visible spectrum of the TrHb centred at approximately 630 nm was also 













































truncated haemoglobin group the haem spin state has been shown to vary amongst 
organisms (40), and in the C. jejuni Ctb it occurs as a mixture of low and high-spin 
haemic states (43). 
The H. pullorum SdHb exhibits g-values of 3.23 and 2.97 that are typical of low 
spin haem containing proteins (Figure 6.5c). We speculate that tyrosine B10 residue 
(at position 29 in the amino acid sequence of H. pullorum, Figure 6.1) may act as 
the sixth haem ligand, as suggested for the group I truncated haemoglobin of the 
protozoan Chlamydomonas eugametos (71). The number of biochemically 
characterized bacterial single domain haemoglobins, is o far, limited to two C. 
jejuni and Vitreoscilla sp. strain C1 and in both cases, the haem is predominantly in 
the high spin state (72, 73). Thus, H. pullorum SdHb seems to have a different 
structural haem environment. 
 
Figure 6.5 Spectroscopic studies of H. pullorum haemoglobins. UV-visible spectra 
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H. pullorum genome contains three peroxiredoxin-like genes 
The analysis of the H. pullorum genome also revealed the presence of 
three putative peroxiredoxin-like homologs, namely HPMG_00817 (Prx1), 
HPMG_00739 (Prx2), and HPMG_ 00529 (Prx3)2, which shown sequence 
similarity with the peroxiredoxins of the Bcp/PrxQ, AhpC/Prx1 and Tpx sub-
families, respectively. The H. pullorum Prx1, Prx2 and Prx3 share, respectively, 
amino acid sequence identity and similarity with the Bcp (61% I/72% S), AhpC 
(69% I/60% S) and Tpx (83% I/72% S) proteins of C. jejuni, and with the Bcp 
(52% I/77% S), AhpC (46% I/66% S) and Tpx (87% I/66% S) peroxiredoxins of H. 
pylori. 
Peroxiredoxins are characterized by a highly conserved catalytic cysteine 
residue referred as the peroxidatic cysteine (CP) in its catalytic centre (Figure 6.6). 
When present, a second conserved cysteine residue that forms a disulfide linkage 
with CP during the catalytic cycle, termed resolving cysteine (CR), is localized 
outside the catalytic centre (Figure 6.6). Moreover, besides the catalytic cysteines 
some peroxiredoxins contain other non-conserved cysteine residues that apparently 
are not involved in catalysis (e.g. S. aureus AhpC, C. jejuni and E. coli Tpx, Figure 
6.6).  
Comparison analysis of amino acid sequence of H. pullorum Prx1 shows the 
presence of a conserved cysteine at position 45, corresponding to a potential CP and 
at position 50, corresponding to a potential CR; H. pullorum Prx2 has two conserved 
cysteines, one at position 49 (a putative CP) and another at 169 (a putative CR), and 
an additional non-conserved cysteine at position 156. H. pullorum Prx3 has two 
conserved cysteines localised at position 58 (a puttive CP) and 92 (a putative CR) 
(Figure 6.6). In addition to the CP, peroxiredoxins contain the highly conserved 
proline, threonine and arginine residues in its catalytic centre (74) that we can see 
marked with one asterisk in Figure 6.6, and are present in the amino acid sequences 
of H. pullorum peroxiredoxins. 
  
                                                          
2 prx1, prx2 and prx3 genes are also annotated as HPMG_RS04115, 











































































































































































































































Figure 6.6 Amino acid sequence comparison of H. pullorum HPMG_00817, 
HPMG_00739, and HPMG_ 00529 gene products with the best studied bacterial 
peroxiredoxins. Protein sequences: H. pullorum (Hpu_Prx1), H. pylori (Hpy_Bcp), 
C. jejuni (Cj_Bcp), H. hepaticus (Hh_Bcp), S. aureus (Sa_Bcp) and E. coli 
(Ec_Bcp) peroxiredoxins belonging to Bcp/PrxQ subfamily; H. pullorum 
(Hpu_Prx2), H. pylori (Hpy_AhpC), C. jejuni (Cj_AhpC), H. hepaticus 
(Hh_AhpC), S. aureus (Sa_AhpC), and E. coli (Ec_AhpC) belonging to AhpC/Pxr1 
subfamily; and H. pullorum (Hpu_Prx3), H. pylori (Hpy_Tpx), C. jejuni (Cj_Tpx), 
S. aureus (Sa_Tpx) and E. coli (Ec_Tpx) peroxiredoxins belonging to Tpx 
subfamily. The potential peroxidatic cysteine residue is shaded in red, the potential 
resolving cysteine in blue and the non-conserved cysteines in yellow. The 
conserved proline and threonine present at the catalytic site and the distal conserved 
arginine are marked with an asterisk. Alignments were done using the Clustal X 
algorithm. 
 
Expression of H. pullorum peroxiredoxins in stressed cells 
Since peroxiredoxins are usually involved in oxidative stress defence, we 
also studied the expression pattern of H. pullorum peroxiredoxin genes and the 
phenotype of the mutant strains towards hydrogen peroxide. The expression of the 
peroxiredoxin genes in H. pullorum treated with 50 µM of hydrogen peroxide, for 
30 min, and with 50 µM peroxynitrite, for 15 min, was quantified by quantitative 




























































































































in the presence of peroxynitrite and the expression of prx3 was augmented in cells 
exposed to hydrogen peroxide. The prx1 gene did not suffer a significant increase 
in its expression in response to the same stress generators (Figure 6.7). 
 
 
Figure 6.7 Effect of the oxidative and nitrosative stress on the ranscription of H. 
pullorum peroxiredoxin genes. Fold variations of the expression of the genes prx1 
(black bars), prx2 (grey bars), and prx3 (white bars), upon exposure of the H.
pullorum wild type strain to 50 µM hydrogen peroxide (H2O2) or 50 µM 
peroxynitrite (PN). Fold change values represent the ratio of the expression level of 
treated culture to that of untreated, and is adjusted to the constitutive gyrA gene 
expression. At least two biological samples were analysed in duplicate.  
 
 
Phenotypical analysis of H. pullorum peroxiredoxin mutants  
Single ∆prx1, ∆prx2 and double ∆prx1∆prx2 H. pullorum deletion mutants 
were constructed. However, in spite of several attemp s, the ∆prx3 deletion was not 
successful that suggests the prx3 gene is essential for H. pullorum.  
Even in the absence of the stress, the ∆prx2 and ∆prx1∆pxr2 mutants 
showed a significantly decrease of the growth rate nd viability (Figure 6.8). 
Therefore, the single ∆prx2 and double ∆prx1∆pxr2 mutants were excluded from 
the subsequent studies. We tested the growth of these strains in two different types 
of liquid medium, because, the subsequent susceptibility assays with hydrogen 
























while the assays with peroxynitrite would be performed with BB, as peroxynitrite 
seems to decompose quickly in contact with BHI.  
 
 
Figure 6.8 Behaviour of H. pullorum ∆prx2 and ∆prx1∆prx2 mutants under normal 
growth conditions. Growth (a, b) and viability (c) of H. pullorum wild type (full 
circles), ∆prx2 mutant (open triangles) and double ∆prx1∆prx2 mutant (open 
squares) in BHI-βCD (a) and in BB complemented with 2.5% FCS (b, c). Values 
represent the mean ± standard error of the mean of two independent experiments. 
 
Growth of the H. pullorum ∆prx1 mutant was analysed under stress 
conditions generated by 1 mM and 5 mM hydrogen peroxide, and 50 µM 
peroxynitrite. Its viability was also analysed upon i fection of J774A.1 
macrophages. 
H. pullorum ∆prx1 mutant showed no increased sensitivity to hydrogen p roxide 
(Figure 6.9a and b) and peroxynitrite (Figure 6.9c), which suggests that Prx1 does 























































differences were seen in the survival of the ∆prx1 mutant comparatively to the wild 




Figure 6.9 Effect of oxidative and nitrosative stress on H. pullorum wild type and 
∆prx1 mutant. Growth of H. pullorum wild type (full circles) and ∆prx1 mutant 
(open circles) in BHI-βCD medium with 1 mM (a) and 5 mM (b) hydrogen 
peroxide, and in BB complemented with 2.5% FCS and 50 µM peroxynitrite (c). 




















































Figure 6.10 Survival of H. pullorum wild type and the prx1 mutant upon 
macrophage infection. Activated J774A.1 macrophages w re infected with H. 
pullorum wild type (black bars) and ∆prx1 mutant (light grey bars), at a MOI of 
100. Viable counts were determined after 2 and 6 h of infection. Values are means 
± standard error of the mean of one experiment analysed in triplicate. 
 
Prx1, Prx2 and Prx3 have peroxynitrite reductase activity  
As observed in SDS/PAGE gel, the purified H. pullorum Prx1, Prx2 and 
Prx3 have a molecular mass of approximately 20, 24 and 19 kDa, respectively, 
which agrees with the molecular mass derived from the gene sequence plus the His-
tag. The UV–Visible spectra of the H. pullorum peroxiredoxins indicate that these 
proteins have no metal co-factors. Peroxynitrite proved to be promptly degraded by 
the reduced proteins Prx1, Prx2 and Prx3. A representative data set collected, at 5 
°C, is shown in Figure 6.11. From the kinetic traces acquired at 310 nm, it can be 
clearly appreciated that peroxynitrite, when mixed with the buffer alone (100 mM 
phosphate buffer pH = 7.0 plus 0.2 mM DTPA), is stable over the first 100 ms 
(dashed lines). A significantly faster decomposition is instead observed when 
peroxynitrite is mixed with any of the three proteins in the reduced state (solid 
lines). At 5 °C, the reaction with Prx1 or Prx2 was sufficiently slow to be time-
resolved by stopped-flow technique (Figures 6.11a and 6.11b). In contrast, despite 

























fraction of the reaction took place over the first milliseconds, thus overlapping with 
a small artefactual signal invariantly observed immediately after mixing (Figure 
6.11c). Therefore, whereas the initial rates could be reliably measured for the 
reaction of peroxynitrite with Prx1 and Prx2, such analysis could not be performed 
in the case of Prx3, the reaction being too fast. A a control, we confirmed that no 
reaction is observed over the same time scale (100 ms), if the H. pullorum proteins 
are pre-oxidized with an excess of hydrogen peroxide (~ 300 µM) prior to mixing 
with peroxynitrite (not shown). 
In agreement with previous reports (75), in the case of Prx1 and Prx2 the initial rate 
of peroxynitrite decomposition was found to be proportional to the protein 
concentration, the reaction with Prx1 being slightly faster than with Prx2 (~ 5 x 105 
M−1·s−1 vs ~ 2 x 105 M−1·s−1) (Figure 6.12). Peroxynitrite decomposition by reduced 
Prx3 was much faster than observed with Prx1 and Prx2, the reaction time courses 
being compatible with a second-order rate constant k above 106 M−1·s−1. The k 
values estimated for the H. pullorum Prx1 and Prx2, are similar to those measured 
at the same temperature for the Giardia peroxiredoxins (75). The values fall within 
the range reported for peroxiredoxins from different microbial sources (69), taking 
into account that the published values were obtained at higher temperature (25 °C 
or 37 °C). 












Figure 6.11: Reaction of reduced H. pullorum peroxiredoxins with peroxynitrite. 
Absorption changes measured at 310 nm after anaerobically mixing peroxynitrite 
(ONOO−) with Prx1 (a), Prx2 (b) or Prx3 (c) at increasing concentrations. 
Temperature = 5 °C. Concentrations after mixing: (A) [Prx1] = 0 - 2.0 - 4.0 - 8.1 - 
16.2 - 32.5 - 65.0 µM, [ONOO−] = 19 µM; (B) [Prx2] = 0 - 10.1 - 21.2 - 42.5 - 85.0 
µM, [ONOO−] = 24 µM. (C) [Prx3] = 0 - 2.5 - 5.0 - 10.1 - 21.2 - 42.5 - 85.0 µM, 




Figure 6.12 Initial rate of peroxynitrite decomposition by H. pullorum Prx1 and 
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concentrations of Prx1 (closed circles) and Prx2 (open circles). From linear 
regression analysis, the following second-order rate constants were estimated: k ~ 5 
x 105 M−1·s−1 (Prx1) and k ~ 2 x 105 M−1·s−1 (Prx2). 
 
6.4 Discussion  
We showed that H. pullorum contains two haemoglobins that are highly 
similar to the single domain haemoglobin (Cgb) and to the group III truncated 
haemoglobins of C. jejuni (Ctb). H. pullorum haemoglobins were induced in 
response to GSNO, as C. jejuni cgb and ctb, which were also shown to be up-
regulated in response to several nitrosative stress generators, including GSNO 
through the NO-responsive regulator NssR (28, 39, 45). Another indication for the 
role of H. pullorum haemoglobins in NO protection was the complementation 
assays showing that the GSNO sensitive phenotype of the E. coli mutant lacking the 
NO-detoxifying flavohemoglobin (Hmp) was relieved upon expression of H. 
pullorum SdHb and TrHb. According to our results, the single domain 
haemoglobins Cgb of C. jejuni (26) and Vhb of Vitreoscilla fused with a 
flavoreductase domain from R. eutropha (30), as well as the group I HbN of M. 
tuberculosis (24) and group II HbO of P. haloplanktis (36) were also shown to 
restore the growth defect of an E. coli ∆hmp mutant exposed to nitrosative stress. 
M. tuberculosis HbN overexpression also provided substantial protection for the 
Salmonella enterica Typhimurium hmp mutant growing in the presence of nitrogen 
species (31). Furthermore, the expression of the group III truncated haemoglobin 
Ctb of C. jejuni in the E. coli ∆hmp mutant protected aerobic respiration from NO 
inhibition compared to cells carrying an empty vector (26) although it did not 
complement the growth defect of the E. coli ∆hmp (38).  
The H. pullorum ∆sdHb mutant exhibited a higher sensitivity towards nitrosative 
stress generated by GSNO, as observed for the C. jejuni ctb mutant (26, 28). 
Furthermore, in our study, H. pullorum SdHb improved the ability of H. pullorum 
to survive to the nitrosative stress generated by macrophages. Therefore, as in the 
case of C. jejuni Cgb, our results indicate a role of H. pullorum SdHb in nitrosative 
stress protection.  










In spite of upregulated in the presence of nitrosative stress, and have restored the 
phenotype of an E. coli ∆hmp, the H. pullorum ∆trHb mutant was not sensitive to 
the nitrosative stress generated by GSNO, which suggests a predominant role of H.
pullorum SdHb over TrHb in nitrosative stress defence (76). This phenotype pattern 
observed for H. pullorum TrHb was similar to the one observed for C. jejuni Ctb, 
with the exception that H. pullorum TrHb complemented the growth defect of E. 
coli ∆hmp in the presence of GSNO and C. jejuni Ctb did not. Furthermore, TrHb 
did not improve the H. pullorum survival upon macrophage infection. This result 
differs from that of M. tuberculosis HbN in macrophage survival, as the 
overexpression of HbN was shown to improve the survival of M. tuberculosis 
within THP-1 and mouse peritoneal macrophages (77), and the survival of the 
heterologous hmp deficient Salmonella within mouse peritoneal macrophages (31). 
This difference may be explained by the different number and type of the 
haemoglobin genes present in their respective genoms that may lead to the same 
enzymatic functions occurring in different haemoglobin classes. Since M. 
tuberculosis has two truncated haemoglobins, and H. pullorum has one truncated 
and one single domain haemoglobin, the SdHb of the latt r may exert a similar 
function as the Mycobacterium HbN truncated haemoglobin.  
Interestingly, the double ∆sdHb/∆trHb H. pullorum mutant was not as sensitive as 
the ∆sdHb upon macrophage infection, possible due to the up-regulation of other H. 
pullorum defences in consequence of the double mutation. These observations are 
in agreement with the C. jejuni haemoglobin studies, in which the double mutant 
lacking both cgb and ctb genes was more resistant to GSNO than the single cgb 
mutant, but slightly sensitive than the wild type and ctb mutant strains (26).  
H. pullorum prx1, the homolog of bacterial Bcps, was not induced an did 
not conferred protection from hydrogen peroxide. Contrary to our results, 
Burkholderia cenocepacia (78), E. coli (52) and P. gingivalis (79) bcp mutants 
were susceptible to hydrogen peroxide, and the bcp deficient H. pylori was shown a 
weaker sensitivity to hydrogen peroxide (47). Furthe more, in E. coli and H. pylori, 
Bcp was shown to detoxify hydrogen peroxide, but with a lower efficiency than 
bacterial AhpC and Tpx proteins, and exhibited a preference for organic peroxides 





peroxynitrite, the Prx1 protein was endowed with peroxynitrite activity, which 
points for a role of this protein in nitrosative stress protection. Since bacteria 
typically possess multiple scavenging systems for the same toxic substrate (82), the 
lack of phenotype observed for the H. pullorum ∆prx1 mutant could be explained 
by the presence of another enzymes in H. pullorum that detoxify hydrogen peroxide 
and peroxynitrite, and may compensate the Prx1 absence. Also, the C. jejuni single 
bcp was not more susceptible than the wild type strain to hydrogen peroxide and 
nitrosative stress agents however, a double mutation in the bcp and tpx genes 
rendered the strain hypersensitive (48). Finally, as observed in our study for H. 
pullorum Prx1, Burkholderia Bcp was not required for macrophage survival (78).  
The H. pullorum ∆prx2 and ∆prx1/∆pxr2 mutants showed a growth defect 
even under normal growth conditions. Previous work also reported that the ahpC of 
H. pylori, a homolog of H. pullorum prx2, is a critical factor for H. pylori viability 
as the H. pylori ahpC mutants were only obtained under low oxygen conditions and 
were highly susceptible to the normal microaerobic growth conditions of H. pylori 
(59, 83). H. pullorum prx2 was up-regulated in response to peroxynitrite and 
showed activity towards peroxynitrite. The S. typhimurium, M. tuberculosis, and H. 
pylori AhpC were shown to detoxify peroxynitrite with similar second order rate 
constants as H. pullorum Prx2 (53). 
The construction of the prx3 deletion strain was hindered, which suggests 
that this peroxiredoxin may be essential in H. pullorum. Interestingly, Prx3 was 
shown to be upregulated in response to hydrogen peroxide, suggesting a role of this 
protein in protecting H. pullorum from oxidative stress. Furthermore, Prx3 
exhibited the highest peroxynitrite activity among the three H. pullorum 
peroxiredoxins, suggesting an important role in peroxynitrite detoxification. In 
similarity with M. tuberculosis Tpx, Prx3 was shown to reduce peroxynitrite with 
an activity of approximately one log higher than the ones reported for the bacterial 
AhpC enzymes (53, 54). 
In conclusion, this is the first study focusing on the defence mechanisms of 
the potential human pathogen H. pullorum against the antimicrobials produced by 
the innate immunity. We reported that a single domain globin has a main role in the 










protection of H. pullorum and that peroxiredoxins are also involved in nitrosative 
stress protection of H. pullorum. 
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7.1 H. pullorum interaction with the host  
H. pullorum has been considered an emergent foodborne pathogen as it 
was recently isolated from fresh poultry meat and has been associated with several 
gastrointestinal and hepatic human disorders (1). In spite of its pathogenic potential, 
the infection process and the host immune response to this bacterium are poorly 
studied. Our work provides new data regarding the int raction of H. pullorum with 
the host innate immune cells.  
We have demonstrated that H. pullorum is phagocytised by mammalian 
macrophages. Similar results were observed for H. pylori that even though usually 
classified as an extracellular pathogen, can penetrate the epithelial barrier and be 
phagocytized.  
Our data further revealed that H. pullorum increases the production of NO by host 
macrophages. Also, H. pylori and H. hepaticus (2) were previously shown to induce 
the transcription of the enzyme iNOS. Furthermore, H. pullorum was shown to be 
susceptible to macrophage killing in a NO-dependent manner. Similarly, H. pylori 
was shown to be susceptible to the NO generated by activated macrophages. 
However, studies reported that when in contact with non-activated macrophages, 
some H. pylori strains can downregulate NO production, inhibit its internalisation 
by phagocytes or impair the maturation of phagosomes upon phagocytosis, thus 
being able to survive the host immune response (see Chapter 2). Our study suggests 
that RNS contribute for H. pullorum elimination. We also observed a correlation 
between the levels of NO produced by macrophages and the levels of H. pullorum 
phagocytised. Similar behaviour was so far only observed for P. gingivalis (3) and 
S. aureus (4), to which a higher production of NO correlated with higher bacterial 
phagocytosis.  
This work showed that H. pullorum triggers the expression of the 
inflammatory genes TNF-α, IL-1β, IL-6 and MIP-2 (the murine homolog of IL-8) 
upon contact with murine macrophages. Other H licobacter species were reported 
to promote the transcription of inflammatory cytokines in host cells and to induce a 
strong local inflammatory response, which is correlated with the promotion of 
cellular lesions that may lead to carcinogenesis. In particular, H. pylori and H. 











hepaticus induce the expression of TNF-α, IL-1β, IL-6 and IL-8 by host cells (2, 5, 
6).  
The induction of cytokine transcription promoted by H. pullorum, is consistent with 
their ability to increase NO production in macrophages, as the obs rved induced 
cytokines have been associated with iNOS activation (7). Moreover, the data are in 
agreement with previous studies showing that H. pullorum induced IL-8 in human 
gastric and intestinal epithelial cell lines (8, 9). The induction of IL-8 secretion in 
epithelial cells was shown to be mediated by H. pullorum cytolethal distending 
toxin (CDT) through the NF-κβ pathway, but a CDT-independent IL-8 induction 
was also reported in the same study. As H. pullorum LPS has the highest biological 
activity within the Helicobacter genus, and promoted NF-κβ activation, those 
authors suggested that in addition to CDT, the IL-8 expression could also be 
promoted by the LPS of H. pullorum (9, 10). Therefore, the activation of 
macrophages by H. pullorum may involve NF-kB pathway activation through H.
pullorum CDT activity and by interaction of LPS with the host cells. In contrast to 
the highly reactive LPS of H. pullorum and other Gram-negative bacteria such as E. 
coli and S. typhimurium (11), H. pylori LPS has a remarkably low reactivity, which 
seem to be used as a strategy to avoid macrophage activation (see Chapter 2).  
The effect of NO in H. pullorum viability and cell morphology was 
analysed. H. pullorum was shown to be susceptible to the in vitro nitrosative stress 
generated by several nitrosative stress agents in a concentration-dependent manner, 
as also observed for other human pathogens such as H. pylori (12). H. pullorum 
susceptibility to NO was also dependent on the bacterial growth phase at which the 
stress was applied, with H. pullorum cells being substantially more susceptible at 
the earlier exponential than at the exponential and stationary phases. H. pylori also 
responds differently to environmental changes on a growth phase dependent 
manner. For example, while H. pylori exponential growing cells were rapidly killed 
by iron depletion, the stationary-phase cells showed a remarkable ability to survive. 
Moreover, under iron starvation H. pylori exhibited a gene transcription pattern that 





Exposure of H. pullorum to nitrosative stress generated by spermine-NONOate (0-
0.1 mM for 24 h), did not result in the formation of coccoid cells. Several studies 
reported that some Helicobacter species change their morphology from a bacillary 
to a coccoid form, in response stresses, such as acid pH, temperature, nutritional 
starvation, and oxidative and nitrosative stress. H. pylori NCTC 11637 is rapidly 
converted to a coccoid morphology under low concentrations of peroxynitrite (14). 
Also, Cole and co-workers reported that GSNO causes th  conversion of H. pylori 
SD14 bacilli to a coccoid morphology at a concentration of 0.1 mM for 24 h, or 
after 4 h of incubation at a concentration of 3 mM (15). However, for H. pylori 
26695 and B128 strains, Saraiva and co-workers report d that GSNO (200 µM) did 
not induced morphological changes (16). Therefore, th  morphological conversion 
of H. pylori in response to nitrosative stress seems to be depen nt on the strain.  
Although the formation of H. pullorum coccoid cells was not observed, exposure to 
nitrosative stress induced a decrease in the average length of the cells and the 
formation of some “U”, “V” and “S” cell shapes, which may signify the presence of 
some H. pullorum cells in an earlier stage of cocci conversion. In other studies, 
“U”, “V” and “S” H. pylori cell shapes were described as intermediate forms that 
occur before the complete cellular conversion from bacilli to cocci (17, 18). 
Previous work showed that H. pullorum i) is able to invade human 
intestinal cells (19), ii) promotes cellular toxicity through the expression of CDT 
(20), and iii) induce an inflammatory response in epithelial human cell lines. This 
work further informed that H. pullorum triggers inflammation in the host and that is 
susceptibility to high levels of NO.  
 
7.2 Defence mechanisms of Helicobacter species against nitrosative stress 
In spite of the data demonstrating the capacity of H. pullorum to activate 
the innate immunity and its susceptibility to nitrosative stress ((8, 9), Chapter VI), 
until now, no mechanisms of protection against nitrosative stress were studied in H. 
pullorum. The genome of H. pullorum has two haemoglobin-like genes 
(HPMG_00954 and HPMG_00979), which products belong to the single domain 











haemoglobin and to the group III truncated haemoglobin families, in contrast of 
what is observed for H. pylori. These proteins present a high degree of sequence 
similarity to the C. jejuni single domain (Cgb) and truncated (Ctb) haemoglobins. 
The single domain haemoglobin of H. pullorum (SdHb) was shown to be induced 
by GSNO, restore the growth of an E. coli mutant lacking the NO-detoxifying 
flavohaemoglobin (Hmp), and protect bacterial growth from GSNO (Chapter VI). 
A similar phenotype was observed for the Cgb of C. jejuni (see Chapter III, section 
3.4.2).  
The similar functions observed for H. pullorum SdHb and C. jejuni Cgb are in 
accordance with their high degree of amino acid sequence similarity. Although also 
sharing a high degree of similarity with C. jejuni Cgb and H. pullorum SdHb, the 
single domain haemoglobin of Vitreoscilla (Vhb) seems to have a major role in 
oxygen transport and oxidative stress protection instead of being involved in 
nitrosative stress defence (Chapter III, section 3.4).  
In agreement with their high sequence similarity, both H. pullorum and C. jejuni 
truncated haemoglobins have a similar phenotype in the presence of NO. As for C. 
jejuni Ctb, the gene encoding the H. pullorum truncated haemoglobin was up-
regulated by GSNO, and upon expression restored the GSNO sensitive phenotype 
of an E. coli hmp mutant strain. Nevertheless, the mutant strains were not sensitive 
to GSNO. Less conflicting results were obtained for the group I M. tuberculosis 
HbN, and the group II M. leprae HbO and P. haloplanktis Ph-2/2HbO truncated 
haemoglobins, which were demonstrated to detoxify NO, or peroxynitrite in the 
case of Ph-2/2HbO, and to protect against nitrosative stress (see Chapter III, section 
3.4). Our in vivo results corroborate the in vitro phenotype of the H. pullorum 
haemoglobins mutants demonstrated in the GSNO growth susceptibility assays, as 
the H. pullorum SdHb but not the TrHb, contributes to the ability of H. pullorum to 
survive to macrophage killing. Altogether, these observations suggest a primary 
role of the single domain haemoglobin relatively to the truncated haemoglobin in 
the defence of H. pullorum and C. jejuni against nitrosative stress.  
H. pullorum has three peroxiredoxins-like sequences belonging to the Bcp/PrxQ 





as is observed for H. pylori and C. jejuni, herein named H. pullorum Prx1, Prx2 and 
Prx3, respectively. H. pullorum Prx1 has peroxynitrite activity, which value is 
within the range of values reported for other bacterial peroxiredoxins (Table 7.1). 
To date, no other bacterial peroxiredoxin belonging to the same family was reported 
to detoxify peroxynitrite. A redundant role of peroxiredoxins in stress defence due 
to its overlapping substrate specificities was previously reported in other organisms. 
Since H. pullorum has three peroxiredoxins and all three showed activity owards 
peroxynitrite, it is possible that the activity of Prx2 and Prx3 may compensate for 
the loss of prx1, thus explaining the lack of H. pullorum prx1 phenotype towards 
peroxynitrite. It was previously described that E. coli and H. pylori Bcp, the protein 
homolog of H. pullorum Prx1, detoxifies hydrogen peroxide, and that E. coli bcp 
protected against hydrogen peroxide. Contrary to E. coli bcp, H. pullorum prx1 was 
not induced by hydrogen peroxide, and did not confer growth protection from 
hydrogen peroxide. It is possible that the phenotype is masked by the activity of the 
two other peroxiredoxins, or even of enzymes, such as catalase that may 
compensate the lack of prx1.  
  






















Prx1/AhpC 1.2 × 106 pH 6.8; 25 ºC (21) 
Helicobacter pullorum 
Prx2 





Prx1/AhpC 1.3 × 106 pH 6.8; 25 ºC (21) 
Salmonella typhimurium 
AhpC 
Prx1/AhpC 1.5 × 106 pH 6.8; 25 ºC (21) 
Human Prx2 Prx1/AhpC 1.4 × 107 pH 7.4; 25 ºC (22) 
Plasmodium falciparum 
TPx1 
Prx1/AhpC 1.0 × 106 pH 7.4; 37 ºC (23) 
Sacharomyces cerevisiae 
Tsa1 
Prx1/AhpC 7.4 × 105 pH 7.4; 25 ºC (24) 
Sacharomyces cerevisiae 
Tsa2 
Prx1/AhpC 5.1 × 105 pH 7.4; 25 ºC (24) 
Trypanosoma brucei 
TXNPx 
Prx1/AhpC 9.0 × 105 pH 7.4; 37 ºC (25) 
Trypanosoma cruzi 
TXNPx 
Prx1/AhpC 7.2 × 105 pH 7.4; 37 ºC (25) 
Giardia intestinalis Prx1a Prx1/AhpC 4.0 × 105 pH 7.0; 4 ºC (26) 
Giardia intestinalis 
Prx1b 
Prx1/AhpC 2.0 × 105 pH 7.0; 4 ºC (26) 
Helicobacter pullorum 
Prx1 
Bcp/PrxQ 5.0 x 105  pH 7.0; 5 ºC 
This 
study 
Xylella fastidiosa PrxQ Bcp/PrxQ 1.0 × 106 pH 7.4; 37 ºC (27) 
Helicobacter pullorum 
Prx3 





TPx 1.5 × 107 pH 7.4; 25 ºC (28) 
Human Prx5 Prx5 7.0 × 107 pH 7.8; 25 ºC (29) 
M. tuberculosis AhpE AhpE 1.9 × 107 pH 7.4; 25 ºC (30) 
Table adapted from (31) 
 
H. pullorum prx2 seems to be an essential gene for the survival of the bacterium 
under the tested in vitro conditions. Interestingly, in H. pylori the ahpC is a key 
gene, as the H. pylori ahpC mutants were only obtained under extremely low 
oxygen conditions, showed impaired ability to growth under normal microaerobic 





the correspondent gene mutations in other bacteria. H. pullorum prx2 was shown to 
be up-regulated in response to peroxynitrite, and like its AhpC homolog in S. 
typhimurium, M. tuberculosis, and H. pylori, has peroxynitrite activity. The activity 
of Prx2 towards peroxynitrite is, however, slightly lower than that reported for 
other bacterial homologs (Table 7.1). 
The H. pullorum prx3 mutant strain was not possible to be isolated, in co trast to 
what was previously observed for the prx3 homologs in H. pylori and in other 
bacteria. Among the three H. pullorum peroxiredoxins, Prx3 exhibited the highest 
peroxynitrite activity, which indicates an importan role of Prx3 in peroxynitrite 
detoxification. Also, H. pullorum Prx3 showed a similar value of peroxynitrite 
activity than the one previously observed for its M. tuberculosis Tpx homolog 
(Table 7.1). H. pullorum Prx3 is up-regulated by hydrogen peroxide stress, which 
indicates a role of this protein in protection against hydrogen peroxide stress. In 
accordance, E. coli and H. pylori Tpx were previously reported to reduce hydrogen 
peroxide and to confer protection against hydrogen p roxide (see Chapter 3, section 
3.5).  
Figure 7.1 summarizes the studied systems that protect H. pullorum against host 
antimicrobials.  
 
Figure 7.1 Schematic representation of the H. pullorum defences against nitrosative 

























pullorum cells from nitrosative injury through detoxification of the nitric oxide 
(NO) produced by iNOS or released from other reactive nitrogen species, such as 
nitrosoglutathione (GSNO). The H. pullorum truncated haemoglobin (TrHb) seems 
also to be involved in NO protection, by a mechanism similar to that of SdHb. H. 
pullorum uses three peroxiredoxins, (Prx1, Prx2 and Prx3, to convert peroxynitrite 
(ONOO-) to form nitrite (NO2-) and water (H2O). The scavenging enzymes are 
represented in green and the damaging compounds are repr sented in red. 
Superoxide: O2-; phagocyte NADPH oxidase: NOX. 
 
Concerning H. pylori, this bacterium was reported to have two 
nitroreductases, RdxA and FrxA that until now have be n described as involved in 
metronidazole activation. Also, mutations in these nzymes have been associated 
with H. pylori resistance to metronidazole (32). In this work, a new function for one 
of the H. pylori nitroreductases as a defence mechanism against nitrosat ve stress 
nitrosative stress was revealed. The biochemical and kinetic characterization of the 
protein FrxA proved that, apparently, is a typical nitroreductase, binding FMN and 
reducing a large range of nitro-substituted compounds. The fact that the enzyme is 
active for nitrocompounds under aerobic conditions, showed that FrxA belongs to 
the family of the oxygen-insensitive or type I nitroreductases (see Chapter 3, 
section 3.3). H. pylori FrxA reduces nitrofurantoin and nitrofurazone, with activity 
values that are within the range of activities usually observed for bacterial 
nitroreductases (Table 7.2). Sisson and co-workers showed that overexpression of 
H. pylori frxA conferred nitrofurantoin and nitrofurazone reductase activity to a 
nitroreductase-deleted E. coli strain, and that inactivation of frxA increased the 
resistance of H. pylori to nitrofurantoin. The activity toward nitrofurans herein 






Table 7.2 Activity for nitrofurantoin and nitrofurazone reduction by bacterial 
nitroreductases 
 Activity (μmol·min-1·mg-1 of protein) 
Organism Enzyme Nitrofurantoin Nitrofurazone  Metronidazole References 
Bacillus 
subtillis 
NfrA1 ND 97 ND (33) 
Escherichia 
coli 
NfsA 82 73 ND (34) 
NfsB 21* 13* ND (35) 
Helicobacter 
pylori 
RdxA 0.0010 0.0019 9.0 (36, 37) 
FrxA 
2.0 0.5 < 0.0002 (37) 
0.5 1.1 0.6 This study 
Staphylococcus 
aureus 
NfrA 15 20 ND (38) 
NtrA 14 15 ND (39) 
* NADH was used as electron donor instead of NADPH. ND - not determined. 
Table adapted from (40). 
 
The expression of FrxA in cells of E. coli promoted the activation of metronidazole; 
however, the isolated FrxA exhibited no metronidazole reductase activity (37). We 
showed that FrxA reduces metronidazole, indicating he in vivo involvement of H. 
pylori FrxA in metronidazole activation, which is consistent with the presence of 
mutations in frxA of metronidazole resistant H. pylori strains. Nevertheless, the 
metronidazole activity of FrxA is approximately 10-fold lower comparatively to 
RdxA (Table 7.2), which corroborates the much higher fr quency of resistance to 
metronidazole in H. pylori strains containing rdxA mutations.  
In bacteria, the toxic compound nitrosoglutathione (GSNO), that results 
from the reaction between the scavenging tripeptide glutathione and NO, promotes 
nitrosylation of the cysteine residues of proteins thus compromising protein 
function and bacterial survival (see Chapter I, section 1.3). Enzymes such as the E. 
coli glutathione-dependent formaldehyde dehydrogenase (FALDH) and the 
nitroreductase NtrA of S. aureus were previously shown to reduce GSNO and 
protect the strain from GSNO toxicity (39).  
Besides the typical capacity of nitroreductases to reduce nitrocompounds, H pylori 
FrxA was also shown able to reduce the toxic S-nitrosothiol compounds GSNO, S-
nitrosocysteine and 3-nitrotyrosine, the later a product of tyrosine nitration that 
usually occurs in the tyrosine residues of proteins exposed to nitrosative stress. 











From all the substrates tested in our study, FrxA showed the lowest affinity for 3-
nitrotyrosine and the highest affinity for the S-nitrosothiols (Chapter IV, Table 4.2). 
When compared with other microbial GSNO reductases, uch as the S. aureus NtrA 
(39) and E. coli FALDH (41), FrxA has the highest affinity for GSNO, and in 
contrast with S. aureus NtrA, FrxA exhibits a higher efficiency towards GSNO than 
for nitrocompounds. All these observations lead us to conclude that the reduction of 
S-nitrosothiols may be the main function of FrxA. Moreover, as S. aureus NtrA and 
E. coli FALDH were not shown to metabolize S-nitrosocysteine, the capacity to 
reduce both the S-nitrosothiol compounds S-nitrosocy teine and GSNO seems to be 
a particular feature of H pylori FrxA. 
The transcription of rxA was induced in response to nitrosative stress generated by 
GSNO and spermine-NONOate. FrxA was shown to afford p otection against 
nitrosative stress, as the deletion of frxA lead to a dramatic decrease in the GSNO 
reductase activity of H. pylori cells, and conferred in vitro growth resistance to 
GSNO. Similar observations were reported for S. cerevisiae (41), Haemophilus 
influenzae (42) and S. pneumoniae (43) FALDH mutants. Also, the S. aureus NtrA 
mutant strain was shown to be more sensitive to GSNO (39). The herein reported 
ability of FrxA to protect against nitrosative stress and to confer virulence upon 
mice infection is possibly related to the enzyme capa ity to detoxify S-nitrosothiols. 
As some proteins that are essential for H. pylori in vivo survival and pathogenesis, 
such as urease and AhpC, were reported to be S-nitrosylated and inactivated upon 
exposure to nitrosative stress (12), the enzyme FrxA may constitute an important 
detoxifying mechanism in this bacterium. Similarly to FrxA, the NorH (44) and 
AhpC (45) enzymes, that detoxify NO and peroxynitrite, respectively, contribute to 
the H. pylori successful colonization of mice stomach. Moreover, NorH afforded 
bacterial protection against iNOS-mediated macrophage killing. Therefore, NorH 
and FrxA constitute important enzymes for the H. pylori resistance to nitrosative 
stress and virulence.  
Altogether this work unveiled some of the enzymes that permit 
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